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Abstract 
In an effort to dissect the mechanism of interaction of IDPs, in this thesis we focus on 
Prothymosin α (ProTα) and nuclear factor erythroid 2-related factor 2 (Nrf2), intrinsically 
disordered proteins, in the Nrf2 mediated oxidative stress response. Kelch-like ECH-
associated protein 1 (Keap1) is an inhibitor of Nrf2, a key transcription factor of 
cytoprotective genes. Under unstressed conditions, Keap1 interacts with Nrf2 in the 
cytoplasm via its Kelch domain and suppresses Nrf2 activity. During oxidative stress, Nrf2 is 
released from Keap1 and is shuttled to the nucleus, where it initiates pro cell survival gene 
transcription.   ProTα also interacts with the Kelch domain and mediates the import of Keap1 
into the nucleus to inhibit Nrf2 activity.  
To gain a molecular basis understanding of the oxidative stress response mechanism, 
the interaction between ProTα and the Kelch domain of Keap1 has been delineated using 
nuclear magnetic resonance spectroscopy (NMR), isothermal titration calorimetry (ITC), 
peptide array analysis, and site-directed mutagenesis.  The results revealed that ProTα retains 
a high level of flexibility, even in the Kelch-bound state.  Mutational analysis pinpointed that 
the region 38NANEENGE45 of ProTα is crucial for the interaction with the Kelch domain, 
while the flanking residues play relatively minor roles in the affinity of binding.  
A high yield purification protocol with complete backbone NMR resonance 
assignment lays the foundation for structural and biophysical studies of the full length-Neh2 
domain of the human Nrf2.  In this work the full-length Neh2 domain was used to investigate 
binding to Kelch in the presence of cancer causing somatic mutations. 
 iii 
 
To understand the mechanistic links between Keap1 mutations and cancer 
pathogenesis, the molecular effects of a series of mutations (G333C, G364C, G379D, G350S, 
R413L, R415G, A427V, G430C, and G476R on the structural and target recognition 
properties of Keap1 are investigated.  These mutations are found to exert differential effects 
on the protein stability and target binding. Together with the proposed Hinge-and-Latch 
mechanism of Nrf2/Keap1 binding, these results provide important insight into the molecular 
impact of different somatic mutations on Keap1’s function as an Nrf2 repressor.  
 
Keywords: oxidative stress response; Nrf2; Prothymosin α; Keap1; intrinsically  disordered 
proteins, nuclear magnetic resonance; protein dynamics; protein-protein interactions; 
isothermal titration calorimetry 
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Chapter 1  
 Introduction 1
 
 Intrinsically Disordered Proteins 1.1
Intrinsically disordered proteins (IDPs) are functional proteins that lack a well-
defined three dimensional structure (Dunker, Lawson et al. 2001; Garza, Ahmad et al. 
2009).  The discovery of these unstructured proteins challenged the long accepted protein 
structure-function paradigm, which states that the three dimensional structure is a pre-
requisite for a protein to perform its biological activity.  While there is no doubt that for 
some proteins structure and function are related, it is now widely accepted that many 
biologically active proteins do not conform to a well folded structure.  These disordered 
proteins generally lack sufficient hydrophobic residues required for a protein to form a 
three-dimensional organized entity.  In fact, it has been reported that on average typical 
disordered proteins have a lower composition of Phe, Ile, Trp, Tyr , Cys, Val and Leu 
residues (Romero, Obradovic et al. 2001; Dunker, Brown et al. 2002a; Vucetic, Brown et 
al. 2003).  These proteins are found to be rich in prolines and charged residues, especially 
Lys, Glu, and Arg amino acids (Romero, Obradovic et al. 2001; Dunker, Brown et al. 
2002a; Vucetic, Brown et al. 2003).  A few examples of disordered proteins with these 
properties include Prothymosin α, α-synuclein, non-Aβ component of AD amyloid 
precursor protein (NACP), and Apo-cytochrome c (Stellwagen, Rysavy et al. 1972; Gast, 
Damaschun et al. 1995; Weinreb, Zhen et al. 1996; Uversky, Gillespie et al. 2000a).   
Because of differential amino acid composition of ordered and disordered proteins, many 
predictors have been developed that allow determining unstructured proteins/regions with 
2 
 
 
high accuracy.  Some of these bioinformatics programs used for protein structural 
analysis are PONDR, GLOBPLOT, DIOPRED2 and DisEMBLE (Romero, Obradovic et 
al. 1997; Uversky, Gillespie et al. 2000a; Dunker, Brown et al. 2002b; Linding, Russell et 
al. 2003; Ward, Sodhi et al. 2004).   
Structural analyses of disordered proteins/domains have revealed that many IDPs 
do not behave as true random coils, rather these proteins span several conformations that 
interconvert and contain local elements of secondary structure (Dyson and Wright 2002; 
Dyson and Wright 2005).   The backbone bonds and angles of such proteins fluctuate 
over time, with no definite values, thus, resulting in ensembles of various structures, 
referred to as “protein clouds” (Dunker and Uversky 2010).   Extended regions, regions 
with residual secondary structure, domains with secondary structure, and domains with 
poorly packed side chains have all been observed in many proteins lacking structure 
(Uversky 2011; Uversky 2013a).  The SH3 domain of the Drosophila signal transduction 
drk protein illustrates this phenomenon best as it exists between folded and unfolded 
states in aqueous buffer and experiences multiple conformations in the unfolded state 
(Zhang and Forman-Kay 1995; Choy and Forman-Kay 2001). Similarly, FG-
nucleoporins contain long disordered regions that adopt different conformations (from a 
molten globule to a fully extended-coil) under physiological conditions (Milles and 
Lemke 2011).   
 Intrinsic disorder is not just restricted to full-length proteins; in fact, unstructured 
regions are part of many well folded proteins and are associated with crucial biological 
functions (Wright and Dyson 1999).  Analyses of genome sequences using disorder 
predictors have identified about 35-51% of proteins in eukaryote that contain disordered 
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regions of 40 or more consecutive residues (Dunker, Obradovic et al. 2000).  41% of 
human plasma membrane proteins are reported to contain ID regions of 30 or more 
residues (Minezaki, Homma et al. 2007).  An example of a protein with ordered and 
disordered regions is p53.  It is a structured homo-tetramer, the core domains of which 
are linked by the disordered N and C-terminal domains, responsible for transcriptional 
activation and regulation, respectively, (Bell, Klein et al. 2002; Dawson, Muller et al. 
2003).   
The prevalence of IDPs and intrinsically disordered regions (IDPRs) and their 
significance in cellular tasks necessitated revision of the structure-function paradigm to 
include these proteins and regions (Uversky 2002). The new view describing protein 
structure and function includes proteins with well folded structure, pre-molten globules, 
molten globules, and native coils; and is referred by the “The Protein Quartet model,” 
(Figure 1.1) (Uversky 2002; Uversky 2013a).  According to this new model, biological 
functions can be performed by proteins in any of the four conformations and under the 
course of their biological activity these proteins can transition between various structural 
rearrangements (Uversky 2013a).   For example, the 50S ribosomal proteins, L22 and 
L27, and 30S ribosomal protein S19 are unfolded in solution; however, they exist as well-
folded rigid structures in the functional ribosomes (Venyaminov, Gudkov et al. 1981; 
Yusupov, Yusupova et al. 2001; Uversky 2002).  Additionally, Prothymosin α is a highly 
flexible protein but transforms into a compact structure in the presence of zinc ions; this 
transition in structure facilitates its interaction with targets (Uversky, Gillespie et al. 
2000b; Yi, Boys et al. 2007).  
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Figure 1.1. The Protein Quartet Model. This new model takes into 
account protein function from any of the four conformations (Ordered, 
pre-molten globule, molten globule, and random coil) and proteins can 
switch conformations between any of these four states (figure adapted 
from Uversky 2002). 
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The discovery of IDPs raises the question as how these proteins avoid the cellular 
degradation machinery? Hochstrasser explains that proteolytic degradation is tightly 
regulated in eukaryotic cells and is only initiated in when a protein undergoes 
ubiquitination (Hochstrasser 1996).  In this case, unfolded proteins can carry out their 
specific roles but experience rapid turnover (Wright and Dyson 1999).  Comprehensive 
analyses of IDP regulation inside the cell has shown that mRNA encoding IDPs have 
higher decay rates, and these proteins are modulated by post-translational modifications 
to have shorter half-lives (Gsponer, Futschik et al. 2008; Uversky 2011).  It has also been 
suggested that evolution in sequence allows disordered proteins to perhaps avoid the 
unfolded protein response altogether (Uversky and Dunker 2013b).    
1.1.1  IDP Characterization  
 The lack of a well-defined structure complicates structural studies of IDPs.  In 
fact, since IDPs do not conform to a true random coil, a stable unique structure is not 
attainable for an IDP of interest.  The aim of IDP structural studies is to determine 
conformational propensities, transient long range interactions and regions of restricted or 
high mobility.  Such information can always be beneficial in determining the biological 
function of the protein under study (Eliezer 2007).  Several methods such as X-ray 
crystallography, Circular Dichroism (CD) spectropolarimetry, protease digestion, small 
angle X-ray scattering (SAXS), disorder predictors (listed above), and Nuclear Magnetic 
Resonance (NMR) spectroscopy can be used in characterizing intrinsic disorder in a 
protein (Dunker, Lawson et al. 2001; Uversky and Longhi 2011).  Crystallography, CD, 
and other methods only indicate the presence of disorder in a protein.  For example, in 
crystallography, a disordered region is indicated by missing electron density.  A 
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downside to identifying disorder by this method is that whether the missing region is due 
to intrinsic disorder in a protein or a result of experimental error cannot be known 
without performing further experiments (Dunker, Lawson et al. 2001).  Similarly, CD 
provides semi-quantitative data allowing to distinguish between ordered, molten globule 
and random coil structures (Dunker, Lawson et al. 2001).  It cannot provide residue 
specific information with regards to what regions of the protein are ordered and 
disordered.  NMR on the other hand can detect structure, provides motional information 
per residue, and can be used to map the binding interface of IDPs with targets (Choy and 
Forman-Kay 2001; Paci, Vendruscolo et al. 2002; Juneja and Udgaonkar 2003; Dyson 
and Wright 2004; Kay 2005).   
1.1.2 IDP Functions 
The structural flexibility that arises due to intrinsic disorder in proteins plays a 
significant functional role in biological processes.  The vast functions of IDPs include 
regulation of transcription and translation, cellular signal transduction, the storage of 
small molecules, and membrane transport (Dunker, Lawson et al. 2001; Dunker, Cortese 
et al. 2005; Garza, Ahmad et al. 2009).  A well characterized example of disordered 
transcriptional activation domain is the kinase-inducible activation (KID) domain of 
CREB, which interacts with the KIX domain of CBP (Radhakrishnan, Perez-Alvarado et 
al. 1998; Dunker, Oldfield et al. 2008).  Similarly, in the eukaryotic translation initiation 
pathway the eIF4G in the large multi subunit protein-RNA complex, required for 
recruitment of the ribosomes, is devoid of structure in the absence of its target (Hershey, 
McWhirter et al. 1999; Uversky 2002).    
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Intrinsic disorder is also found within molecular chaperones, proteins that assist 
RNA or other misfolded proteins in attaining their ordered structure (Todd, Lorimer et al. 
1996; Tompa and Csermely 2004).  The disorder segments in chaperones are believed to 
help adopt well folded structures by either loosening the unfolded/misfolded structure or 
function as recognition elements (Tompa and Csermely 2004).  The A1 protein of 
heteronuclear ribonucleoprotein (hnRNP) has a disordered Gly-rich C-terminal domain 
that is involved in renaturation and facilitates assembly of the RNP complex (Pontius and 
Berg 1990).  Another chaperone with structural disorder is the p23, a co-chaperone of 
Hsp90 (Weikl, Abelmann et al. 1999).  
Structural adaptability of IDPs allows them to interact with multiple partners and 
perform various functions, thus classifying IDPs as moonlighting proteins (Tompa, Szasz 
et al. 2005).  Moonlighting is the ability of a protein to perform a number of unrelated 
tasks (Jeffery 1999; Jeffery 2004).  Examples of IDPs involved in moonlighting are the, 
p21Cip1/WAF1 and p27, IDPs that regulate cell proliferation through activating or inhibiting 
cyclin dependent kinases (Cheng, Olivier et al. 1999; Olashaw, Bagui et al. 2004; 
Dunker, Oldfield et al. 2008).  Likewise, p53, which is a tumor suppressor, is involved in 
gene expression, apoptosis induction, DNA repair, and response to cellular stress (Cheng, 
LeGall et al. 2006).  
1.1.3  IDP Advantages 
Although flexibility is observed in all states of protein conformation, the extreme 
dynamic nature of IDPs is more advantageous than folded and molten globular proteins 
in carrying out certain cellular functions (Mittag, Kay et al. 2009).   A detailed analysis of 
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IDP functional advantages is recently published by Uversky (Uversky 2013a).  Some 
functional advantages of IDPs include the presence of a large interactive surface, 
promoting fast and easy recognition of a binding partner (Dunker, Lawson et al. 2001; 
Dyson and Wright 2005).  The large surface area facilitates specific binding and allows 
for easy dissociation from partners when required (Dunker, Lawson et al. 2001; Dyson 
and Wright 2005).  This type of behavior is observed in regulatory signaling proteins 
which form protein complexes rapidly to target specific gene expression and have high 
turnover rate ensuring the proteins are not present for a long period of time (Sugase, 
Dyson et al. 2007).  
Due to lower steric hindrance compared to natively structured proteins, IDPs 
often behave as hub proteins, proteins that are involved in a large number of distinct 
interactions (Dunker, Cortese et al. 2005).  This property of IDPs allows them to take part 
in multiple biological processes.  For example, p53 uses the flexibility in its disordered 
regions to bind to multiple targets (Oldfield, Meng et al. 2008).  More so, it adopts 
different conformations upon interaction with different partners, allowing the protein to 
take part in many cellular functions some of which are stated earlier (Cheng, LeGall et al. 
2006; Oldfield, Meng et al. 2008).  
IDPs are solvent exposed, thus, posttranslational modification sites (PTMs) are a 
common occurrence in IDP sequences (Dunker, Brown et al. 2002a; Dunker, Brown et al. 
2002b; Xie, Vucetic et al. 2007).  Several types of post-translational modifications that 
can include acetylation, ADP-ribosylation, ubiquitination, prenylation, carboxylation, 
glycosylation, methylation, ubiquitination, and SUMOylation are found within disordered 
regions (Iakoucheva, Radivojac et al. 2004; Radivojac, Iakoucheva et al. 2007; Xie, 
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Vucetic et al. 2007).  These modifications are usually reversible and are associated with 
signaling and regulation (Xie, Vucetic et al. 2007).  An illustrative example is the p53 
protein, in which most known PTM sites occur within the disordered N and C terminal 
domains, and modifications of these sites determine the function, localization and 
turnover rate of p53 (Bode and Dong 2004).  
1.1.4 IDPs in Disease 
IDPs are involved in many diverse biological roles, therefore, it is apparent that 
malfunction of these proteins can play a vital role in various health disorders.  Causes 
leading to aberrant function of these proteins rises due to misfolding of partially folded 
regions, point mutations, exposure to internal or external toxins, impaired post-
translational modifications, impaired trafficking, loss of binding partner, oxidative 
damage or an increased chance of degradation (Dunker, Oldfield et al. 2008).  IDPs are 
found in several pathological conditions, such as, cardiovascular diseases, diabetes, 
cancer, and neurodegenerative disorders (Dunker, Oldfield et al. 2008). Sequence 
analyses of proteins by disorder predictors have shown approximately 79% and 61% of 
cancer and cardiovascular associated proteins, respectively, to contain regions of disorder 
(Iakoucheva, Brown et al. 2002; Uversky, Oldfield et al. 2008).  This high prevalence of 
IDPs in human diseases has given rise to the ‘disorder in disorder’ concept, referred to as 
the D2 concept (Uversky, Oldfield et al. 2008).  Some examples illustrating the D2 
concept include the  Aβ-peptides in Alzheimer’s disease and α-synuclein in Parkinson’s 
disease, which are in a partially folded states pre-amyloid formation (Tompa 2009; 
Frimpong, Abzalimov et al. 2010), and myelin basic protein (MBP), dysregulations of 
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which are linked to human autoimmune demyelinating disease multiple sclerosis 
(Homchaudhuri, De Avila et al. 2010).  
1.1.5 IDPs as potential drug targets 
The abundance of IDPs in cell signaling and regulatory roles and their frequency 
in human pathogenesis makes them unique drug targets.  However traditional drug 
design, which relies on well-defined structures of proteins/regions, is an ineffective 
means to target IDPs in health disorders (Cheng, LeGall et al. 2006).  In order to target 
IDPs, new approaches, accounting for the lack of structure in IDPs need to be considered 
(Cheng, LeGall et al. 2006).  Two approaches have been put forward to target IDPs in 
disease.  The first method takes into account the ability of IDPs to fold upon target 
binding (Cheng, LeGall et al. 2006).  The drug target mimics the bound state ordered 
structure of the targeted IDP and competes for interaction with the binding partner.  The 
successful design of ‘Nutlins’ targeting the p53-Mdm2 interaction is a great example of 
targeting disordered regions with small molecules in cancer prevention (Vassilev 2004; 
Vassilev, Vu et al. 2004; Cheng, LeGall et al. 2006; Uversky 2013a).  The ‘Nutlins’ 
mimic the bound state structure of the disordered N-terminal region of p53, which forms 
a helix upon binding to Mdm2,  and binds to target with higher affinity.  Oral treatment 
of mice with ‘nutlins’ resulted in 90% inhibition of tumor growth (Klein and Vassilev 
2004; Vassilev 2004; Vassilev, Vu et al. 2004).   
An alternative practical method to block IDP protein-protein interaction is to 
target IDP binding sites with small molecules (Cheng, LeGall et al. 2006).  This method 
has been effectively applied to the transcription factor c-Myc, which forms a complex 
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with its heterodimerization partner Max, and is associated with various types of cancers 
(Hammoudeh, Follis et al. 2009; Uversky 2013a).  The small molecule upon complex 
formation induces conformational changes in the binding site of c-Myc and prevents its 
interaction with Max (Hammoudeh, Follis et al. 2009).  This technique can also be 
applied to disordered proteins that experience “functional misfolding.”  That is, some 
disordered proteins adopt non-native conformations that result in protein-protein 
interactions and consequently unwanted cellular activity  (Uversky 2012).  Binding of 
small molecules to these misfolded regions can stabilize these states in IDPs, therefore, 
preventing the occurrence of non-native interactions (Uversky 2012; Uversky 2013a).  
1.1.6 Functional Related Folding of IDPs 
Structural studies of IDPs in protein-protein interaction has established that a 
coupled folding process occurs when an IDP interacts with a globular protein or another 
IDP (Wright and Dyson 2009).  As stated formerly, some disordered proteins are 
completely devoid of structure under physiological conditions, while others contain 
residual structure or short amphipathic motifs called ‘molecular recognition features’, 
more commonly known as MoRFs (Oldfield, Cheng et al. 2005; Mohan, Oldfield et al. 
2006).  These MoRFs consist of approximately 20 residues and are proposed to function 
in signaling and recognition of protein or nucleic acid partners (Oldfield, Cheng et al. 
2005).  Alpha-helix, β, irregular, and complex MoRFs are recognized and these short 
disordered segments are observed to undergo a disorder-to-order transition upon target 
binding (Oldfield, Cheng et al. 2005; Vacic, Oldfield et al. 2007).   The coupled folding  
results in stable formation of helices, β-strands or other irregular structures in target 
bound state (Vacic, Oldfield et al. 2007).  The C-terminal domain of the p21 protein 
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contains a β-MoRF, which interacts with the proliferating cell nuclear antigen (PCNA) 
and blocks DNA replication (Gulbis, Kelman et al. 1996; Vacic, Oldfield et al. 2007).  
Another well characterized example of a protein that undergoes transition to an ordered 
state is that of the kinase-inducible transcriptional-activation domain (KID) of CREB 
mentioned earlier.  The KID domain exists as a disordered region both in the full length 
and in isolation (Dyson and Wright 2005).  Upon binding to its target, the KIX domain of 
CREB-binding protein (CBP), adopts a helix-turn-helix conformation (Radhakrishnan, 
Perez-Alvarado et al. 1998; Dyson and Wright 2005; Sugase, Dyson et al. 2007).  
Another example that best illustrates a protein that can bind to multiple partners and 
adopt different structure is of p53, which can form a helix, a sheet, and two different 
irregular structures when binding to four different partners (Dunker, Oldfield et al. 2008).   
1.1.7 IDPs and Fuzzy Complexes 
The couple folding of IDPs revived the classical structure-function paradigm, 
suggesting that upon binding IDPs behaved as “traditional” folded proteins (Dunker, 
Oldfield et al. 2008).  Detailed analyses of IDPs in complex states recognized that 
coupled folding is not applicable to all IDPs.  Several examples of unstructured proteins 
in ligand-bound state have made it evident that disorder can exist even in complex states 
and has important implications in cellular functions (Tompa and Fuxreiter 2008). The 
term “fuzziness” has been suggested by Tompa et al. to emphasize the importance of this 
structural obscurity that rises in protein-protein interactions.  Structural fuzziness in the 
ligand bound state has been categorized into five distinct models; polymorphic, clamp, 
flanking, random coil, or the sequence independent model (Tompa and Fuxreiter 2008).   
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 In polymorphic complexes, single or multiple well-defined conformations are 
observed in the target-bound states and these structures can be resolved (Tompa and 
Fuxreiter 2008).  Interestingly, these multiple conformations are able to perform discrete 
biological functions.  Fox example, the human pancreatic ribonuclease (RNase 1), which 
is responsible for many cellular functions including cleavage of single stranded RNA, 
double stranded RNA and double stranded RNA-DNA hybrids. Several conformations 
are observed for the loop regions, involved in various enzymatic activities, and for side 
chains of critical residues on the surface, implicated in membrane binding, translocation, 
and RNA hydrolysis (Kover, Bruix et al. 2008).  Similarly, depending on the binding 
affinity, disordered loop of dihydropyridine receptor (DHPR) binds ryanodine receptor 
(RyR) and can result in activation or inhibition of the RyR channel opening (Haarmann, 
Green et al. 2003; Fuxreiter and Tompa 2012).  It has been implied that these different 
activities result from different interactions between the disordered loop and gating 
residues of the RyR channel (Fuxreiter and Tompa 2012). 
The clamp model describes a protein with two ordered regions connected by a 
segment or linker that remains disordered in the complex state (Tompa and Fuxreiter 
2008; Fuxreiter and Tompa 2012). The ordered regions serve as a clamp and are  
conformationally restricted by the linker, which  is not involved in direct protein-protein 
interactions  (Fuxreiter and Tompa 2012).  A great example illustrating the clamp model 
is the myosin VI protein, which interacts with actin polymer via its two heads that are 
separated by an 80 residue disordered region (Rock, Ramamurthy et al. 2005; Fuxreiter 
and Tompa 2012).   
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The flanking model takes into consideration the disordered regions around 
MoRFs or other recognition elements such as linear motifs (Tompa and Fuxreiter 2008; 
Fuxreiter and Tompa 2012).  Deleting these flanking regions can impact target binding 
(Zor, Mayr et al. 2002; Fuxreiter and Tompa 2012).  As observed in the case of KID 
binding to the KIX domain of CBP, in which only a segment of 29 residues adopts helical 
structure, deletion or extension in the surrounding disordered region can decrease the Kd 
of the complex formation.  A recently reported example of flanking model is a small 
chloroplast protein CP-12 in the complex state with the glyceraldehyde-3-phosphate 
dehydrogenase, GAPDH, involved in light/dark regulation of Calvin cycle (Mileo, 
Lorenzi et al. 2013).  The binding site of CP-12 forms an α-helix in GAPDH bound state, 
while the remaining flanking regions remain unstructured. 
When the entire or most of the IDP remains unstructured in the bound state, a 
random model complex is formed (Fuxreiter and Tompa 2012).  Biophysical studies of 
these IDPs suggest that such proteins behave similarly in the free and target-bound states, 
thus they show absence of ordered structure in all states (Fuxreiter and Tompa 2012).  
The single-stranded DNA binding protein  samples several unstructured conformations in 
the bound state with the DNA (Savvides, Raghunathan et al. 2004).   Sic1, a disordered 
protein, inhibits cyclin-dependent kinase (CDK) activity by binding to CDK via multiple 
sites. Interestingly, it retains its dynamic structure in the target bound state (Mittag, 
Orlicky et al. 2008).  
The fifth group classifying fuzzy complexes are proteins that interact in a 
sequence independent manner (Fuxreiter and Tompa 2012).  Structural differences in the 
bound state are ascribed to the variation in amino acid contacts.  Interchanges of residues 
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in the binding site do not affect target recognition, as witnessed for Ewing’s sarcoma 
fusion proteins (Ng, Potikyan et al. 2007; Fuxreiter and Tompa 2012).  The dynamic 
interaction between the acidic transcription activator Gcn4 and one activator-binding 
domain of the mediator subunit Gal11/Med15 (Brzovic, Heikaus et al. 2011) is another 
great example for sequence independent model.  In the bound state the Gcn4 forms a 
helix, which adopts multiple orientations in the binding cleft of Gal11 (Brzovic, Heikaus 
et al. 2011). 
1.1.8 Ligand binding studies of IDPs 
Several techniques are available for studying interactions of intrinsically 
disordered proteins with targets.  Some of these include crystallography, CD, surface 
plasmon resonance (Gerothanassis., Anastassios et al. 2002), isothermal titration 
calorimetry (ITC), and NMR.   NMR spectroscopy is by far the most suitable tool for 
investigating details of IDPs in their target bound state.  Many parameters in NMR, such 
as chemical shifts, line widths and relaxation rates are atom specific and contain 
information about the local conformation and dynamics of IDPs (Uversky and Longhi 
2011).   Like NMR, Isothermal titration calorimetry is another unique method that allows 
the study of molecular interactions of IDPs with proteins, nucleic acids, small organic 
molecules, metals, and ions (Pierce, Raman et al. 1999).   Both these methods are the 
main experimental techniques used to study IDP interactions with targets in the work 
presented here. 
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 Oxidative Stress 1.2
Reactive oxygen species (ROS) and free radicals are present in all aerobic 
organisms (Martindale and Holbrook 2002; Fulda, Gorman et al. 2010).  These ROS 
species are either generated within the cell through signal transduction pathways, in the 
process of metabolism, or by exposure to an external insult (Martindale and Holbrook 
2002).  Normally, the cell maintains equilibrium between the production of ROS and the 
antioxidant species, and under these normal conditions the ROS can play important role 
in regulatory functions (Martindale and Holbrook 2002).  However, when this balance is 
disrupted, the cell experiences oxidative stress.  The increase in ROS can jeopardize cell 
survival by causing damage to nucleic acids, proteins, carbohydrates and lipids (Finkel 
and Holbrook 2000).  Hence, the cell initiates a defense response in order to return to 
homeostasis by combating the ROS.  Alternatively, if the severity of the insult is high, 
signaling pathways for cell death are activated (Finkel and Holbrook 2000; Martindale 
and Holbrook 2002).   
The signaling pathways activated to combat ROS include the extracellular signal-
regulated kinase (ERK), c-Jun amino-terminal kinase (JNK) and p38 mitogen-activated 
protein kinase (MAPK) signaling cascades, the phosphoinositide 3-kinase (PI(3)K)/Akt 
pathway, the nuclear factor (NF)-ƙB signaling system, p53 activation, and the heat shock 
response pathways (Finkel and Holbrook 2000; Martindale and Holbrook 2002).  The 
heat shock response, ERK, PI(3)K/Akt and NF-ƙB signaling pathways encourage cell 
survival, whereas activation of p53, JNK and p38 are associated with cell death (Finkel 
and Holbrook 2000).   
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Oxidative stress is the most accepted etiopathological factor in many diseases 
including cancers, atherosclerosis, diabetes mellitus, rheumatic diseases, autoimmune 
disorders and neurodegenerative disorders (Figure 1.2) (Calabrese, Lodi et al. 2005; 
Mihaela Ilie 2012).  Because of its important role in major diseases, the oxidative stress 
has gained significant consideration in research with over 3000 publications in the last 
five years in PubMed alone.  One major pathway activated in response to oxidative stress 
is the Nuclear (erthyroid 2-like) related factor 2 (Nrf2) pathway.  The Nrf2 mediated 
oxidative stress response plays a major role in xenobiotic detoxification and is the main 
focus of the work presented in this thesis. 
 Key players in the Nrf2 mediated Oxidative Stress Response 1.3
The signalling and regulatory pathways in the cell are highly complex processes 
with many proteins/enzymes taking part to perform distinct functions.  Correspondingly, 
the Nrf2 mediated response  to oxidative stress involves many players.  For the purpose 
of this work, following is a brief description of a few of the key players involved in this 
pathway.  
1.3.1  Nrf2  
The nuclear factor erythroid 2 (NFE-2)-related factor 2, more commonly known 
as Nrf2, was first discovered during studies of the β-globins.  In these works, targets for 
the DNase I hypersensitive site 2, also known as AP1-NFE2 (activating protein 1 and 
nuclear factor erythroid 2) motif, in β-globins were being cloned (Moi, Chan et al. 1994).  
The hunt for transcription factors that bind to the  AP1-NFE2 site led to the discovery of  
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Figure 1.2. Implications of oxidative stress in pathology.  Oxidative stress is 
associated with many different diseases involving different organs of the human 
body as illustrated in this diagram.  This wheel diagram was adapted and modified 
from (Mihaela Ilie 2012) 
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several targets from the cap ‘n’ collar (CNC) subfamily of the basic leucine zipper (bZIP) 
transcription factors which include the p45-NFE2 (Andrews, Erdjument-Bromage et al. 
1993), Nrf1 (Chan, Han et al. 1993),  Nrf2 (Moi, Chan et al. 1994) Nrf3 (Kobayashi, Ito 
et al. 1999) as well as BACH1(Oyake, Itoh et al. 1996) and BACH2 (Muto, Hoshino et 
al. 1998).  
 The CNC family of transcription factors are characterized by the presence of the 
CNC domain composed of a 43 amino acid region that is conserved amongst mammals, 
birds, fish and insects and is located at the N-terminus of the DNA binding domain 
(Sykiotis and Bohmann 2010).  The DNA-binding domain includes a nuclear localization 
signal, which has been shown to be functional in p45, Nrf2 and BACH2 (Hoshino, 
Kobayashi et al. 2000; Theodore, Kawai et al. 2008; Perdomo, Fock et al. 2010).  
BACH1 and BACH2 proteins are defined by the presence of a BTB (Broad complex, 
Tramtrack, Bric-a-brac) domain required for protein–protein interaction (Oyake, Itoh et 
al. 1996).  Additionally, most CNC factors are known as transcriptional activators; 
however, BACH1 and BACH2 function as transcription repressors (Sykiotis and 
Bohmann 2010).  Interestingly, none of the CNC based transcriptional factors bind to 
DNA independently, rather each first forms a complex with a small MAF protein, another 
bZIP protein (Igarashi, Kataoka et al. 1994).  The resulting obligate heterodimeric 
complexes bind to NFE2 (Nuclear Factor-Erythroid 2), MARE (Maf recognition 
element), ARE (antioxidant response element) and StreB (stress-response element)/EpRE 
(electrophile response element) type DNA binding sites (Chevillard and Blank 2011).   
Of the many CNC proteins, the role and regulation of the Nrf2 has been most 
extensively studied.  The important role for the Nrf2 in the protection from xenobiotic 
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and oxidative stresses was first shown in the analyses of Nrf2-null mice (Itoh, Chiba et al. 
1997).  Although, these mice were viable and displayed no phenotypic defects, they were 
sensitive to extrinsic and intrinsic oxidative assaults.  For instance, Nrf2-null mice exhibit 
an increased formation of DNA adducts in the lung when exposed to diesel exhaust 
(Aoki, Sato et al. 2001), severe form of liver toxicity is developed after administration of 
acetaminophen (Enomoto, Itoh et al. 2001), an increased susceptibility to cigarette 
smoke-induced emphysema (Iizuka, Ishii et al. 2005) and an aggravated bleomycin-
induced pulmonary ﬁbrosis is developed (Kikuchi, Ishii et al. 2010).  Additionally, Nrf2 
knockout mice unexpectedly develop various inflammatory disorders, including 
glomerulonephritis and immune-mediated hemolytic anemia, multi-organ autoimmune 
inflammation (Lee, Chan et al. 2004; Ma, Battelli et al. 2006; Yoh, Itoh et al. 2001). 
Structural analysis has revealed six evolutionary conserved domains in the Nrf2 
protein that are named Neh1 through Neh6 (Itoh, Wakabayashi et al. 1999).  Figure 1.3 
depicts these six domains including their roles and functions.  Neh1, in the c-terminal half 
of Nrf2, constitutes the basic DNA binding domain and the leucine zipper for 
dimerization with targets (Itoh, Wakabayashi et al. 1999; Sun, Chin et al. 2009). 
Acetylation of the Neh1 domain by p300/CBP results in promoter-specific DNA binding 
of Nrf2 (Sun, Chin et al. 2009).  The carboxy-terminal Neh3 domain of Nrf2 is important 
for the transcriptional activity of Nrf2 and may play role in recruiting components of the 
transcriptional complex (Nioi, Nguyen et al. 2005).  The Neh4 and Neh5 regions are 
transactivation domains which synergistically regulate transcriptional activation of 
cytoprotective genes (Itoh, Wakabayashi et al. 1999; Zhang, Hosoya et al. 2007).  The 
Neh2 and Neh6 are involved in mediating Nrf2 degradation (McMahon, Thomas et al.  
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Figure 1.3. Structural topology of the Neh2 domain of human Nrf2. 
There are six highly conserved domains (Neh1 to Neh6) in the Nrf2 transcription 
factor. Neh2 is located in the N-terminus and is found to interact with the Keap1to 
negatively regulate the Nrf2 protein. Neh1 and Neh3 are the C-terminal basic 
leucine zipper containing domains that dimerize with the small Mafs and bind to 
ARE sequences in DNA. Neh4 and Neh5 are transactivation domains that are 
identified to interact with the co-activator CBP/p300 during transcriptional 
activation in the nucleus.  The Neh6 interacts with E3 ligases thus mediates Nrf2 
degradation.  Diagram based on the review by Kansanen et al. 2013 (Kansanen., 
Kuosmanen et al. 2013).   
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2004).  The Neh2 domain of the Nrf2 protein has been structurally characterized and has 
been shown to be intrinsically disordered containing little secondary structural content 
(Tong, Katoh et al. 2006).  This N-terminal domain is involved in the negative regulation 
of Nrf2.  It has been shown that the absence of this domain leads to increase in the 
transcription activity of the Nrf2 protein (Itoh, Wakabayashi et al. 1999). 
1.3.2 Keap1 
The Keap1 (Kelch-like ECH-associated protein1) protein was identified as an 
Nrf2 regulating protein using a yeast two-hybrid system (Itoh, Wakabayashi et al. 1999).  
The human Keap1 is composed of 624 amino acids containing high density of cysteine 
residues and has five distinct domains: the N-terminal region, the Bric-a-Brac, tramtrack, 
broad-complex (BTB), a cysteine rich intervening region (IVR), Kelch domain or the 
double glycine repeat region (DGR), and the C-terminal domain.   A structural topology 
of the Keap1 domains and their biological roles is provided in Figure 1.4a along with a 
box identifying the cysteine rich regions (Figure 1.4b).   Based on Figure 1.4b it is clear 
that Keap1 is a cysteine rich protein with the mouse and human Keap1 containing 25 and 
27 cysteine residues respectively (Dinkova-Kostova, Holtzclaw et al. 2002).  The 
presence of high number of cysteine residues suggests that these cysteines may be 
involved in sensing changes in the cellular redox status (Dinkova-Kostova, Holtzclaw et 
al. 2002).  Various studies have demonstrated that the sulfhydryl groups of various Keap1 
cysteine residues can be directly altered by oxidation, reduction and alkylation. Of these 
151, 273 and 288 (Figure 1.4b, residues in red) appear to be critical for the dissociation of 
Nrf2 from the Keap1-Nrf2 complex (Dinkova-Kostova, Holtzclaw et al. 2002;  
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Figure 1.4. Structural topology of the Keap1 and a schematic diagram of the 
Keap1 bound to Nrf2. (a) Structural topology of the Keap1 highlighting the five 
distinct domains of the protein. The BTB domain is responsible for the 
homodimerization of the Keap1 protein. The BTB and the IVR regions are responsible 
for proteasome dependent degradation of Nrf2. The Kelch domain interacts with the 
Neh2 domain anchoring Nrf2 to the actin cytoskeleton. (b) Cysteine residues localized 
in the five distinct domains of the Keap1 protein.   Cys residues that play crucial role in 
the regulation of Nrf2 are highlighted in red. (c) Schematic diagram of the Keap1-Nrf2 
complex displaying the hinge and latch mechanism of interaction between the Neh2 
domain of Nrf2 and the Kelch domain of Keap1. Figure is adapted and modified from 
(Kansanen., Kuosmanen et al. 2013). 
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Wakabayashi, Dinkova-Kostova et al. 2004; Kobayashi and Yamamoto 2006).  
Additionally, the involvement of BTB and IVR domains (where these critical cysteine 
residues reside) of Keap1 in Nrf2 degradation has been shown to be crucial in recruiting 
ubiquitin-proteasome factors (Kobayashi, Kang et al. 2004).  
The Kelch and C-terminal regions of the Keap1 are responsible for anchoring the 
Nrf2 in place, allowing its ubiquitination (Kang, Kobayashi et al. 2004).  The crystal 
structure of the Kelch domain has revealed a six bladed β-propeller conformation with 
several conserved amino acids that are important for maintaining the hydrogen bond 
network, linking the propeller blades and forming the hydrophobic core of the protein 
(Li, Zhang et al. 2004).   In particular, there is a conserved glycine doublet found in each 
blade of the Kelch domain (Li, Zhang et al. 2004).  These two glycine residues are 
involved in an intrablade hydrogen bond network that may be instrumental in the folding 
of individual blade structures.  As demonstrated in Figure 1.4c, two motifs, namely the 
DLG (latch) and the ETGE (hinge), in the Neh2 domain of Nrf2 independently associate 
with the Kelch domain of Keap1 (Padmanabhan, Tong et al. 2006; Tong, Katoh et al. 
2006). 
1.3.3 Keap1-Cul3-RBX1 Ligase Complex 
Keap1 serves as a substrate linker protein for Cul3-RBX1 ligase complex to 
ubiquitinate proteins and subsequently target them for degradation by the 26S proteasome 
(Furukawa and Xiong 2005).  An illustrative diagram of the Keap1 in complex with the 
Cul3-RBX1 ligase complex is presented in Figure 1.5.  This figure 1.5 demonstrates how 
Keap1 anchors the Nrf2 for ubiquitination.  The ubiquitination of a substrate protein such 
as Nrf2 is normally accomplished by consecutive reactions initiated by ubiquitin  
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Figure 1.5. Keap1 as a substrate adaptor for the cullin3-RBX1 ligase complex. 
Nrf2 interacts with two Keap1 proteins via its DLG and EETGE motifs to the Kelch 
domains.   The Keap1 protein forms a homodimer via the BTB domain and interacts 
with the Cul3-RBX1 complex.  The RBX1-E2 synthesizes a polyubiquitin chain that 
is transferred to the Nrf2 by the Ub-E3.  Figure  is made based on the works of 
Taguchi, 2011 (Taguchi, Motohashi et al. 2011).    
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activating enzymes and involves three steps.  First step is the ubiquitin activation, 
performed by E1; second step involves conjugation of the ubiquitin to the protein and this  
is completed by the E2 enzyme; the third step, performed by the E3 enzyme, is the 
ubiquitin ligation (Hochstrasser 1996).  The E3 consists of scaffold Cullin protein that is 
bound to the Ring box protein-1 (RBX1) (Deshaies 1999) (Figure 1.5).  The RBX1 is a 
small 108 residue protein with a RING finger domain (Ohta, Michel et al. 1999).  The 
RING proteins are capable of activating E2 enzymes to synthesize polyubiquitin chains in 
the presence of E1 (Furukawa, Ohta et al. 2002).   
The Cullin proteins are evolutionary conserved scaffold proteins that play a 
critical role in post-translation modification of proteins involving ubiquitin.  There are 
eight Cullin proteins that have been identified to date, Cul1 to Cul7 and PARC (p53-
associated, parkin-like cytoplasmic protein) (Sarikas, Hartmann et al. 2011).   Keap1 has 
been found to associate favorably with the Cul3 protein (Figure 1.5) (Kobayashi, Kang et 
al. 2004; Zhang, Lo et al. 2004).   Cul3 assemble E3 ligases by bringing the RING-E2 
and substrates together (Furukawa, Ohta et al. 2002; Furukawa and Xiong 2005).   
1.3.4 Antioxidant Response Element 
The antioxidant response element (ARE) was discovered by Rushmore et al as a 
cis-acting regulatory enhancer sequence in the upstream region of the rat glutathione S- 
transferase Ya (GST Ya) subunit (Rushmore and Pickett 1990).   Characterization of the 
ARE sequence in the rat GST Ya by mutational analysis delineated the ARE core 
sequence to 5’-TGACnnnGC-3’, which is essential for both basal and inducible activity 
of the GST Ya (Rushmore, Morton et al. 1991).   In addition to the rat GST Ya gene, the 
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ARE is responsible for activation and induction of several other genes, including the rat 
and human NAD(P)H:quinone oxidoreductase 1 (NQO-1) protein, γ-glutamylcysteine 
catalytic (γ-GCSh) and regulatory (γ-GCSl) subunits, and heme oxygenase (HO-1) 
(Favreau and Pickett 1991; Jaiswal 1991; Inamdar, Ahn et al. 1996; Mulcahy, Wartman 
et al. 1997; Moinova and Mulcahy 1998; Wild, Gipp et al. 1998).  
Venugopal et al established Nrf2 as a critical regulator of the ARE sequences 
(Venugopal and Jaiswal 1996).  In their works, Venugopal et al discovered increased 
CAT activity from an ARE-CAT construct upon expression of transfected Nrf2.  The 
CAT activity was found to diminish in the presence of a mutant ARE-CAT construct.  In 
vivo studies using gene knockout mice demonstrated Nrf2 as a regulator for the 
transcription activation of ARE-responsive genes (Itoh, Chiba et al. 1997).  Expression 
levels of γ-GCSh and NQO-1 were reduced in Nrf2-null mice when compared with the 
heterozygous mice (Itoh, Chiba et al. 1997; Chanas, Jiang et al. 2002).   
1.3.5 Role of stress mediated cell signaling kinases 
Stress-related signaling kinases, mitogen-activated protein kinase (MAPK), p38 
MAPK, phosphatidylinositol 3-kinase (PI3K), c-Jun-N-terminal kinase (JNK), 
endoplasmic reticulum (ER)-resident kinase (PERK), and protein kinase C (PKC) have 
been reported to mediate Nrf2 regulation of ARE-responsive genes (Alam, Wicks et al. 
2000; Yu, Chen et al. 2000; Zipper and Mulcahy 2000; Huang and Ingber 2002; Balogun, 
Hoque et al. 2003; Cullinan, Zhang et al. 2003; Keum, Yu et al. 2006; Xu, Yuan et al. 
2006).  Many of these kinases directly phosphorylate Nrf2 and activate the transcription 
of ARE-regulated genes.  Interestingly, both positive and negative regulation of Nrf2 has 
been associated with the p38 and the JNK kinases (Alam, Wicks et al. 2000; Yu, Chen et 
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al. 2000; Zipper and Mulcahy 2000; Huang and Ingber 2002; Balogun, Hoque et al. 2003; 
Cullinan, Zhang et al. 2003; Keum, Yu et al. 2006; Xu, Yuan et al. 2006).    
1.3.6 Prothymosin alpha  
Prothymosin-alpha (ProTα), a precursor to thymosin α, is a well-studied protein 
with diverse roles in the cells ranging from protecting cells from apoptosis to cell 
proliferation (Gomez-Marquez, Segade et al. 1989; Evstafieva, Belov et al. 2003).  The 
natural abundance of ProTα and its evolutionary conservancy implies its importance to 
biological activity (Haritos, Tsolas et al. 1984; Hannappel and Huff 2003).   Due to the 
nature of tasks it participates in, a dual role has been associated with ProTα (Ioannou, 
Samara et al. 2012).  Intracellularly, ProTα controls the cell cycle by inhibiting apoptosis, 
regulates DNA remodeling during cell proliferation, and controls gene expression by 
interacting with the histone H1(Szabo, Ehleiter et al. 1992; Wu, Shiau et al. 1997; 
Karetsou, Kretsovali et al. 2002).  Extracellularly, ProTα has been shown to stimulate 
immune response (Ioannou, Samara et al. 2012).  For instance, treatment of mice with 
ProTα resulted in their protection from infections associated with Candida albicans (Pan, 
Haritos et al. 1986).  In lymphocytes, it has been demonstrated that ProTα increased 
antigen induced T cell proliferation, production of interleukins and T cell receptors 
(Baxevanis, Frillingos et al. 1990; Ioannou, Samara et al. 2012).  Amongst its vast 
functions, in 2005 the Karapetian group ascribed an additional important role for ProTα 
in the Nrf2-Keap1 signaling pathway (Karapetian, Evstafieva et al. 2005).  This group 
discovered that the Keap1-Cul3-RBX1 ligase complex, required for the ubiquitination of 
Nrf2, is deviant of a nuclear localization signal (Karapetian, Evstafieva et al. 2005).  The 
Keap1-Cul3-RBX1 ligase complex binds to ProTα and passes the nuclear membrane 
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using ProTα nuclear localization signal (Niture and Jaiswal 2009).   Since ProTα is one of 
the major focuses of this study, it is discussed in further detail in Chapter 2. 
 Mechanism of Nrf2 transcription Regulation 1.4
Over the last decade scientific research has answered many questions relating to 
the mechanism by which Nrf2 mediated gene transcription is regulated (Taguchi, 
Motohashi et al. 2011; Tkachev, Menshchikova et al. 2011; Baird, Lleres et al. 2013).   
Based on scientific reports, Keap1 appears to be a key negative regulator of the Nrf2 
protein involving physical entrapment of the inactive Nrf2 to the cytoplasmic actin 
filaments under unstressed conditions (Itoh, Wakabayashi et al. 1999; Kang, Kobayashi 
et al. 2004).  During oxidative or electrophilic stress, the Nrf2 liberates from the Keap1 
anchorage complex and newly synthesized Nrf2 accumulates in the nucleus leading to 
Nrf2-ARE transcription of cytoprotective genes (Kobayashi, Kang et al. 2004; Jain and 
Jaiswal 2006; Kobayashi and Yamamoto 2006).  A detailed schematic diagram of the 
pathway is presented in Figure 1.6.   
The current mode of Keap1-Nrf2 interaction is described as a “hinge and latch” 
model, where two distinct motifs in the Neh2 domain of Nrf2, the DLG and ETGE 
motifs, are shown to interact with the Kelch domain of Keap1 (Tong, Katoh et al. 2006; 
Tong, Kobayashi et al. 2006; Tong, Padmanabhan et al. 2007).  It has been determined 
that the immobilization of the Nrf2 by Keap1 occurs in a sequential manner where the 
high affinity site, ETGE motif, binds first, followed by the docking of the DLG motif 
onto a second Kelch domain of the homodimer Keap1 (Li, Zhang et al. 2004; 
Padmanabhan, Tong et al. 2006; Tong, Kobayashi et al. 2006; Tong, Padmanabhan et al. 
2007).  The ETGE motif locks the Nrf2 in place, whereas, the DLG motif is responsible  
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Figure 1.6. Schematic diagram of the Keap1-Nrf2 mediated gene transcription. 
(a) In a regular cell environment, two Keap1 molecules bind to the N-terminal Neh2 domain of 
the Nrf2 via the DLG and ETGE motif.  Nrf2 is polyubiquitinated by the Cul3-based E3 ligase 
complex and targeted for degradation by the 26S proteasome. (b) During stress conditions, the 
Nrf2-Keap1 complex is disrupted, leading to accumulation of Nrf2 in the nucleus. (c) The Nrf2 
forms a complex with the small Maf proteins and binds to the ARE sequences of target DNA, 
initiating transcription of Phase II enzymes.  Once the cellular environment returns to normal 
conditions, the nuclear Nrf2 is sequestered by the Keap1 to return Nrf2 concentrations also to 
normal levels.  The Keap1 lacks a nuclear localization signal, and thus is exported to the nucleus 
in complex with the ProTα.  The schematic diagram is based on the work presented in (Taguchi, 
Motohashi et al. 2011) 
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for orienting the N-terminal lysine residues of Nrf2 for ubiquitination (Kobayashi, Kang 
et al. 2004).  The presence of stressors triggers conformational changes in the Keap1 
(Dinkova-Kostova, Holtzclaw et al. 2002).  These structural changes in the Keap1 cause 
release of the DLG motif; however, the ETGE remains bound.  The Nrf2 binds to the 
Keap1 in this manner until Keap1 is saturated.  This results in free cytoplasmic Nrf2 
which is transported to the nucleus for the transcription of cytoprotective gene expression 
(Tong, Katoh et al. 2006).   
An alternative manner of Nrf2 regulation by Keap1 has been recently proposed 
and is called the cyclic model.  Based on this model the Nrf2 is not released from the 
Keap1-Cul3-RBX1 ligase complex; rather, the orientation of the DLG motif is shifted 
such that the lysine residues required for ubiquitination are no longer accessible by the 
E2-ubiquitin conjugating enzyme (Baird, Leres et al. 2013). Thus Nrf2 proteosomal 
degradation is disrupted and newly synthesized Nrf2 escapes into nucleus and 
transcription of enzymes that allow restoration of cellular environment is initiated (Itoh, 
Chiba et al. 1997; Itoh, Wakabayashi et al. 1999).   
Once the cellular environment is restored, the Nrf2 concentrations in the nucleus 
need to be regulated (Niture and Jaiswal 2009).  Interestingly, the Keap1 lacks a nuclear 
localization signal and is shuttled to the nucleus in complex with ProTα, where, ProTα 
dissociates and Nrf2 degradation is initiated again to reestablish homeostatic conditions 
(Niture and Jaiswal 2009).  
 Positive and Negative Regulators of Nrf2  1.5
Many cellular mechanisms are in place to regulate Keap1 or Nrf2 in a manner that 
increases or abolishes the expression of ARE-dependent genes (Tkachev, Menshchikova 
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et al. 2011).  Several proteins stabilizing the Nrf2 transcriptional activity have been 
reported in literature, including the DJ-1, p21Cip1/WAF1, p62 (sequestosome 1), CR6-
interacting factor 1 (CRIF1), and PALB2 (Clements, McNally et al. 2006; Chen, Sun et 
al. 2009; Kang, Hong et al. 2010; Ma, Cai et al. 2012).   
The disordered p62 is an adapter protein that carries multiple functions within the 
cell.  It is involved in carrying ubiquitinated proteins to the proteasome, and by products 
of degradation to the lysozymes (Seibenhener, Geetha et al. 2007).  The protein is also 
required for carrying aggregated, damaged or unfolded/misfolded proteins to the 
lysozyme (Tkachev, Menshchikova et al. 2011;Seibenhener, Geetha et al. 2007).   
Intriguingly, p62 contains a sequence similar to the ETGE motif of Neh2 and competes 
for Keap1 binding with the DLG site of Neh2 (Jain and Jaiswal 2006; Cino, Killoran et 
al. 2013). The p62 is known to target Keap1 for degradation (Taguchi, Fujikawa et al. 
2012). As a result, the Nrf2 degradation is halted, and an increase in cytoprotective 
enzyme expression is observed (Jain and Jaiswal 2006).  The Kelch domain is a hub for 
many other disordered proteins and its interaction with other targets liberates Nrf2 to 
carry transcriptional activity.  
Another alternative mode of Nrf2 stability is adopted by the disordered 
p21Cip1/WAF1.  However this disordered protein competes with the Keap1 for binding to 
the DLG motif of Neh2 domain (Chen, Sun et al. 2009; Tkachev, Menshchikova et al. 
2011).  By inhibiting Nrf2 ubiquitination, p21 increases the activation of antioxidant 
defense pathway.  p21 is also known to increase cell survival by its involvement in cell 
cycle arrest and cellular repair processes (Chen, Sun et al. 2009; Taguchi, Motohashi et 
al. 2011).  
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Many other mechanisms are in place that regulate the transcriptional activity of 
Nrf2.  Few of these methods include phosphorylation of the Y568 residue of Nrf2 by 
Tyrosine kinase Fyn in the nucleus resulting translocation of Nrf2 from nucleus to the 
cytoplasm where it is degraded by Keap1 (Jain and Jaiswal 2007; Tkachev, 
Menshchikova et al. 2011).  Other negative regulators of the pathway compete for 
binding to the DNA instead. For example, the association of BACH1 with ARE 
sequences prevents Nrf2 mediated gene expression (Sun, Brand et al. 2004; MacLeod, 
McMahon et al. 2009).   
 Dual Nature of Nrf2 in Cancer 1.6
The Keap1-Nrf2 pathway is considered to behave as a “double-edged sword” 
(Hayes and McMahon 2006).  On one side, the expression of detoxifying enzymes helps 
eliminate ROS, prevents DNA damage and can repress cancer metastasis (Satoh, 
Moriguchi et al. 2010; Taguchi, Motohashi et al. 2011).  On the other hand, constitutive 
Nrf2 activity in cancer cells provides advantages for tumour cell proliferation (Taguchi, 
Motohashi et al. 2011).  The constitutive cellular activity of Nrf2 arises when it escapes 
Keap1 facilitated degradation.  Many somatic mutations in Nrf2 and Keap1 have been 
reported in tumor derived cell lines or cancer tissues that results in the disruption of Nrf2 
regulation (Padmanabhan, Tong et al. 2006; Hayes and McMahon 2009; Hast, Cloer et al. 
2014).  Mutations in the Neh2 domain of Nrf2 have been mostly discovered within the 
ETGE and DLG motifs of the Neh2 domain, resulting in the disruption of Keap1-Nrf2 
complex formation (Shibata, Kokubu et al. 2008; Kim, Oh et al. 2010).   
Mutations within the Keap1, although reported in all three domains, are 
predominant in the Kelch domain of Keap1 (Singh, Misra et al. 2006; Ohta, Iijima et al. 
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2008; Shibata, Kokubu et al. 2008; Network 2012; Yoo, Kim et al. 2012; Hast, Cloer et 
al. 2014).  Unlike the Nrf2, many of the mutations reported in the Kelch domain of 
Keap1 are away from the binding interface with targets, yet are shown to inhibit Nrf2  
regulation. Thus somatic mutations in Keap1 are linked to conformational changes that 
compromise its ability to ubiquitinate Nrf2 (Lo, Li et al. 2006; Hayes and McMahon 
2009).  Table 1.1 lists few mutations, the type of cancers they associated with and their 
location in the Kelch domain.   
 IDPs in the Nrf2 mediated Oxidative Stress Response 1.7
ProTα and Nrf2 are both intrinsically disordered proteins that play critical roles in 
the oxidative stress response (Itoh, Chiba et al. 1997; Uversky, Gillespie et al. 1999; 
Karapetian, Evstafieva et al. 2005; Tong, Katoh et al. 2006; Niture and Jaiswal 2009).   
As depicted in the crystal structures presented in Figure 1.7 both of these proteins interact 
with the positively charged loop regions located at the bottom vicinity of the Kelch 
domain (Lo, Li et al. 2006; Tong, Padmanabhan et al. 2007; Padmanabhan, Nakamura et 
al. 2008).  
As illustrated by several examples, the biophysics of protein-protein interactions is 
quite unique for individual systems.  Many IDPs undergo disorder to order transitions 
upon binding to targets, while others remain flexible even in the ligand bound states. 
Characterizing the binding interface of IDPs in protein-protein interaction can have 
important implication in drug discovery (Cheng, LeGall et al. 2006).  Since a protein-
protein interaction involving one structured and one disordered partner seems more  
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Table 1.1. A list of somatic mutations identified within the Kelch domain of 
Keap1 (Forbes, Bindal et al. 2011). * mutations studied in this work 
Residue  Amino Acid Mutation Reoccurrence Type          Tissue  
Mutations in the binding interface  
334 Y334H Substitution - Missense Lung 
336 R336 Substitution - Nonsense Lung 
364 G364S Substitution - Missense Lung 
364 G364C* Substitution - Missense Lung 
413 R413L* Substitution - Missense Lung 
415 R415G* Substitution - Missense Lung 
415 R415C Substitution - Missense Lung 
460 R460G Substitution - Missense Lung 
460 R460S Substitution - Missense Lung 
461 I461V Substitution - Missense Lung 
479 D479G Substitution - Missense Lung 
480 G480W Substitution - Missense Lung 
483 R483C Substitution - Missense Lung 
509 G509W Substitution - Missense Lung 
524 G524C Substitution - Missense Lung 
527 G527F Substitution - Missense Lung 
554 R554Q Substitution - Missense Lung 
555 S555C Substitution - Missense Lung 
556 A556S Substitution - Missense Lung 
572 Y572C Substitution - Missense Lung 
601 R601W Substitution - Missense Lung 
603 G603W Substitution - Missense Lung 
 
Mutations in the double GG repeats 
333 G333S Substitution - Missense Lung 
333 G333C* Substitution - Missense Lung 
369 V369L Substitution - Missense Lung 
379 G379D* Substitution - Missense Billary tract  
428 V428V Substitution - coding silent Pancreas 
430 G430C* Substitution-Missense Lung 
475 V475L Substitution - Missense Skin 
476 G476R* Substitution - Missense Lung 
522 A522V Substitution - Missense Breast 
524 G524C Substitution - Missense Lung 
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Residue Amino Acid Mutation Type  Tissue 
Other mutations 
324 V324M Substitution – Missense Oesophagus 
326 R326H Substitution – Missense Endometrium 
350 G350S* Substitution-Missense Gastric, AD 
362 R362Q Substitution – Missense Lung 
389 D389Y Substitution – Missense Lung 
397 N397 Deletion - In frame Lung 
407 A407V Substitution - Missense Prostate 
409 M409T Substitution - Missense Kidney 
417 G417R Substitution - Missense Lung 
417 G417E Substitution - Missense Lung 
418 V418M Substitution - Missense Lung 
418 V418L Substitution - Missense Lung 
419 G419W Substitution - Missense Lung 
427 A427V* Substitution-Missense Lung 
444 E444 Substitution-Nonsense Kidney 
449 E449 Substitution - Nonsense Breast 
452 L452 Deletion - Frameshift Breast 
453 V453 Insertion - Frameshift Breast 
459 R459Q Substitution - Missense Skin 
470 R470S Substitution - Missense Lung 
470 R470C Substitution - Missense Lung 
470 R470H Substitution - Missense Lung 
471 L471L Substitution - coding silent Stomach 
488 E488D Substitution - Missense Endometrium 
493 E493D Substitution - Missense Lung 
497 W497L Substitution - Missense Lung 
503 M503K Substitution - Missense Lung 
506 I506V Substitution - Missense Lung 
519 I519 Insertion - Frame shift Endometrium 
544 W544R Substitution - Missense Kidney 
544 W544C Substitution - Missense Lung 
558 G558G Substitution - coding silent 
Large 
Intestine 
559 I559I Substitution - coding silent Lung 
563 Q563E Substitution - Missense Lung 
572 Y572C Substitution - Missense Lung 
579 D579Y Substitution - Missense Kidney 
584 Y584 Deletion - Frameshift Kidney 
588 T588 Insertion - Frameshift Lung 
593 E593 Substitution - Nonsense Liver 
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Figure 1.7. Crystal structures of the ProTα and Neh2 peptides bound to the Kelch domain of Keap1.  
(a) peptides mimicking binding motifs of ProTα (red) (PDB id: 2Z32) and the high affinity ETGE motif of 
Neh2 domain (green) (PDB id: 2FLU) bound to the Kelch propeller (Lo, Li et al. 2006; Padmanabhan, 
Nakamura et al. 2008).  (b) The DLG motif of Neh2 bound to the Kelch domain of Keap1 (PDB id: 2DYH) 
(Tong, Padmanabhan et al. 2007).  All three peptides interact with the same surface of the Kelch domain.  
(b) (a) 
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promising in therapeutic intervention (Cheng, LeGall et al. 2006; Dunker, Oldfield et al. 
2008), understanding the mechanism of binding, structural and dynamic characterization 
of IDPs in their free and target-bound states is necessary for successful drug design.  
Nrf2 and ProTα are great examples to understand the part IDPs play in biological 
processes as these two proteins have vital roles in cellular maintenance.  Their activity in 
oxidative stress response pathway, especially, the dual nature of Nrf2 in cancers, makes 
them interesting candidates for delineating the mechanisms by which IDPs function in the 
cell and thus great drug targets.  In this work the nature of Nrf2 and ProTα interactions in 
full length have been investigated with Keap1.  Additionally, target binding with Keap1 
has been scrutinized in the presence of somatic mutations associated with cancers (listed 
in Table 1.1).  
 Scope of thesis 1.8
The main objectives that are investigated in this work include: 
I. Determining the underlying mechanism of interaction of full length 
ProTα and Neh2 domain of Nrf2 with Keap1.   
II. A new high yield purification protocol for the Neh2 domain of human 
Nrf2 is presented and allows studying full length target binding with 
the Kelch domain of human Keap1 
III. Investigation of the role of selected disease associated mutations, 
reported in Keap1, on target binding to ProTα and Nrf2 
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In chapter 1, the interaction occurring between the disordered ProTα and the 
Kelch domain of human Keap1 has been extensively characterized.  ITC, NMR and 
peptide array techniques were used to delineate the amino acids in ProTα involved in 
affecting binding to the Kelch domain of human Keap1.  Additionally, spin relaxation 
and amide exchange experiments helped elucidate that the nature of disordered ProTα 
interaction with the Keap1 as a fuzzy one, where ProTα retains its disordered nature even 
in target bound states.  
 A new high yield purification protocol, in chapter 2, provided pure Neh2 sample 
used for the structural characterization of the full length Neh2 domain of human Nrf2 and 
for binding studies with the Kelch domain of human Keap1.  Higher content of residual 
structures including α-helical and β-turn propensities were observed at the N and C-
terminals, respectively, in the Neh2 domain.  Additionally, NMR studies of the DLG and 
ETGE motifs in full-length context suggested possible contacts between the N and C 
terminal residues.   
Nine somatic mutations occurring in the Kelch domain of the human Keap1 
(highlighted in Table 1.1) were selected and their effects on the structural integrity of 
Kelch domain and binding to ProTα and Nrf2 were scrutinized.  Mutations in the double 
glycine repeat regions destabilized the Kelch domain and resulted in protein aggregation.  
Amino acid substitutions in the interface and in other regions did not affect the secondary 
structural content of the Kelch domain.  Nonetheless, mutations in the binding interface 
compromised complex formation with targets, especially to the DLG motif of Neh2.  
These results provide new insights into IDP protein-protein interaction and their roles in 
diseases.    
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Chapter 2  
 Fuzzy complex formation between Prothymosin α and the 2
Kelch domain of Keap1 
. 
 Introduction 2.1
Prothymosin α (ProTα) is a 12-kDa acidic protein with multiple biological 
functions (Haritos, Goodall et al. 1984; Pan, Haritos et al. 1986; Frillingos, Frangou-
Lazaridis et al. 1991).  It is highly conserved in mammals, is widely distributed in various 
tissues, and has a distinct amino acid composition (Haritos, Goodall et al. 1984; Pan, 
Haritos et al. 1986; Frillingos, Frangou-Lazaridis et al. 1991).  Its protein sequence lacks 
aromatic and Cys residues, and about 50% of the sequence is composed of either Glu or 
Asp. These acidic residues are mostly localized in the center of the protein sequence 
(Haritos, Goodall et al. 1984; Pan, Haritos et al. 1986; Frillingos, Frangou-Lazaridis et al. 
1991; Diaz-Jullien, Perez-Estevez et al. 1996; Segade and Gomez-Marquez 1999).  A 
nuclear localization signal, TKKQK, exists in the C-terminal region (Rubtsov, 
Zolotukhin et al. 1997; Trumbore, Wang et al. 1997).  Early studies of ProTα had shown 
that the protein is unstructured under non-denaturing conditions but can adopt a partially 
folded conformation at acidic pH (Gast, Damaschun et al. 1995; Uversky, Gillespie et al. 
1999).  We have extensively characterized the structural and dynamic properties of this 
protein under physiological buffer conditions by using nuclear magnetic resonance 
(NMR) spectroscopy and electrospray ionization mass spectrometry (ESI-MS) (Yi, Boys 
et al. 2007). The results clearly demonstrated that ProTα is largely disordered and 
extremely dynamic, with only a slight propensity for β-strand structure. However, the 
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protein can adopt more compact conformations upon binding to zinc ions (Yi, Boys et al. 
2007). 
ProTα is an oncoprotein expressed at high levels in proliferating cells. It increases 
cell proliferation by shortening the G1 phase of the cell cycle (Rodriguez, Vinuela et al. 
1998). Studies have shown that in the absence of ProTα, cells undergo apoptosis or are 
unable to divide (Sburlati, Manrow et al. 1991; Rodriguez, Vinuela et al. 1999; 
Evstafieva, Belov et al. 2000).  ProTα also binds histones (Papamarcaki and Tsolas 1994; 
Diaz-Jullien, Perez-Estevez et al. 1996; Karetsou, Sandaltzopoulos et al. 1998; Martic, 
Karetsou et al. 2005), plays a role in chromatin remodeling (Karetsou, Sandaltzopoulos et 
al. 1998; Karetsou, Martic et al. 2004), acts as a transcription activator through CREB 
binding protein (Karetsou, Kretsovali et al. 2002; Subramanian, Hasan et al. 2002), 
prevents formation of the apoptosome (Qi, Wang et al. 2010; Jiang, Kim et al. 2003; 
Piacentini, Evangelisti et al. 2003; Malicet, Giroux et al. 2006), and facilitates movement 
of charged particles within the nucleus and surrounding environment (Enkemann, Ward 
et al. 2000). Further, the protein suppresses HIV-1 by inducing production of type 1 
interferon (Mosoian, Teixeira et al. 2010; Kubota, Adachi et al. 1995; Mosoian, Teixeira 
et al. 2007), plays a neuroprotective role after ischemic events (Ueda, Fujita et al. 2007; 
Fujita, Ueda et al. 2009), and functions as a tumor-associated protein in human colon 
cancer, lung cancer, urinary tract cancer, and breast cancer (Dominguez, Magdalena et al. 
1993; Tsitsiloni, Stiakakis et al. 1993; Traub, Jost et al. 2006; Gou, Tong et al. 2009; 
Tsai, Jou et al. 2009). Recent studies have shown that ProTα also has an important role in 
the oxidative stress response (Karapetian, Evstafieva et al. 2005; Niture and Jaiswal 
2009).  
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Cells are constantly attacked by reactive oxygen species, electrophiles, 
carcinogens, and xenobiotics (Itoh, Chiba et al. 1997; Primiano, Sutter et al. 1997). 
Pathological conditions, such as neurodegenerative diseases, arthritis, cancer, and 
cardiovascular diseases, can arise if cells fail to counteract oxidative stress by inducing 
cytoprotective gene expression (Itoh, Chiba et al. 1997; Primiano, Sutter et al. 1997; 
Pratico, Rokach et al. 2004; Kim and Guengerich 2005; Schulze and Lee 2005).  Nuclear 
factor erythroid 2-related factor 2 (Nrf2) is one of the key regulators of the cellular 
responses to oxidative stress (Venugopal and Jaiswal 1996; Itoh, Chiba et al. 1997; Itoh, 
Tong et al. 2004). Nrf2 is a bZIP transcription activator of cytoprotective genes 
(Venugopal and Jaiswal 1996; Itoh, Chiba et al. 1997). The protein consists of six 
domains, Neh1 to Neh6 (Itoh, Wakabayashi et al. 1999).  The N-terminal Neh2 domain, 
which is intrinsically disordered (Tong, Katoh et al. 2006), is involved in maintaining 
homeostatic levels of Nrf2 through binding to Keap1 (Kelch-like ECH-associated protein 
1) (Itoh, Wakabayashi et al. 1999).  
ProTα plays a crucial role in the Nrf2 signaling pathway by mediating the nuclear 
import of Keap1/Cul3-RBX1 ligase complex in order to lower Nrf2 levels in the nucleus, 
allowing the cell to return to normal conditions (Niture, Kaspar et al.2010 ; Niture and 
Jaiswal 2009). Once in the nucleus, ProTα dissociates from the Keap1/Cul3-RBX1 ligase 
complex, allowing Nrf2 to bind to the complex for degradation (Niture, Kaspar et al. 
2010; Niture and Jaiswal 2009). 
The interaction between mouse ProTα and Keap1 has been studied previously. 
Using the yeast two hybrid system and different protein constructs, amino acids 32 to 52 
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in the mouse ProTα have been identified to be crucial for the interaction with the Kelch 
domain of Keap1 (Karapetian, Evstafieva et al. 2005).  Padmanabhan et al. expanded on 
these findings by structurally analyzing the mouse ProTα-Kelch complex (Padmanabhan, 
Nakamura et al. 2008).  A 16-mer peptide composed of 39AQNEENGEQEADNEVD54 of 
mouse ProTα was crystallized with the Kelch domain (Padmanabhan, Nakamura et al. 
2008).  The structure reveals that the negatively charged ProTα peptide binds to the basic 
bottom face of the β-propeller structure of Kelch, forming many electrostatic interactions, 
especially via the ENGE motif of ProTα.  It is noteworthy that the electron density 
corresponding to residues 49-54 of the ProTα peptide was missing, suggesting this part 
of the peptide may not adopt a stable conformation upon binding to Kelch 
(Padmanabhan, Nakamura et al. 2008).  Compared to the structures of Neh2-Kelch (Lo, 
Li et al. 2006; Padmanabhan, Tong et al. 2006; Padmanabhan, Nakamura et al. 2008), the 
EENGE motif of ProTα and the EETGE motif in the Neh2 domain bind to the same site 
on the Kelch domain (Padmanabhan, Nakamura et al. 2008).  
Although ProTα has multiple biological functions and many targets, very limited 
structural information about this disordered protein is available, especially concerning its 
target interactions.  The crystallographic study of ProTα-Kelch peptide-protein complex 
is the only detailed structural characterization of ProTα in a target bound-state form 
(Padmanabhan, Nakamura et al. 2008).  However, the molecular mechanism by which 
full-length ProTα binds to Kelch remains unclear. Many disordered proteins undergo 
disorder-to-order transition upon binding to their targets (Wright and Dyson 1999;Dyson 
and Wright 2005; Wright and Dyson 2009). These protein-protein interactions are 
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frequently enthalpy driven because the loss of conformational freedom of an intrinsically 
disordered protein (IDP) upon target binding is usually significant, with a resulting 
unfavorable entropy change (Wright and Dyson 1999; Bordelon, Montegudo et al. 2004; 
Fink 2005; Meszaros, Tompa et al. 2007; Sugase, Dyson et al. 2007). IDPs can also 
interact with targets via preformed structural elements, perhaps lessening the entropy loss 
and modulating the affinity of binding (Kumar, Ma et al. 2000; Tsai, Ma et al. 2001; 
Fuxreiter, Simon et al. 2004). Intriguingly, some IDPs remain disordered even in 
complexes with targets (Fuxreiter 2012 ; Fuxreiter and Tompa 2008; Zhuo, Ilangovan et 
al. 2010).  Due to the crucial roles ProTα and Keap1 have in the oxidative stress 
response, in this study, experimental approaches were employed to delineate the 
molecular basis of their binding. The result will not only lead to a better understanding 
how these two proteins function in the Nrf2 pathway, it will also provide insight into 
designing drugs that specifically target the interactions between Keap1 and its disordered 
partners (Cino, Fan et al. 2013; Uversky 2012 ; Wang, Cao et al. 2011 ; Cheng, LeGall et 
al. 2006; Hammoudeh, Follis et al. 2009).  
 Materials and Methods 2.2
2.2.1 Protein Expression and Purification  
The expression and purification of human ProTα was reported previously (Yi, 
Brickenden et al. 2008). The pET15b plasmid carrying the human Kelch cDNA, a kind 
gift from Dr. Mark Hannink at the University of Missouri-Columbia, was transformed 
into E. coli BL21 (DE3) cells (Novagen). The protein was overexpressed in M9 minimal 
media and induced by adding 0.5 mM isopropyl-β-D-thiogalactopyranoside (IPTG; 
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Bioshop). After 18 h induction at 16 °C, the bacteria were harvested and stored at -20 °C. 
The his-tagged protein was purified by affinity chromatography using Ni-Sepharose 6 FF 
beads (Amersham Biosciences). The eluted protein was dialyzed against TE buffer (20 
mM Tris-HCl, 1 mM EDTA, 1 mM DTT, 100 mM NaCl). The His-tag was cleaved with 
human alpha-thrombin (Haematologic Technologies), and protein was further purified 
with HiLoad Superdex 75 column (GE Healthcare). The final protein sample was 
dialyzed in 50 mM sodium phosphate buffer, 100 mM NaCl, 1 mM DTT, pH 7.   
2.2.2 Peptide synthesis   
The ProTα peptide (98% in purity), 38NANEENGEQEA48 was ordered from 
GenScript USA Inc. The lyophilized peptide was dissolved in 50 mM Sodium phosphate 
buffer, 100 mM NaCl, 1 mM DTT for ITC and NMR experiments.   
2.2.3 Site-directed mutagenesis of wild-type ProTα 
Wild-type ProTα in pET15b plasmid was subjected to point mutagenesis using 
the Stratagene Quikchange II site-directed mutagenesis kit. The primers used for each 
point mutation are included in Supplemental data. Over expression and purification of 
mutant variants of ProTα were carried out with the similar procedure used for the wild-
type ProTα (Yi, Brickenden et al. 2008).  
2.2.4 Primers used for point mutations. 
E41P: 5’ CCCTGCTAACGGGAATGCTAATCCGGAAAATGGGGAGC 3’ 
E45G: 5’ TAATGAGGAAAATGGGGGGCAGGAGGCTGACAATG 3’ 
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E45A: 5’ TAATGAGGAAAATGGGGCGCAGGAGGCTGACAATG 3’ 
E51A: 5’ CAGGAGGCTGACAATGCGGTAGACGAAGAAGAG 3’ 
E51G: 5' CAGGAGGCTGACAATGGGGTAGACGAAGAAGAG 3' 
E51Y: 5'GGGGAGCAGGAGGCTGACAATTACGTAGACGAAGAA 3' 
E47A: 5' GAAAATGGGGAGCAGGCGGCTGACAATGAGGTA 3' 
E47R: 5' GAGGAAAATGGGGAGCAGCGCGCTGACAATGAGGTAGAC 3' 
D49A: 5' GGAGCAGGAGGCTGCCAATGAGGTAGACG 3' 
N36A: 5' ATGGAAGAGACGCCCCTGCTGCCGGGAATGCTAATG 3' 
G44A: 5' GGAATGCTAATGAGGAAAATGCGGAGCAGGAGGCTG 3' 
2.2.5 NMR spectroscopy 
All NMR experiments (except the amide hydrogen exchange experiments) were 
performed on a Varian Inova 600MHz spectrometer equipped with xyz-gradient triple 
resonance probe at 25 °C in buffer containing 50 mM sodium phosphate, 100 mM NaCl, 
1 mM DTT, and 10% (v/v) D2O (Cambridge Isotope Laboratories). 1 mM of sodium 2, 2-
dimethyl-2-silapentane-5-sulfonate (DSS, Sigma) was added to each NMR sample as an 
internal standard for the chemical shift referencing (Wishart, Bigam et al. 1995). All 
NMR data were analyzed with NMRPipe (Delaglio, Grzesiek et al. 1995), and the spectra 
were analyzed with NMRView (Johnson 2004).  
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For the NMR titration experiments, unlabeled Kelch was titrated into 600 µL of 
150 µM 15N-labeled ProTα until a 1:2 molar ratio (ProTα : Kelch) point was reached.  
1H-15N HSQC spectra were collected for each titration point.  
Backbone 15N longitudinal relaxation rates (R1), relaxation rates in rotating frame 
(R1ρ), and steady-state 1H-15N NOE relaxation parameters of 150 µM 15N-labeled ProTα 
were measured in both the free state and the Kelch bound state (unlabeled 300 µM Kelch) 
using identical parameters as described previously (Yi, Boys et al. 2007).  
Amide hydrogen exchange (HX) rate measurements were performed at 25 oC on a 
Bruker Avance 800 MHz spectrometer equipped with cryogenic probe (National 
University of Singapore) using the method recently proposed by Fan et al (Fan, Lim et 
al.). The HX rates of 15N-labeled ProTα (180 µM) were measured in both the free state 
and the Kelch-bound state (unlabeled 450 µM Kelch) using the following mixing times: 
20, 30, 40, 50, 60, 70, 80, 90, 100, 120, 140, 160, 190, 220, 260, and 300 ms. For each 
mixing time, data sets with and without the suppression of radiation damping were 
collected in interleaved manner and each FID was acquired with 6 scans.  A reference 
spectrum was collected for each sample using a long interscan delay (10 s) and by 
removing the first 1H pulse and the mixing period in the pulse sequence as mentioned in 
the reference (Fan, Lim et al. 2011). The data were processed using NMRPipe (Delaglio, 
Grzesiek et al. 1995). For each isolated peak, signal intensities were fitted to Equation 1 
(Equation 9 in the reference (Fan, Lim et al. 2011) in order to determine the exchange 
rates. 
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 (1) 
where f is the fractional steady-state water magnetization; R1H is the relaxation rate of an 
amide proton; Iref is the equilibrium magnetization of the amide proton, which is equal to 
two times of the peak intensity of the amide in the reference spectrum when it is recorded 
with the same number of scans as the other spectra; IEX(t) is the peak intensity of the 
amide correlation at mixing time t, which is obtained from the difference spectrum of two 
interleaved data sets;  t0 is the latency interval; and R1w is the longitudinal relaxation rate 
of water. In the data fitting, f, t0, and R1w were set to 0.90, 17.4 ms, and 0.3 s-1, 
respectively. The protection factor (P) of the backbone amide proton of each amino acid 
was calculated as the ratio of the intrinsic HX rate (kint) of random coil to the 
experimentally determined HX rate. The kint values were estimated with SPHERE web 
server (http://www.fccc.edu/research/labs/roder/sphere/sphere.html) (Bai, Milne et al. 
1993; Connelly, Bai et al. 1993).  
2.2.6 Analytical ultracentrifugation 
Analytical ultracentrifugation technique was employed to determine the binding 
stoichiometry of ProTα to the Kelch domain of Keap1.  Sedimentation equilibrium 
experiments were performed in a Beckman-Coulter Optima XL-A analytical 
ultracentrifuge (Beckman Coulter, Palo Alto, CA) with an AN60Ti rotor.  Six-sector 
Epon-charcoal centerpieces with quartz windows were used.  Protein samples were 
dialyzed in 50 mM phosphate, 100 mM NaCl, 1 mM DTT, at pH 7.0.  Data were 
collected at 22,000 rpm following 24 h equilibration period at 4°C.  Kelch absorbance at 
280 nm was measured with 10 replicates with a step size of 0.002 cm.   Data were fitted 
64 
 
 
to a single species model using Microsoft Origin 7.0 software.  Partial specific volume 
for Kelch was calculated to be 0.7219 mL/g based on the amino acid composition.  The 
solvent density was measured to be 1.008 g/mL.  Protein concentrations were calculated 
by protein quantification methods, Lowry for ProTα and Bradford assay for Kelch, as 
well as by amino acid analysis (Advanced Protein Technology Centre, The Hospital for 
Sick Children, Toronto, ON).  
2.2.7 Isothermal titration calorimetry (ITC) 
ITC experiments were carried out on a MicroCalTM VP-ITC.  All purified protein 
samples were dialyzed into 50 mM sodium phosphate, 100 mM NaCl, 1 mM DTT at pH 
7.0.  For titrations, purified Kelch and ProTα were prepared to 60 µM and 790 µM, 
respectively, in dialysis buffer, and each was degassed prior to titration.  Kelch was 
loaded into the 1.42 mL cell, and ProTα was loaded into the syringe (300 µL).  Titrations 
were performed at 25 °C starting with initial injection of 3 µL, followed by 59 larger 
injections of 5 µL, with spacing of 360 s (except for the ProTα peptide with spacing of 
120 s).  The sample cell was stirred at 300 rpm throughout the experiment. The buffer 
blank was performed under the same conditions and showed negligible heats of binding.  
The dissociation constant (Kd), stoichiometry of binding (N), binding enthalpy (∆H), and 
entropy (∆S) were obtained by non-linear least squares fitting of the data to a single-site 
binding model provided with the data analysis software (Origin 7).  Baselines were 
subtracted from final data using Origin software.  All protein concentrations were 
determined using Lowry (for ProTα) and Bradford (for Kelch) assays. Protein 
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concentrations were confirmed by amino acid analysis (Advanced Protein Technology 
Centre, The Hospital for Sick Children, Toronto, ON).    
2.2.8 Peptide array 
A twenty-residue, 38NANEENGEQEADNEVDEEEE57, ProTα peptide spot array 
was ordered from the Peptide and Peptide Array Synthesis Facility at the University of 
Western Ontario. The peptide membrane was hydrated, blocked with 5% skim milk, and 
then probed with the Kelch domain of Keap1. His Probe-HRP was used to detect the 
ProTα peptide-Kelch interaction. The peptide array membrane was developed with the 
ECL Lightening Plus kit (Perkin Elmer, Mississauga, ON) before exposing to film.   
 Results 2.3
2.3.1 Mapping the Kelch-binding region on ProTα by NMR spectroscopy 
The Keap1-binding region on the full-length human ProTα was identified by 
using NMR spectroscopy. A two-dimensional 1H-15N heteronuclear single quantum 
coherence (HSQC) spectrum of 15N-labeled ProTα was collected (Figure. 2.1a). The lack 
of chemical shift dispersion in the 1H dimension of the spectrum indicates that the protein 
was intrinsically disordered in the absence of Kelch.  This result is consistent with our 
previous structural characterization of ProTα carried out in a buffer with lower ionic 
strength (Yi, Boys et al. 2007). 
Changes in the chemical environment of ProTα upon binding to the Kelch 
domain were then probed by a series of 1H-15N HSQC experiments acquired with 
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increasing concentrations of unlabeled Kelch (Figure 2.1a). Additions of Kelch led to the 
perturbations of several ProTα backbone 1H/15N resonances. Significant chemical shift 
changes or attenuations in peak intensity were observed for N36, G37, N38, A39, N40, 
N43, G44, D49, and N50, as well as several unassigned residues (Yi, Boys et al. 2007). 
Notably, the dispersion of NMR signals in the 1H dimension remained very narrow, 
indicating that ProTα did not undergo global disorder-to-order transition upon binding to 
the Kelch domain of Keap1. Aside from the resonance changes mentioned above, most of 
the peaks in the 1H-15N HSQC spectra remain unchanged in position. This result strongly 
suggests that the dynamic nature of the rest of ProTα was retained upon target binding. 
To identify the conformational changes of ProTα induced by the binding of 
Kelch, backbone 13Cα/β chemical shifts were analyzed using the residue-specific 
secondary structure propensity (SSP) program developed by Forman-Kay and co-workers 
(Marsh, Singh et al. 2006).  This method combines different chemical shifts and 
generates a single score for each residue between 1 and -1, indicative of fully formed α-
helical structure and β-strand structure, respectively.  SSP scores of ProTα in the absence 
and presence of Kelch were compared. The result (Figure 2.1b) shows that moderate 
changes occurred in SSPs of ProTα in the segment spanning residues 36-52; however, 
the rest of the protein had similar SSP scores in the absence and presence of Kelch. 
Notably, in the bound state, amino acids in region 35-53 had SSP scores ranging only 
from -0.34 to 0.17, indicating a lack of stable secondary structure in this region.  
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Figure 2.1.  NMR titration experiments of ProTα with Kelch. 1H-15N HSQC 
spectra of ProTα alone (blue) and with 2 equivalents of Kelch domain. Close-up 
views of the 1H-15N HSQC spectra, showing selected chemical shift changes 
during the titration, are shown. (b) SSP scores for ProTα in the free (blue) and 
bound state with Kelch, calculated using 13Cα and 13Cβ chemical shifts. Residues 
for which SSP scores were not calculated are represented by a tick mark. The 
regions showing significant changes in SSP correspond to peaks on the HSQC 
spectrum that undergo large chemical shift changes. 
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2.3.2 Disordered ProTα forms a fuzzy complex with the Kelch domain of Keap1 
To further characterize the dynamic properties of the ProTα-Kelch complex, 
backbone 15N spin relaxation and steady-state 1H-15N NOE experiments were performed 
on the free and Kelch-bound states of ProTα. These experiments are commonly used in 
studying protein dynamics and are particularly valuable for probing motions on the ps-ns 
timescale (Kay 1998). Figure 2.2 shows the 15N R1, R2, and steady-state 1H-15N NOEs 
measured for 15N-labeled ProTα (150 µM) in the absence and presence of 300 µM of 
unlabeled Kelch.  Forty-three assigned residues (out of the 110 ProTα residues) with well 
resolved peaks were included in the data analysis. In the absence of Kelch, all of these 43 
residues have R1 values within a narrow range of 0.87 to 3.13 s-1 (2.45 s-1 in average) 
(Figure 2.2a).  Interestingly, addition of Kelch led to insignificant changes in the R1 
values of ProTα (0.85 – 3.06 s-1, average = 2.47 s-1).  In the absence of Kelch, the R2 
values ranged from 0.5 to 5.3 s-1. Notably, for a globular protein with similar molecular 
weight of ProTα, residues in structured regions are expected to have R2 ~ 10 s-1 (Walma, 
Aelen et al. 2004). Upon addition of Kelch, small, yet significant, increases in R2 values 
were observed for most of the residues (Figure 2.2b). Larger increases were noted for 
residues in the region 30-53, which are involved in the interaction with Kelch, as 
identified by the chemical shift mapping result mentioned in the previous section.  
The steady-state 1H-15N NOE is sensitive to fast internal motion, a good indicator 
of protein mobility on the ps-ns timescale (Peng and Wagner 1992; Kay 1998). 
Generally, large negative NOE values are observed in flexible regions of a protein(Peng 
and Wagner 1992).  In the free state, NOE values of ProTα were mostly negative, which  
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Figure 2.2. Backbone 15N relaxation experiments of ProTα in the free 
(blue) and bound state with 2 equivalents of Kelch. (a) R1 (longitudinal) 
relaxation rate.  (b) R2 (transverse) relaxation rate. (c) steady-state 1H-15N 
NOE. 
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is consistent with the disordered nature of this protein (Figure 2.2c).  In the Kelch-bound 
state, increases in the NOE values were observed for residues 30 to 59 (-0.49 to 0.17), 
indicating that this region became more restricted in motion (Figure 2.2c).  Notably, for 
residues in a structured complex of size ~46 kDa, the NOE values are expected to be 
~0.8. Note that the errors of the measurements are significant for those peaks with NOEs 
close to zero.  
To further investigate the nature of the ProTα-Kelch interaction, we conducted 
NMR amide hydrogen exchange experiments to probe the changes in solvent 
accessibility of ProTα upon binding to Kelch (Fan, Lim et al. 2011).  Protection factor, 
which is defined as the ratio of the intrinsic to the measured exchange rate, was 
determined for backbone amides of ProTα (with isolated signals) in the absence and 
presence of Kelch (Figure 2.3). The low protection factor values of ProTα (0.3 – 5.5; 
average of 1.6) in the absence of Kelch indicate that the backbone amides were largely 
exposed to solvent, as expected for a highly unstructured protein like ProTα. 
Interestingly, no dramatic increases in protection factor values were observed upon 
addition of Kelch. Even though moderate increases in protection factor values for N38, 
E45, N50, and G60, were observed, these values were significantly smaller than those 
observed in folded proteins. For instance, residues located in the secondary structure 
elements of lysozyme have amide protection factors of 103-108 (Radford, Buck et al. 
1992).  
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Figure 2.3.  Protection factor (P) of backbone amides in ProTα in the 
absence (blue bars) and presence of Kelch (red *).  
The P value of each amino acid was calculated as the ratio of the intrinsic HX 
rate (kint) of random coil to the experimentally determined HX rate. The kint 
values were estimated using the SPHERE web server 
(http://www.fccc.edu/research/labs/roder/sphere/sphere.html) (Bai, Milne et al. 
1993; Connelly, Bai et al. 1993) 
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2.3.3 Identifying crucial residues of ProTα for Kelch binding 
Permutation peptide arrays were used to examine the roles that individual residues 
in ProTα play in the interaction with the Kelch domain. A series of 20-mer peptides, 
spanning residues 38-57 of human ProTα, were synthesized on a functionalized cellulose 
membrane and then probed with the Kelch protein. Each of the wild-type residues 38-57 
was substituted with any of the 19 amino acids (Figure 2.4).  Cys residues were excluded 
in the permutations to avoid formation of covalent linkages to Kelch during probing, 
which would result in false positives. Based on the signal intensities observed in the 
peptide array experiments, mutations that significantly attenuated the binding of the 
ProTα peptides to Kelch were identified.  Many mutations in the 38NANEENGE45 region 
were found to be detrimental to Kelch binding, whereas replacing other residues outside 
this region had negligible effects on protein-peptide interactions.  In particular, mutations 
of residues E42, G44, and E45 resulted in loss of interaction with Kelch, indicating that 
these three amino acids are critical for the binding.  On the other hand, mutation of N43 
in the 42ENGE45 motif to a Thr or Ser enhanced the binding to Kelch.  
In the peptide array experiment, the E41P mutation also resulted in a higher 
affinity of binding between Kelch and the ProTα peptide. The side chain of E41 forms 
hydrogen bonds across the binding interface with Kelch (Padmanabhan, Nakamura et al. 
2008).  Replacing the glutamate in this position with a non-polar proline was expected to 
lead to loss of favorable interactions.  Therefore, based on the peptide array result, it was 
unclear why the E41 P mutant of ProTα displayed a higher affinity to Kelch.   
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Figure 2.4. Permutation peptide array experiments.  
20-mer peptides of ProTα (residues 38-57) were immobilized on a cellulose membrane and then probed with the Kelch 
domain of Keap1. The left column shows the wild-type sequence and positions of the amino acids that were permutated 
(mutations specified at the top of second column). The ‘+’ in the second column indicates wt 20-mer sequence and is used 
as a positive control.  Array was repeated twice. Intensity of each permutation was qualitatively measured and compared to 
wild-type, and results reported are based on what was observed consistently in the two arrays.  Columns, on the right side 
indicate amino acid residues that weaken, strengthen, or have no effect on the binding affinity between the 20-mers and 
Kelch. As shown in the array, mutations in the EENGE motif are poorly tolerated.  AA, amino acid; X, every amino acid 
except Cys and those mentioned as weaker or stronger; wt, wild-type. 
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2.3.4 Quantitative analysis of ProTα and Kelch interaction 
To obtain quantitative information for the ProTα-Kelch interaction, isothermal titration 
calorimetry (ITC) was used to measure the thermodynamic parameters of binding. 
Parameters, including the binding stoichiometry (n), dissociation constant (Kd), enthalpy 
change (ΔH), and entropy change (ΔS) of binding, were obtained for the wild-type and a 
series of mutational variants of full-length ProTα. The results are summarized in Table 
2.1. To evaluate the contributions of ProTα residues distant from the Kelch binding motif 
to the affinity of binding, we first compared the affinity of Kelch to the full-length ProTα 
and an 11-mer peptide spanning residues 38-48 (Padmanabhan, Nakamura et al. 2008).  
Figure 2.5a & b show the integrated isotherms exhibiting a single-phase curve, which 
were fitted best to a single-site binding model. The binding stoichiometry obtained for 
both the peptide and full-length protein are close to 1, indicating 1:1 binding between 
ProTα and Kelch protein. The result is also in agreement with the stoichiometry derived 
from sedimentation equilibrium experiments (Figure 2.6 and Table 2.3).  
The dissociation constant of the full-length ProTα-Kelch complex was 
determined to be 2.6 ± 0.4 µM by ITC. Interestingly, the 11-mer ProTα peptide bound 
slightly tighter (Kd = 1.79 ± 0.09 µM) to Kelch compared to full-length ProTα. Despite 
the similar Kd values, the ∆H and ∆S of these two binding processes were very different. 
The results (Table 2.1) indicate a larger entropy loss when the ProTα peptide bound to 
Kelch. The more negative ∆S value was compensated for by the more favorable ∆H, 
resulting in similar Kd values for both full-length ProTα and its peptide.  
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Table 2.1. Thermodynamic parameters for binding of the full-length ProTα, ProTα peptide, and ProTα mutants 
to Kelch domain of Keap1 at 25 °C (first set) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*n is the stoichiometry, Ka, and Kd are the association and dissociation constants, respectively. ∆G = -RTlnKa,  
where T is the temperature in Kelvin, R is the gas constant.  ∆H and ∆S are the enthalpy and entropy  
changes, respectively. Each experiment was repeated twice; the values obtained between the two runs were 
similar. Values listed in the tables are based on one run, and the data for the duplicate run is provided in the 
supplementary data (Table 2.2).  
  
 
WT Kelch 
 
 
n 
 
Ka 
(105 M-1) 
 
Kd  
(µM) 
 
∆H 
(kcal/mol) 
  
 T∆S 
(kcal/mol) 
∆G 
(kcal/mol) 
Full length 
ProTα 
1.06 ± 0.02 3.8 ± 0.6 2.6 ± 0.4 -14.8 ± 0.4 -7.19 -7.61 ± 0.09 
ProTα Peptide 
EENGE 
0.93 ± 0.00(4) 5.6 ± 0.3 1.79 ± 0.09 -22.6 ± 0.1 -14.76 -7.84 ± 0.03 
N36A 0.95 ± 0.00(5) 1.53 ± 0.05 6.5 ± 0.2 -10.1 ± 0.6 -3.03 -7.07 ± 0.02 
E41P 1.10 ± 0.00(2) 19.2 ± 0.8 0.52 ± 0.02 -14.17 ± 0.04 -5.60 -8.57 ± 0.02 
E47A 1.08 ± 0.16 0.069 ± 0.006 145 ± 13 -15.2 ± 0.3 -9.96 -5.24 ± 0.05 
E47R 0.93 ± 0.09 0.33 ±0.03 30 ± 3 -13.1 ± 0.2 -6.94 -6.16 ± 0.05 
D49A 1.04 ± 0.02 1.5 ± 0.2 6.7 ± 0.9 -12.6 ± 0.3 -5.53 -7.07 ± 0.08 
E51A 1.06 ± 0.01 1.14 ± 0.05 8.8 ± 0.4 -12.7 ± 0.2 -5.80 -6.90 ± 0.03 
E51G 1.04 ± 0.01 1.40 ± 0.06 7.1 ± 0.3 -15.23 ± 0.02 -8.21 -7.02 ± 0.02 
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Table 2.2. Thermodynamic parameters for binding of the ProTα peptide, full-length ProTα and its mutants to 
Kelch domain of Keap1 at 25 °C (second set) 
WT Kelch n Ka 
(105 M-1) 
Kd  
(µM) 
∆H 
(kcal/mol) 
  T∆S 
(kcal/mol) 
∆G 
(kcal/mol) 
Full length 
ProTα 
1.04 ± 0.02 3.3 ± 0.3 3.04 ± 0.2 -15.5 ± 0.4 -7.97 -7.53 ± 0.05 
ProTα Peptide 
EENGE 
1.13 ± 0.004 5.7 ± 0.3 1.74 ± 0.08 -23.1 ± 0.1 -15.24  -7.86 ± 0.03 
N36A 0.95 ± 0.04 1.6 ± 0.5 6.1 ± 1.8 -9.9 ± -0.5 -2.8 7.1 ± 0.2 
E41P 1.16 ± 0.002 20.3 ± 0.8 0.49 ± 0.02 -15.05 ± 0.05 -6.45  -8.60 ± 0.02 
E47A 1.10 ± 0.12 0.061 ± 0.002 164± 5 -15.9 ± 0.2 -10.74 -5.16  ± 0.02 
E47R 0.91 ± 0.04 0.303 ± 0.02 33 ± 2 -13.20 ± 0.08 -7.09 -6.11 ± 0.03 
D49A 1.06 ± 0.05 2.2 ± 0.8 4.5 ± 1.6 -12.0 ± 0.7 -4.7 -7.3  ± 0.2 
E51A 0.95 ± 0.01 1.18 ± 0.06 8.5 ± 0.4 -13.2 ± 0.2 -6.28 -6.92 ± 0.03 
E51G 1.05 ± 0.01 1.49 ± 0.05 6.7 ± 0.2 -15.63 ± 0.02 -8.57 -7.06 ± 0.02 
 
* n is the stoichiometry, Ka, and Kd are the association and dissociation constants, respectively. 
 ∆G =-RTlnKa=∆H-T∆S, where T is the temperature and R is the gas constant.∆H and ∆S are the 
 enthalpy and entropy changes, respectively.   
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Figure 2.5. ITC profiles of Keap1 with full length ProTα and its mutant variants. 
(a) Full length wild-type ProTα (b) EENGE ProTα 11-mer peptide (c) N36A (d) 
E41P (e) G44A (f) E45G (g) E47A (h) E47R (i) E51G 
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Figure 2.6. Sedimentation equilibrium analysis of Kelch and ProTα binding. 
Pure Kelch protein at a concentration of 10 µM was centrifuged with various 
concentrations of ProTα (to achieve a ratio of 1:0.5, 1:1, and 1:2 with the Kelch 
domain) at 4°C at 22 000 rpm. The upper panel represents the residual values for 
the fits.   
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Table 2.3. Molecular weight values of Kelch calculated from the sedimentation 
equilibrium experiment. 
Protein Concentration 
(µM) 
Calculated MW 
(Da) 
Observed MW  
(Da) 
Kelch 10 33915.85 34565 ± 338 
Kelch 
 
ProT α 
10 
 
5 
 
39952.76 
 
41551 ± 331 
Kelch 
 
ProT α 
10 
 
10 
 
45989.67 
 
44978 ± 396 
Kelch 
 
ProT α 
10 
 
20 
 
45989.67 
 
46793 ± 379 
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The charge complementarity between ProTα and Kelch is crucial for their 
interaction. The highly acidic Kelch-binding motif of ProTα binds to the positively 
charged bottom face of the β-propeller structure of Kelch, forming multiple salt bridges 
and hydrogen bonds across the interface (Padmanabhan, Nakamura et al. 2008). As 
aforementioned, Karapetian et al. demonstrated that the E45G/E51G double mutant of 
ProTα is not capable of binding to Kelch (Karapetian, Evstafieva et al. 2005). To further 
delineate the roles that E45 and E51 play in the interface, binding affinities of the E45G, 
E45A, E51A, and E51G full-length ProTα mutants to Kelch were measured. The results 
show that E45 is critical for the interaction with Kelch, as the mutation of this residue to 
Ala or Gly completely abolished the binding to Kelch (Table 2.1 and Figure 2.5f).  This 
observation is consistent with the peptide array result and is in agreement with the 
crystallographic data (Padmanabhan, Nakamura et al. 2008), which illustrate that the 
side-chain of E45 forms hydrogen bonds with multiple amino acids on Kelch. Mutations 
of E51 (Table 2.1 and Figure 2.5i), on the other hand, had little effect on the binding 
affinity to Kelch, indicating that this acidic residue plays only a minor role in mediating 
the interaction of these two proteins.  The peptide array result clarifies that E45, but not 
E51, is indispensable for the protein-protein interaction. 
The peptide array result also indicates that the mutation of E47, which is located 
close to the 42ENGE45 motif, to any other amino acid (except for R, D, and W) leads to a 
decrease in binding affinity to Kelch. Based on the charge complementarity at the ProTα 
and Kelch interaction sites, the result of the E47R mutation is unexpected. To validate 
this finding, binding affinities of E47R and E47A to Kelch were determined by ITC 
(Table 1 and Figure 2.5g & 2.5h).  Results show that while the Ala mutation caused a 55-
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fold decrease in the binding affinity to Kelch, the increase in Kd for E47R was less 
significant (Kd = 30 µM compared to 2.6 µM for the wild-type).  
E41 is another acidic residue that showed an interesting result in the peptide array 
experiment. The crystal structure of the mouse ProTα-Kelch peptide-protein complex 
reveals that the side-chain of E41 is involved in hydrogen bonding with Kelch 
(Padmanabhan, Nakamura et al. 2008).  However, mutation of this acidic amino acid to a 
non-polar proline residue increased the binding affinity to Kelch (Table 2.1 & Figure 
2.5d).  ITC measurements confirmed that the E41P mutant has a more favorable ∆Gbind 
compared to the wild-type ProTα (-8.57 kcal/mol vs. -7.61 kcal/mol; Table 2.1), mainly 
due to the less negative value of the ∆S component.  
Based upon the peptide array result, G44 is another residue that is essential for 
binding Kelch. To confirm this finding, the binding affinity of the G44A mutant to the 
Kelch domain was determined. As expected, no interaction of this mutant with Kelch was 
detected by ITC (Figure 2.5e).  Nevertheless, this specific mutation was very helpful in 
validating the backbone assignments around this amino acid.  The other two mutants that 
were constructed for the same purpose were N36A and D49A.  Both mutational variants 
bound to Kelch with moderately lower binding affinities (with Kd of 6.5 and 6.7 µM, 
respectively), compared to wild-type ProTα (Table 2.1 & Figure 2.5c).  Although the 
N36 was excluded from the crystallographic study of the peptide-protein complex of 
ProTα and Kelch, and the electron density of D49 was absent in the crystal structure 
solved (Padmanabhan, Nakamura et al. 2008), both the NMR chemical shift perturbations 
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and ITC results indicate that these two flanking residues also contribute moderately to the 
binding of ProTα and Kelch. 
 Discussion 2.4
To better understand the molecular mechanism underlying the oxidative stress 
response, the intrinsically disordered ProTα interaction with the Kelch domain of 
Keap1was extensively studied.  Many examples of IDPs are provided in literatures that 
undergo disorder-to-order transition upon binding to their targets through the coupled 
binding and folding process (Sugase, Dyson et al. 2007; Wright and Dyson 2009). 
Remarkably, our studies of the ProTα-Kelch complex have revealed that ProTα retains 
its disordered nature, even in the bound state.  This finding is supported by the 
observations that the resonance signals of ProTα in the 1H-15N HSQC experiments were 
clustered in a narrow range from 7.9 ppm to 8.6 ppm, both in the free and bound states 
(Figure 2.1a). Significant chemical shift changes were observed only for amino acids 35-
50. Most of these residues have also been identified as crucial in mediating the 
interaction between the mouse homologs of ProTα and Kelch (Karapetian, Evstafieva et 
al. 2005; Padmanabhan, Nakamura et al. 2008).  The crystal structure of mouse Kelch in 
complex with a ProTα peptide spanning amino acids 39-54 (corresponding to residues 
38-53 in human) reveals that this particular segment of ProTα forms a β-turn 
conformation upon binding to the bottom side of the β-propeller structure of Kelch 
(Padmanabhan, Nakamura et al. 2008). The binding interface is found to be highly 
complementary in charge, with the acidic amino acids in ProTα playing crucial roles in 
interacting with multiple Arg residues located on the binding surface of Kelch 
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(Padmanabhan, Nakamura et al. 2008). In particular, the EENGE motif in ProTα 
(residues 41-45 in human ProTα) was shown to be essential for the Kelch binding 
(Padmanabhan, Nakamura et al. 2008).  Our NMR titration results are in agreement with 
these previous findings, and importantly, we show that several other residues flanking the 
EENGE motif also display attenuation in resonance signals, indicating they may also be 
involved in Kelch binding.  
Compared to the changes in the 1H-15N HSQC of 15N-labeled Neh2 upon binding 
to Kelch, the spectral changes observed for free and bound ProTα were less dramatic. 
Tong et al. have demonstrated that sharp resonance signals of disordered Neh2 were 
severely broadened out upon addition of Kelch (Tong, Katoh et al. 2006).  In the presence 
of a two molar ratio of Kelch, most of the resonance signals of Neh2 disappeared, likely 
due to the significant increase in molecular tumbling time through the formation of a 
large molecular weight complex or as the result of intermediate conformational exchange 
between the free and bound states. In contrast, the sharpness of resonance signals 
prevailed throughout the NMR titration experiments for the majority of residues in 
ProTα. Moreover, spin relaxation experiments showed that addition of Kelch led to 
insignificant changes in the R1 values of ProTα (0.85 – 3.06 s-1, average = 2.47 s-1). 
These observed R1 values are systematically larger than expected for a folded protein 
with similar molecular weight of ProTα (van Ingen, Baltussen et al. 2006; Kim, Fuzery et 
al. 2009).  For instance, the D39A mutant of the128-residue apo-IscU has an averaged R1 
value of 1.64 s-1 measured under the same magnetic field strength and temperature (i.e., 
600 MHz; 298 K), while the averaged R1 value of the 105-residue PAH2B domain of 
mSin3B is 1.45 s-1 (at 293 K) (van Ingen, Baltussen et al. 2006; Kim, Fuzery et al. 2009). 
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The higher R1 values for ProTα are the result of a large amplitude of internal motion on 
the ps-ns timescale in the protein. Meanwhile, small, yet significant, increases in R2 
values were observed for most of the residues (Figure 2.2b) upon addition of Kelch, 
particularly in the region 30-53. The increases in R2 suggest that this particular region 
became more restricted in motion upon binding to Kelch (Kay 1998). However, the 
observed R2 values are still significantly smaller than expected for a 46 kDa (the sum of 
molecular weights of ProTα and Kelch) complex (Walma, Aelen et al. 2004).  Further, 
the NOE values of ProTα remained predominantly negative upon binding to Kelch, 
indicative of a flexible protein lacking secondary structure (Figure 2.2c). NOEs of 
residues in the region directly involved in forming the binding interface with Kelch 
became positive (increases up to 0.17), but these positive values were still significantly 
lower than expected for a 46-kDa complex with well-defined structure. Moreover, the 
small protection factors determined in the amide exchange experiments are in agreement 
with the low R2 and small NOE values observed, suggesting that ProTα forms a dynamic 
complex with Kelch.  
Peptide array and ITC experiments were conducted to elucidate further the roles 
individual amino acids in the binding region of ProTα play in the ‘fuzzy’ interaction with 
the Kelch domain. The results are compared to the Neh2-Kelch binding. The binding of 
Nrf2 to Keap1 has been described as a “hinge and latch” mechanism (Tong, Kobayashi et 
al. 2006).  The disordered Neh2 domain binds to two Kelch domains of a Keap1 dimer 
via the N-terminal DLG and the C-terminal ETGE motifs, respectively. It has been 
proposed that the complex formation facilitates the ubiquitination of a Lys residue 
located between the DLG and ETGE motifs in sequence, leading to the degradation of 
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Nrf2 (Tong, Katoh et al. 2006; Tong, Kobayashi et al. 2006). Previous studies have 
demonstrated that the ETGE motif of Nrf2 has a higher binding affinity (Ka, ETGE = 12.4 x 
107 M-1) compared to the DLG (Ka, DLG = 2 x 106 M-1) motif for the Kelch domain (Tong, 
Katoh et al. 2006; Tong, Kobayashi et al. 2006). Our ITC results revealed that the 
binding affinity of ProTα (Ka = (3.8 ± 0.6) x 105 M-1) was also significantly weaker than 
that of the Neh2 ETGE motif. Tong et al. reported that the ∆H and T∆S of binding 
between Kelch and mouse Neh2 [∆1-33] with the low affinity DLG motif deleted were -
21.2 and -10.2 kcal/mol, respectively (Tong, Katoh et al. 2006). Large and negative 
values of ∆S are frequently observed for binding involving IDPs mainly due to the 
significant reduction in the conformational entropy (Meszaros, Tompa et al. 2007). 
Interestingly, compared to the thermodynamic parameters obtained in this study, the 
entropic penalty was lower for the dynamic ProTα-Kelch complex formation (Table 2.1). 
On the other hand, the interaction between ProTα and Kelch was weaker based on the 
values of the enthalpy changes. 
Our peptide array result showed evidently that the 42ENGE45 motif is critical for 
binding, since mutations in this region were disruptive. However, exceptions were seen. 
Mutation of N43 to a Thr or Ser enhanced the binding to Kelch. Intriguingly, with the 
ETGE motif, the Neh2 domain of Nrf2 has been shown to have a greater affinity for the 
Kelch domain (Tong, Katoh et al. 2006). Therefore, conversion of the ENGE to an ETGE 
motif in ProTα resulting in a higher binding affinity is not unexpected.  Based on the 
crystal structures of ProTα-Kelch and Neh2-Kelch peptide-protein complexes, both the 
Asn in ProTα and the Thr in Neh2 are not directly involved in the interaction with Kelch. 
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Instead, the side-chains of each of these two amino acids play important roles in 
stabilizing the β-turn conformation of the binding motif by forming hydrogen bonds with 
the peptide backbone (Tong, Katoh et al. 2006; Padmanabhan, Nakamura et al. 2008).  
This finding explains why the N43S mutant of ProTα also showed Kelch binding affinity 
that is similar to N43T, as the hydroxyl group of Ser may still participate in the intra-
molecular hydrogen bonding (Tong, Katoh et al. 2006; Padmanabhan, Nakamura et al. 
2008).  Notably, hydrogen bonds between the N/N and D/T pairs in the 40NEEN43 and 
77DEET80 motifs of ProTα and Neh2, respectively, also contribute to stabilization of the 
β-turn conformation of these proteins in their free states (Cino, Choy et al. 2012; Cino, 
Wong-ekkabut et al. 2011). 
Meanwhile, the binding affinity between ProTα and Kelch increased by 5-fold 
when E41, the residue N-terminal to the ENGE motif, of ProTα was mutated to a Pro 
residue (Ka = 19.2 ± 0.8 x 105 M-1). One possible explanation for the higher affinity of the 
ProTα E41P mutant is that the conformational entropy of the free state is reduced, 
lowering the amount of entropic penalty upon binding. The 40NEENGE45 region of 
ProTα adopts β-turn conformations when bound to the Kelch domain (Komatsu, 
Kurokawa et al. 2010; Padmanabhan, Nakamura et al. 2008).  Pro residues are commonly 
found in position i+1 of β-turns in proteins (Hutchinson and Thornton 1994). The cyclic 
side chain of Pro leads to drastic restriction in the sampling of backbone dihedral angles. 
MD simulation of the E41P peptide (in its free state) showed that it has a high tendency 
to form the bound-state-like β-turn structure (Khan, 2013). Therefore, it seems plausible 
that the incorporation of a Pro at this position leads to a less severe conformational 
87 
 
 
entropy loss upon binding, resulting in a higher binding affinity. Indeed, lowered free 
state conformational entropy is thought to play an important role in the high affinity of 
the Neh2-Kelch domain interaction (Cino, Wong-ekkabut et al 2011. ; Tong, Kobayashi 
et al. 2006).  Another possible explanation is that, since E41 is involved in forming salt 
bridges and hydrogen bonds across the binding interface with Kelch, mutating this 
residue to a non-polar Pro would result in loss of these interactions. The change would 
render this region of the protein more flexible, thus lowering the reduction in 
conformational entropy of the system upon binding.  
Intriguingly, p62, a protein involved in regulation of autophagy, was recently 
found to bind to the Kelch domain of Keap1(Lau, Wang et al. 2010). Crystal structures 
show that ProTα, p62, and Neh2 all interact with the same site on the Kelch domain 
(Lau, Wang et al. 2010; Tong, Katoh et al. 2006; Padmanabhan, Nakamura et al. 2008). 
Even though the Kelch-binding motif in p62, 350PSTGE354, differs from the 41EENGE45 
and 78EETGE82 motifs of ProTα and Neh2, respectively, the Gly and Glu residues at the 
4th and 5th positions are conserved. This observation is consistent with our results that 
these two residues are crucial for the interaction with Kelch (Lau, Wang et al.2010; Tong, 
Katoh et al. 2006; Padmanabhan, Nakamura et al. 2008). Interestingly, the corresponding 
E41 in ProTα is replaced with a Pro residue in p62 (Lau, Wang et al. 2010). ITC 
experiments performed by Komatsu et al. show that the binding affinity of p62 for Kelch 
is Ka = 5.4 ± 0.3 x 105 M-1, (Lau, Wang et al. 2010) which is slightly higher than what 
was determined for ProTα and Kelch (Ka = 3.8 ± 0.6 x 105 M-1).  
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E47 is another residue in ProTα that may help to stabilize the bound-state β-
hairpin structure. Our ITC results (Table 2.1) revealed that mutation of this residue to an 
Ala or Arg decreased the binding affinity to Kelch by 55 fold, and ~10 fold, respectively.  
Since the side-chain of the corresponding Glu was invisible in the crystal structure of 
mouse ProTα-Kelch peptide-protein complex (Padmanabhan, Nakamura et al. 2008), it is 
unclear whether this residue was involved in any intra- or intermolecular interactions. We 
speculate that the side-chain of E47 may be involved in intra-molecular hydrogen 
bonding with N38, and the interaction can still be retained in the E47R mutant. The 
transient interaction between these two residues may also help to stabilize the bound-
state-like β-hairpin structure in the free state of ProTα. 
The NMR and ITC experiments show that even though peptides can be used to 
mimic specific regions of a protein when studying binding, the target recognition 
mechanisms of peptides can differ from that of the full-length protein. As seen in Table 1, 
although the ProTα peptide and protein had similar binding affinities to Kelch, their ∆H 
and ∆S values differed. Based on the observed chemical shift changes of ProTα upon 
target binding and the spin relaxation parameters determined in both the free and bound-
states, only residues around the binding motif were involved in the interaction with Kelch 
while the rest of the protein remained highly disordered. One possible explanation for the 
significant differences in the ∆H and ∆S values is that a greater loss in the conformational 
entropy of the peptide occurred upon binding to Kelch.  This idea is in agreement with 
our earlier computational study of the free-state structure of full-length ProTα and 
peptide using MD simulations(Cino, Wong-ekkabut et al.2011).  In that work, we had 
demonstrated that the full-length ProTα has a higher propensity than the peptide in 
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forming the bound-state-like β-hairpin structure, which can result in a less entropic 
penalty upon coupled binding and folding for the full-length protein. On the other hand, 
the enthalpy change of the ProTα peptide is more negative compared to the full-length 
protein. Since the measured ∆H is the sum of the enthalpy changes due to the binding and 
folding processes, the larger ∆H value of the peptide is likely due to the folding from the 
less bound-state-like conformations. 
Despite the highly dynamic nature of disordered proteins, it has been generally 
accepted that they will adopt a well-defined structure once bound to the target, at least in 
the regions that are directly involved in the interaction.  Several recent examples, 
however, challenge this view and suggest that disordered proteins can still be flexible 
even in the bound states (Fuxreiter 2012; Fuxreiter and Tompa 2008 ; Zhuo, Ilangovan et 
al.2010). For instance, the disordered cyclin-dependent kinase inhibitor Sic1 does not 
undergo a disorder-to-order transition upon binding to Cdc4 (Mittag, Orlicky et al. 2008). 
Instead, NMR studies showed that the multiple and dispersed phosphorylated motifs on 
Sic1 interact with a single binding site on Cdc4 in a dynamic equilibrium manner. This 
unusual binding mechanism has been proposed to lead to the ultrasensitivity to 
phosphorylation, which is crucial for the function of Sic1 in cell cycle regulation (Mittag, 
Orlicky et al. 2008).   Another example of a fuzzy complex is the dynamic interaction 
between clathrin assembly protein AP180 and clathrin (Zhuo, Ilangovan et al.2010). 
NMR studies demonstrated that a large fragment of the clathrin binding domain (CBD) of 
AP180 is disordered.  Interestingly, this protein fragment remains unstructured even in 
the bound form with clathrin.  This dynamic binding mode was speculated to be 
important for the assembly of the clathrin lattice (Zhuo, Ilangovan et al.2010).  
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In summary, the results presented in this chapter show that even though ProTα 
binds to the Kelch domain of Keap1 with low affinity, the interaction is highly specific. 
Only a small region of ProTα is involved in the interaction with the Kelch domain, and 
the protein does not undergo large conformational change upon binding. These properties 
may allow ProTα to also interact with other targets simultaneously. In addition, the fuzzy 
complex formed between the two proteins is probably what allows ProTα to quickly 
dissociate from Keap1 after the latter is translocated into the nucleus (Niture and Jaiswal 
2009).  
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Chapter 3  
 Structural characterization of the full-length Neh2 domain 3
of human Nrf2 and its interaction with the Kelch domain of 
human Keap1 
. 
 Introduction 3.1
The Nrf2 protein belongs to the Cap ‘n’ Collar (CNC) group of transcription 
factors that contain a conserved basic -leucine zipper region (Moi, Chan et al. 1994).  The 
protein contains six domains, and the Neh2 domain at the N-terminal region of Nrf2 is 
responsible for the regulation of the antioxidant pathway (Itoh, Wakabayashi et al. 1999).   
Mouse and human Neh2 domains are typically comprised of 98 residues and the two 
homologs have about 94 % sequence homology (Figure 3.1).   The structure of the human 
and mouse Neh2 domain was simulated using secondary structure predictor PrDOS 
software (Ishida and Kinoshita 2007).  Figure 3.2 shows that there is no difference in the 
disordered nature of the human and mouse Neh2 domain.  Because of the high similarity 
in sequence and the similar structure prediction, differences in structure or function 
between the human and mouse Neh2 homologs are highly unlikely.   
Most Nrf2/Keap1 binding studies have been performed with peptides encoding 
the ETGE and DLG motifs (Lo, Li et al. 2006; Tong, Katoh et al. 2006; Tong, 
Padmanabhan et al. 2007).   It is costly to use synthetic peptides mimicking regions of 
interest.  Moreover, peptides do not always allow proper elucidation of the mechanism of 
interaction with targets as noted for ProTα/Keap1 binding in full-length and peptide  
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Figure 3.1. Sequence alignment of the mouse and human Neh2 domains of Nrf2.  
The Neh2 domain of the human and mouse are composed of 98 residues. The amino 
acid sequence is well conserved between the human and mouse with differences in 
six amino acids (highlighted in red).   
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Figure 3.2. Disorder prediction for the human and mouse Neh2.   
The overlay of the human Neh2 domain (blue) with the mouse Neh2 domain (red) 
shows very minor differences in secondary structure prediction.  A score below 0.5 is 
indicative of structured regions, and above 0.5 is indicative of disordered regions. 
Disorder was predicted by PrDOS (Ishida and Kinoshita 2007) 
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(Khan, Cino et al. 2013).  Tong et al. have reported a purification protocol for the Neh2 
domain of mouse Nrf2 in which 4.0 mg of recombinant Neh2 was obtained.  This method 
was used to extract the recombinant full-length Neh2 domain for binding studies.  
However, the low yield and purity of the sample using the method by Tong et al. were 
not suitable for the human Nrf2.  In this work, an alternative high yield protocol, free 
from impurities, is established for the recombinant Neh2 domain, Neh2ΔETGE and 
Neh2ΔDLG of human Nrf2.  The method described here is not only time and cost 
effective, but importantly, allowed investigation of the full-length Neh2 interaction with 
Kelch in presence of cancer causing mutations (discussed in Chapter 4).  
Structural characterization of the full length Neh2 demonstrated that it is a 
disordered protein with high secondary structure content, thereby, limiting its flexibility 
unlike ProTα (Tong, Katoh et al. 2006; Yi, Boys et al. 2007; Khan, Cino et al. 2013).   
Additionally, hydrodynamic radius of the Neh2 domain indicates a more compact 
structure than the disordered ProTα (Yi, Boys et al. 2007).  The Neh2ΔDLG and 
Neh2ΔETGE NMR HSQC in the free and Kelch bound state implicated presence of long 
range interactions between the N and C terminal regions of the Neh2 domain.   
 Materials and Methods  3.2
3.2.1 Construction of Neh2, Neh2 ΔETGE and Neh2 ΔDLG in E. coli Expression 
Vectors  
The pENTR ™221 vector containing the gene for the full length human Nrf2 
(NM_006164) was purchased from Invitrogen.  Using Gateway cloning, the Neh2 
domain of the human Nrf2 was transferred to a pDEST17 vector containing a his-tag and 
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a TEV cleavage sequence.  The Quickchange Multi site directed mutagenesis kit 
(Strategene) was used to delete the 79ETGE82 region in full length Neh2 domain thus 
creating the Neh2ΔETGE construct using the Neh2 in pDEST17 vector as a template.  
The Neh2ΔDLG, in which the first thirty-three residues of the Neh2 domain are deleted, 
was constructed using the full length Nrf2 in pENTR ™221 as a template.  Using 
Gateway cloning methods, the Neh2ΔDLG construct was transferred to a pDEST17 
vector containing a his-tag and a TEV cleavage sequence.  The Neh2ΔETGE and 
Neh2ΔDLG constructs were first prepared by Tong et al to study the DLG and ETGE 
interaction with the Kelch domain of mouse Keap1 (Tong, Katoh et al. 2006).  
3.2.2 Expression of the Neh2, Neh2ΔETGE and Neh2ΔDLG protein 
Neh2, Neh2ΔETGE and Neh2ΔDLG were over-expressed in the Rosetta 2(DE3) 
pLysS E. coli strain in M9 minimal medium.  The cultures were grown at 37 ºC in the 
presence of Carbenicillin (50 µg/mL) to a density of (A 600) 0.8 AU and then induced 
with 0.5 mM IPTG.   The cultures were allowed to grow over night at 22 ºC in a shaking 
incubator at 250 rpm.  Bacterial cells were harvested by centrifugation at 6,000 x g for 15 
minutes.   The bacterial pellets were resuspended in 40 mL of 1 x Phosphate buffered 
saline (PBS) and centrifuged at 6,000 x g for 15 minutes at 4 ºC in 50 mL centrifuge 
tubes.  Bacterial wet pellets weighing between 2.0 to 2.5 g were routinely obtained.  For 
NMR experiments, the media was prepared with 1 g of 15NH4Cl as the nitrogen source 
for uniformly 15N-labeled protein samples.   For the Neh2 protein backbone assignment, 
the media was prepared with 1 g of 15NH4Cl and 3 g of   13C6-glucose as the sole nitrogen 
and carbon sources, respectively. Analysis of bacterial lysate on SDS-PAGE showed that 
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Neh2, Neh2ΔETGE and Neh2ΔDLG are present in both the soluble and insoluble 
fractions.  
3.2.3 Purification of the Soluble Neh2, Neh2ΔETGE and Neh2ΔDLG protein  
The bacterial pellet of Neh2 was resuspended in lysis buffer (20 mM Tris-HCl, 1 
mM EDTA, pH 8.0).   The resuspension was incubated at 37 ºC for 15 minutes and then 
sonicated 3 x 10 second bursts on ice.  Cell debris was removed by centrifugation at 40, 
000 x g for 30 min at 4 ºC.  The supernatant was applied to Ni-Sepharose 6FF column 
equilibrated with binding buffer (20 mM Tris-HCl, 1 mM EDTA, 10 mM imidazole, 500 
mM NaCl, 10% glycerol, pH 8.0) and was incubated for 2 hours at room temperature.  
The Neh2 protein was eluted in 5 x 5 mL fractions with elution buffer (20 mM Tris-HCl, 
300 mM NaCl, 750 mM imidazole, 10% glycerol, pH 8.0).  Protein fractions were 
dialyzed over night at 4 ºC against 2 L of dialysis buffer (20 mM Tris-HCl, 1 mM EDTA, 
100 mM NaCl, 10% glycerol, pH 8.0 and 1 mM DTT).   After a second dialysis step, the 
protein sample was centrifuged at 40,000 x g for 15 min to remove aggregates.  Protein 
concentration was determined with the Bio-Rad assay (Bradford 1976).  The his-tag of 
Neh2 was removed with TEV protease (1 mg per 15 mg of protein).  The TEV cleaved 
protein sample was applied to equilibrated Ni-sepharose column and incubated for 30 
min at room temperature.  The unbound protein fraction containing the Neh2 domain was 
collected and its concentration was determined by Bio-Rad protein assay (Bradford 
1976).   Protein samples were analyzed on SDS-PAGE for purity.  For experimental 
work, the Neh2 was dialyzed in 50 mM sodium phosphate, 100 mM NaCl, 1 mM DTT, 
5% glycerol, pH 7.0.   The same purification procedure was applied to the Neh2ΔETGE 
and Neh2ΔDLG pellets to obtain soluble protein.   
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3.2.4 Purification of Neh2 and Neh2 ΔETGE protein from Inclusion bodies 
An insoluble bacterial pellet for the full-length recombinant Neh2 domain was 
resuspended in lysis buffer (50 mM Tris-HCl, 1.0% Triton X-100, 100 mM NaCl, 1 mM 
EDTA, 5 mM DTT, pH 8.0).   An equal volume of wash buffer (50 mM Tris-HCl, 0.5% 
Triton X-100, 100 mM NaCl, 1 mM DTT, 1 mM EDTA, pH 8.0) was added to 
homogenize the inclusion body suspension and then centrifuged at 25 000 x g for 30 min 
at 4 ºC.  The pellet was resuspended in solubilization buffer (25 mM Tris-HCl, 300 mM 
NaCl, 1mM EDTA, 8 M Urea, pH 7.8) and then centrifuged at 16 000 x g for 30 min at 
20 ºC. The supernatant was applied to Ni-Sepharose beads that were equilibrated with 
solubilization buffer (no EDTA added) and incubated at room temperature for 2 hours.   
The Neh2 protein was eluted in 5 x 5 mL volume fractions with elution buffer (25 mM 
Tris-HCl, 8 M Urea, 300 mM NaCl, 1 M imidazole, pH 7.8).  The eluted fractions were 
dialyzed in buffer I (25 mM Tris-HCl, 8 M Urea, pH 7.8) over night at room temperature.    
The next day, protein was dialyzed out of urea into buffer II (25 mM Tris-HCl pH 7.8, 
10% glycerol) at 4 ºC.  The his-tag of the Neh2 was removed with TEV protease.  The 
TEV cleaved protein sample was applied to equilibrated Ni-Sepharose beads and 
incubated for 30 min at room temperature.  Unbound protein was collected, protein 
concentration was determined by Bio-Rad protein assay,  and protein samples were 
analyzed on SDS-PAGE (Bradford 1976).   The same purification procedure was applied 
to the Neh2ΔETGE insoluble pellet.    
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3.2.5 Purification of Neh2, Neh2ΔETGE, and Neh2ΔDLG protein with 8 M Urea  
A 2.6 g wet pellet from 1 L of bacterial growth was resuspended in solubilization 
buffer (25 mM Tris-HCl, 8 M Urea, 5 mM imidazole, 300 mM NaCl, and 1 mM EDTA, 
pH 7.5).   The cell lysate was then sonicated for 3 x 10 seconds and centrifuged at 40 000 
x g for 30 min at 20 ºC.  The supernatant was incubated with Ni-Sepharose beads 
equilibrated with solubilization buffer (without EDTA) at room temperature for 2 hours.  
Protein was eluted in 6 x 5 mL volume fractions with Elution buffer (25 mM Tris-HCl, 8 
M Urea, 750 mM imidazole, 300 mM NaCl, pH 7.5).  The eluted protein fractions were 
dialyzed in buffer I (25 mM Tris-HCl, 8 M Urea, 1 mM EDTA, 100 mM NaCl) overnight 
at room temperature.  The following day, the protein was refolded by exchanging the 
protein into dialysis buffer II (25 mM Tris-HCl, 100 mM NaCl, pH 7.5).  Next, his-tag 
was removed from Neh2 by adding 1 mg of his-tagged TEV protease per 15 mg of 
protein and incubated over night at room temperature.   Sample was centrifuged at 40 000 
x g for 30 min at 4 ºC to remove aggregates and precipitate.  Protein was unfolded again 
by adjusting the final urea concentration of the protein sample to 8 M.  The TEV cleaved 
protein sample was then incubated with Ni-Sepharose beads.  Unbound protein was 
collected and dialyzed against buffer I.  The protein was refolded using dialysis buffer II 
at 4 ºC.   For experimental work, the Neh2 sample was dialyzed in 50 mM sodium 
phosphate buffer, 100 mM NaCl, 1 mM DTT, pH 7.0.  The protein concentrations were 
confirmed by Bio-Rad assay (Bradford 1976).  Protein samples were examined on SDS-
PAGE for purity, and samples were sent for Mass spectrometry analysis to ensure the 
protein band corresponded to the correct molecular weight.   
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3.2.6 Analytical Ultracentrifugation Experiments 
Sedimentation velocity and equilibrium experiments were conducted on a 
Beckman Optima XL-A Analytical Ultracentrifuge (Bimolecular Interactions and 
Conformations Facility,University of Western Ontario).  For sedimentation equilibrium, 
the Neh2 sample was run in 6-channel cells with epon-charcoal centerpieces, at a rotor 
speed of 35,000 rpm at 4 °C in an An60Ti rotor.  Absorbance was measured at 280 nm, 
using 0.002-cm radial steps and averaging over 10 readings.  Samples were allowed to 
equilibrate for 16 hours at the desired speed.  Apparent molecular weights of the Neh2 
domain of Nrf2 was calculated using ideal single species model in GraphPad Prism 
program (Briere and Dunn 2006).  For sedimentation velocity, two-channel cell with 
Epon-charcoal centerpieces were used for Neh2 in an An60Ti rotor.  Absorbance was 
monitored at 280 nm at rotor speed of 60,000 rpm (4 °C).  Scans were collected at 10-min 
intervals in 0.003-cm radial steps, averaged over three replicates. Data was analyzed with 
the SEDFIT software (Brown and Schuck 2006). The partial specific volume of the 
protein was calculated from the amino acid composition, using the freeware program 
SEDNTERP (Tom Laue, University of New Hampshire). 
3.2.7 Circular Dichroism  
Secondary structure contents of Neh2, Neh2ΔETGE, Neh2ΔDLG were examined 
by Circular Dichroism (CD) spectropolarimetry using a Jasco J-810 instrument 
(Biomolecular Interactions and Conformations Facility, University of Western Ontario).   
For each protein, ten scans from 260 – 190 nm (100 nm/min at 0.5 increments) were 
recorded using a 1 mm path-length cell at 20 ˚C, averaged and the buffer background was 
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subtracted.  Protein concentrations were quantified by Bio-Rad protein quantification 
assay (Bradford 1976).  The CDSSTR method along with reference set SP175 available 
on the Dichroweb was used to deconvolute the CD data (Lees, Miles et al. 2006).  Protein 
denaturation was followed in the CD at 222 nm.  The temperature was increased at a rate 
of 1 °C/min.  
3.2.8 NMR Spectroscopy  
All NMR experiments were acquired on a Varian INOVA 600 MHz spectrometer 
equipped with a pulsed field gradient triple resonance probe at 25 °C.  All samples 
contained 10% (v/v) D2O (Cambridge Isotope Laboratories), and 1 mM DSS (Sigma) as 
an internal standard for chemical shift referencing.  Protein samples were in buffer 
containing 50 mM sodium phosphate, 100 mM NaCl, 1 mM DTT, pH 7.0.  All data were 
processed with NMR Pipe and NMRDraw (Delaglio, Grzesiek et al. 1995).  Spectra were 
analyzed with NMRView (Johnson 2004).   
The 1H-15N HSQC spectra of the Neh2, Neh2ΔETGE and Neh2ΔDLG were 
collected with protein concentrations ranging from 100 µM to 200 µM.  A 0.4 mM 
uniformly 15N, 13C-labeled sample was used to acquire CBCA(CO)NH and HNCACB for 
the backbone resonance assignment of the full-length Neh2 domain of human Nrf2 
(Sattler 1999).   The Cara software was used for the backbone assignment of the human 
Neh2 domain (Keller 2004). Secondary structure propensity (SSP) scores were calculated 
using the 13Cα/β chemical shifts extracted from the HNCACB experiment (Marsh, Singh 
et al. 2006).  For the NMR titration experiments, a 100 µM 15N-labeled samples with and 
without 200 µM unlabeled Kelch were prepared for Neh2, Neh2ΔETGE and Neh2ΔDLG.  
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1H-15N HSQC NMR experiments were recorded to monitor spectral changes induced 
upon the addition of Kelch protein.    
Backbone 15N longitudinal relaxation rates (R1), relaxation rates in rotating frame 
(R1ρ), and steady-state 1H-15N NOE relaxation parameters of 400 µM 15N-labeled Neh2 
and Neh2ΔDLG were measured. Spectra were collected as 128 x 1072 complex points in 
the t1 and t2 dimensions with spectral widths of 8384.9 and 1458.4 Hz for 1H and 15N 
dimensions, respectively.  The R1, R1ρ relaxation rates and the steady-state 1H-15N NOE 
were calculated using the method described previously (Yi, Boys et al. 2007).   
 Results 3.3
3.3.1 Purification of the Neh2 domain 
The initial method used for the purification of the Neh2 domain involved isolating 
the protein from the soluble fraction of the cell lysate (Tong, Yamamoto et al. 2008).   In 
this method, a large amount of the protein is lost in the unbound and wash fractions 
(Figure 3.3a, lane 4 &5).   The loss of protein in the unbound fraction and wash step 
suggested that the His-tag is not accessible to interact with the Ni-beads.  In this 
purification procedure, more than 50% of the protein is lost in the dialysis, and the His-
tag cleavage step combined.  Additionally, when concentrating the protein to the desired 
volume, protein precipitation was observed leading to further loss in the overall protein 
yield.   
A 10 g wet bacterial pellet obtained from four liters of M9 minimal medium 
prepared with 15N-NH4Cl as the sole ammonium source was used to obtain a 100 µM 
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15N-labeled Neh2 sample to acquire an NMR HSQC of the Neh2 domain.  This 
purification yielded ~3 mg of Neh2 and included contaminants (Lanes 7 and 8 in Figure 
3.3a).    A 1H-15N HSQC of the Neh2 domain obtained from this impure sample is shown 
in Figure 3.4.   The narrow dispersion of the amide proton chemical shifts confirms that 
the human Neh2 domain is also disordered like the mouse Neh2 domain of Nrf2 (Tong, 
Katoh et al. 2006).  Although an NMR HSQC of the Neh2 domain was acquired, 
nonetheless, the Neh2 stability was compromised with this purification method, and due 
to presence of impurities, target binding studies could not be performed.  Alternatively, 
the recombinant Neh2 domain was purified from inclusion bodies in an attempt to 
increase its purity and the final yield.  The purification from the inclusion bodies resulted 
in an even lower yield of 0.6 mg, however, the sample appeared free of contaminants 
(Figure 3.3b, lane 8). 
An alternative strategy was adopted to obtain a pure sample of the recombinant 
Neh2 domain of human Nrf2 for target binding studies.  A 2.5 g pellet obtained from 1 L 
of M9 minimal media growth was suspended in 8M urea and purified under denaturing 
conditions.   The sample was refolded and then subjected to TEV protease to cleave off 
the his-tag.  The Neh2 and TEV mixture was denatured in 8M urea a second time and 
incubated wtih Ni-sepharose beads  to remove the TEV protease as well as any uncleaved 
Neh2.  This method not only resulted in pure Neh2 sample (as depicted in lane 3 of 
Figure 3.5b), but also the overall yield was improved from 0.8 mg to 35 mg, an over 40 
fold increase.   
Overlay of the NMR HSQC spectra of the refolded Neh2 and the soluble Neh2 
(Figure 3.6) confirms that the protein sample obtained by the urea denaturation technique 
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does not result in misfolding of this domain.  The Neh2 sample of 15N-labeled Neh2 
acquired from the urea denaturation process was sent for Mass spectrometry to assess its 
molecular weight.  Figure 3.7a shows a mass spectrum of one specie with a molecular 
weight of 11 810 Da.  The peak at 11 810 Da is in good agreement with the calculated 
molecular weight for the full-length Neh2 domain (MWcal = 11 812Da).   
Another useful analytical method for determining protein molecular weight as 
well as protein oligomeric state in solution is sedimentation equilibrium.  This method 
measures the equilibrium concentration distribution in the presence of a centrifugal field 
(Lewis 1994).  Equilibrium is reached when the effect of centrifugal force on the samples 
is balanced by diffusion (Lewis 1994).  The distribution is dependent on the molecular 
weight of the macromolecule and not its shape (Lewis 1994).  The molecular weight and 
oligomer state of the Neh2 domain were assessed by carrying out sedimentation 
equilibrium experiment at 35 000 rpm.  The results revealed that the Neh2 domain exists 
in the monomeric form in solution corresponding to an average molecular weight of 11 
700 Da (Figure 3.7b).  This observed molecular weight is on par with the expected 
molecular weight of 11 812 Da.  
The Neh2ΔETGE and Neh2ΔDLG constructs of the Neh2 domain were purified 
by denaturing the cell lysate from 1 L of bacterial culture in 8 M urea.   Table 3.1 
presents the Neh2, Neh2ΔETGE and Neh2ΔDLG yields obtained by the different 
purification procedures.  The solubilization of the cell lysate in 8 M urea significantly 
increased the final yield for all three constructs and the resulting protein was of high 
purity.   
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(a) 
(b) 
Figure 3.3. SDS-PAGE (12%) analysis of the overexpression and purification 
of the human Neh2 domain. Purification of Neh2 (a) from soluble fraction. 
Lanes 1 and 9 contain the protein molecular weight markers, with molecular 
weights labeled on the left of the gel. Lane 2 is the post-induction sample. Lanes 
3 and 4 contain soluble and unbound fractions, respectively.  Lane 5 is the wash 
step.  Lane 6 is the dialysis precipitate fraction. Lanes 7 and 8 represent 5 µg and 
10 µg of the final Neh2 protein, respectively. The Neh2 protein runs lower in 
lanes 6, 7 and 8 as the Neh2 was subjected to TEV protease cleavage to remove 
the his-tag present on the N-terminus of the Neh2 domain.  (b) Purification from 
inclusion bodies. Lane 1, molecular weight marker ; Lane 2, post-induction 
sample ; Lane 3, cell lysate ; Lane 4, urea soluble : Lane 5, urea-insoluble ; Lane 
6, unbound ; Lane 7, bound to beads ; Lane 8,his-tagged Neh2 ; Lane 9, his-tag 
free Neh2. 
112 
 
 
  
Figure 3.4. 1H-15N HSQC of the human Neh2 domain of Nrf2.  
1H-15N HSQC NMR spectrum of the 0.1 mM human Neh2 domain of 
Nrf2.  The spectrum was collected in 50 mM sodium phosphate, 100 
mM NaCl, 1 mM DTT, pH 7.0 at 25 ºC.   
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Figure 3.5.  Purification of Neh2 by denaturation in 8M Urea. 
SDS–PAGE (12% gel) (a) analysis of the protein sample during the first step 
of purification.   Lane 1, molecular weight markers; lane 2, cell lysate; lane 3, 
unbound fraction; lane 4, dialysis precipitate; lanes 5, his-tagged Neh2; lanes 
6, his-tagged cleaved Neh2 protein.  (b) analysis of Neh2 samples after 
second denaturation step.  Lane 1, molecular weight markers; lane 2, Neh2 
sample pre Ni-bead binding; Lane 3, the unbound fraction of Neh2 post Ni-
bead binding. 
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Figure 3.6. 1H-15N HSQC of the Neh2 domain of human Nrf2. 
100 µM of 15N-labeled Neh2 obtained from the soluble fraction of the cell 
lysate (black) is overlaid with 100 µM of 15N-labeled Neh2 obtained from urea 
denaturation method (red). 
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(a) 
Figure 3.7. Neh2 Mass spectrum and Stoichiometry. (a) Mass spectrum of 15N-labeled Neh2 domain of human Nrf2.   The 
resulting mass spectrum revealed a peak at 11 810, which is in close agreement with the 11 812 calculated molecular weight of 
the Neh2 domain. (b) Sedimentation equilibrium analysis of the Neh2 domain revealed that Neh2 exists as a monomer in 
solution and corresponds to MW of 11 700 Da, in close agreement with 11 812 calculated molecular weight for the domain. 
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Table 3.1. Protein yield in mg per liter of culture media from different purification 
methods 
 
*ND (Not determined).  The Neh2ΔDLG was not purified from the inclusion bodies as enough 
protein was obtained from the soluble fraction and from urea denaturation protocol. The urea 
denaturation protocol was preferred as the final sample from this procedure was free of 
impurities.  
  
 Neh2wt Neh2ΔETGE Neh2ΔDLG 
Soluble 0.8 mg 0.95 mg 4.0 mg 
 
Inclusion bodies 0.6 mg 2.9 mg ND * 
 
8 M Urea 35 mg 12 mg 30 mg 
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3.3.2 Backbone Assignment of the human Neh2 domain of Nrf2 
The backbone assignment of the human Neh2 domain was completed in order to 
identify amino acids that are involved in forming the binding interface with targets and to 
characterize the structural changes the protein undergoes in the presence of binding 
targets.  Using the HNCACB and CBCA(CO)NH three-dimensional NMR experiments, 
the backbone resonance assignment of the Neh2 domain was completed.  Figure 3.8 
shows a representative 1H-15N HSQC spectrum of the disordered Neh2 domain that is 
narrow in the proton dimension.   Because the Neh2 domain appears to be a disordered 
protein, extensive overlap of resonances is observed making it challenging to complete 
the backbone assignment of this domain. The backbone assignment was further 
complicated by the presence of glutamine, glutamic acid and lysine residues (amino acids 
with similar carbon chemical shifts) in the central region of the Neh2 domain.  
Regardless of the high spectral degeneracy ~ 84 % of the 1HN and 15N resonances of non-
proline residues, 83 % of all Cα and ~ 79 % of all Cβ resonances of the Neh2 domain of 
human Nrf2 were successfully completed (Table 3.2). The assignment of the Neh2 
domain in this work is comparable to the backbone resonance assignment of the Neh2 
domain of the mouse Nrf2 (Tong, Yamamoto et al. 2008).  
Figure 3.9 shows the residue specific secondary structure propensity scores (SSP) 
calculated using the assigned 13Cα/β chemical shifts with the SSP software developed by 
Marsh et al (Marsh, Singh et al. 2006).  Positive values indicate an α-helical secondary 
structural propensity, and negative values indicate a β-strand structural propensity.  The 
SSP scores calculated for the Neh2 domain show that most residues from 17 to 40 in the 
N-terminal region have a tendency to form an α-helical structure.  The center, residues 45  
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Figure 3.8. Backbone resonance assignment of the Neh2 domain of the 
human Nrf2 protein. (a) 1H-15N-HSQC spectrum and backbone resonance 
assignment of the 1H/13C/15N-labeled Neh2 domain of Nrf2. (b) Neh2 protein 
sequence with unassigned residues colored in red and the center region of high 
degeneracy is boxed. 
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Table 3.2. 15N, 13C and 1H resonance assignments for the human Neh2 domain 
Residue HN N Cα Cβ 
2 8.3 120.36 54.74 29.47 
3 8.15 121.23 54.71 41.05 
4 8.08 121.89 55.03 42.44 
5 8.3 121.56 56.12 30.34 
6 8.19 124.84 52.84 41.74 
10 8.35 108.55 44.99 
 11 8.07 122.87 53.06 41.91 
13 8.45 115.76 58.15 64.06 
14 8.5 122.11 56.41 29.28 
15 8.34 120.3 56.4 29.41 
16 8.25 121.01 54.97 40.96 
17 8.21 120.36 56.17 32.75 
19 7.91 121.12 55.72 42.06 
20 7.86 119.7 62.3 38.26 
21 8.09 122.11 55.34 41.43 
22 7.84 119.48 62.44 38.57 
23 8.11 122.65 56.12 41.82 
24 7.96 120.16 57.81 29.3 
25 7.75 120.9 56.56 30.82 
26 8.15 119.92 58.58 29.5 
27 8.3 120.25 54.65 40.82 
28 7.8 119.81 61.4 38.86 
29 8.28 123.31 54.43 41.13 
30 8.23 122.34 55.62 42.22 
31 8.42 108.55 45.71 
 32 7.78 118.39 62.09 32.99 
33 8.35 118.83 58.32 63.71 
34 8.45 123.31 56.62 30.6 
35 8.4 120.47 57.28 30.34 
36 7.92 119.98 62.93 32.48 
37 8.18 123.31 58.28 39.78 
38 8.23 121.78 54.16 40.88 
39 8.3 122.22 59.59 39.07 
40 8.38 115.98 60.51 63.01 
43 8.58 120.03 55.66 32.53 
44 8.16 121.03 54.81 38.77 
45 8.18 120.8 58.11 29.9 
46 8.13 120.58 60.13 38.21 
47 8.34 119.94 58.82 29.33 
48 8.06 120.8 57.49 41.81 
49 8.08 119.26 58.11 28.37 
52 8.26 119.7 58.96 29.48 
53 7.98 121.01 59.05 32.51 
54 8 120.53 57.72 41.88 
62 8.06 121.12 57.65 41.83 
63 8.09 119.92 58.79 29.07 
64 8.05 120.58 58.78 32.36 
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65 8.19 119.15 58.55 28.36 
66 8.15 120.3 54.71 41.09 
69 7.96 122.55 53.51 18.74 
70 8.02 119.05 59.03 39.24 
71 8.03 119.81 58.79 39.23 
72 8 123.53 53.12 19 
73 7.97 117.95 56.13 29.17 
74 7.93 121.89 55.27 42.99 
75 8.43 120.22 57.66 30.09 
76 8.28 124.3 55.31 42.59 
77 8.49 123.2 54.4 41.72 
78 8.54 123.09 57.68 30.17 
79 8.42 120.03 57.53 30.19 
80 8.03 111.28 61.94 70.31 
81 8.42 111.17 45.5 
 82 7.93 119.7 55.96 31.02 
83 8.42 120.8 57.48 39.59 
84 8.3 125.72 52.52 42.39 
86 8.16 121.79 61.01 38.81 
87 8.46 125.72 53.43 28.95 
89 8.4 124.08 52.48 19.2 
90 8.32 119.15 55.73 29.69 
92 8.1 123.09 60.94 38.69 
93 8.53 125.17 55.79 29.45 
94 8.41 117.84 58.36 63.82 
95 8.59 122.98 56.72 30.35 
96 8.23 114.45 61.5 69.74 
97 8.33 118.39 58.32 63.86 
98 8.08 117.08 46.32 
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Figure 3.9. Secondary structure propensity of the Neh2 domain of Nrf2.   
A score of 1 represents a fully helical structure and -1 represents a β-sheet structure.  
The score was calculated based on the Cα and Cβ chemical shifts obtained from the 
HNCACB and CBCA(CO)NH experiments. 
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to 65, of the Neh2 domain appear to be an extended helix, whereas, the C-terminus of the 
domain has a β-structure like propensity based on the assigned residues. 
3.3.3  Neh2 binding to the Kelch domain of the human Keap1 
To ensure that the purified recombinant Neh2 domain was folded properly, the 
binding of Neh2 to the Kelch domain of human Keap1 was examined.  The overlay of the 
1H-15N HSQC spectra of the Neh2 domain in the free and Kelch bound states is shown in 
Figure 3.10.  A significant amount of signal broadening is observed in the Kelch bound 
state spectrum suggesting that the Neh2 protein is able to interact with the Kelch domain 
of Keap1.  Since it is known that the mouse Neh2 domain interacts with two independent 
Kelch domains, the complex formed is almost 80 kDa in size (Tong, Katoh et al. 2006).   
Assuming that the human Neh2 interacts with the Kelch domain in a 2:1 ratio similar to 
the mouse Neh2-Kelch binding, the formation of such a large complex can result in 
slowing the tumbling time of the Neh2 protein, thus providing an explanation for the 
observed disappearance of the resonance signals in the Neh2-Kelch bound state HSQC 
spectrum (Figure 3.10).    
The Neh2ΔETGE and Neh2ΔDLG, low affinity binding motif and high affinity 
binding motif, respectively, were created to study their binding properties with the Kelch 
domain of the human Keap1 (Tong, Katoh et al. 2006) .  An overlay of the two-
dimensional 1H–15N HSQC spectra of the wild-type Neh2 with the Neh2ΔDLG and the 
Neh2ΔETGE is shown in Figure 3.11a&b.  In the 1H–15N HSQC of the Neh2ΔDLG, we 
observe that the first 33 residues deleted in the construct disappear in the HSQC 
spectrum.  Additionally, peak broadening is observed for residues in the surrounding  
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Figure 3.10. An overlay of 1H-15N HSQC spectrum of Neh2 domain 
(black) and in complex with the Kelch domain of Keap1 (red).  
0.1 mM of 15N-labeled Neh2 full length protein was used to collect the Neh2 
spectrum in the absence of Kelch.  In the Kelch bound state, 0.2 mM of 
unlabeled Kelch domain of Keap1 was added to achieve a 1:2 ratio of Neh2 to 
Kelch 
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Figure 3.11. 1H-15N HSQC of Neh2 variants. (a) overlay of Neh2ΔDLG spectrum (orange) with Neh2 full-length 
(black); (b) overlay of Neh2ΔETGE spectrum (orange) with Neh2 full-length (black).  The backbone resonance 
assignments were transferred from the full length Neh2.  The crowded regions have been enlarged.  Schematic 
diagrams showing the deleted regions have also been shown for each of the Neh2ΔDLG and Neh2ΔETGE. 
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environment including R34, F37, D38 and R43. Interestingly, chemical shift attenuations 
for the C-terminal residues A69, F70, A72, Q73, L74, Q75, and L76 are also seen.  The 
remaining residues that appear in the wild-type and the Neh2ΔDLG spectra align well.  
The proton dimension of the Neh2ΔDLG is also narrow like the wild-type Neh2 domain, 
representative of a disordered protein.   This indicates that the deletion of the first thirty-
three residues in the Neh2 domain does not alter the disorder nature of the Neh2 domain.     
The 1H–15N HSQC overlay of the full length wild type Neh2 domain with the 
Neh2ΔETGE in Figure 3.11b reveals that peaks corresponding to the deleted residues 
E79, T80, G81, E82 disappear confirming that the backbone resonance assignment is 
accurate for these residues.  Additional resonance signal loss is detected for residues Q75, 
L76, D77 and E78.  Chemicals shift changes are also observed in the C-terminal region 
for residues A69, A72, Q73, Q87, S97 and S94.  Minimal signal perturbations are 
observed for N-terminal residues L11, D28, I28, I22, R25, S33 and S40.  Like the 
Neh2ΔDLG deletion, the ETGE deletion also has no impact on the disordered nature of 
the Neh2 domain as most of the protein peaks align well with the wild type spectrum in a 
narrow proton dimension.  Therefore, the Neh2ΔETGE also retains the disordered 
structure of the wild-type Neh2 domain. 
3.3.4 Two site substrate recognition of the human Nrf2-Keap1 system 
The Neh2ΔDLG and Neh2ΔETGE binding to the Kelch domain of the Keap1 
protein were studied by NMR to ensure that the human Neh2 domain indeed interacts via 
the ETGE and DLG motifs with the Keap1 protein as observed for the mouse Nrf2- 
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Figure 3.12. 1H-15N HSQC of Neh2 variants in free and Kelch bound states at 25 ºC and 30ºC.  
(a) Neh2ΔDLG (black), Neh2 ΔDLG and Kelch at 25 ºC (orange), and Neh2ΔDLG and Kelch at 30 ºC (cyan). (b) 
Neh2ΔETGE (black), Neh2ΔETGE and Kelch at 25 ºC (orange), and Neh2ΔETGE and Kelch at 30 ºC (cyan).  
The bound state of Neh2 variants with Kelch was in a 1:2 molar ratio, respectively.   
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Keap1 system (Tong, Katoh et al. 2006).  1H–15N HSQC overlay of the free and Kelch 
bound states of Neh2ΔDLG and Neh2ΔETGE are depicted in Figure 3.11a&b.   The 
Neh2ΔDLG bound to Kelch at 25 ºC shows that the resonance signals for L74, L76, D77, 
E78, E79, T80, G81, E82, L84 residues in the C-terminal region of the Neh2 domain 
undergo line broadening.  This suggests that the ETGE motif of the Neh2 domain 
interacts with the human Kelch domain.  In an attempt to minimize the line broadening 
effect, the temperature was increased by 5 ºC.  1H–15N HSQC of the Neh2ΔDLG bound 
to Kelch obtained at 30 ºC  (Figure 3.12a in cyan) indicates that the resonance signals are 
still not recovered for peaks that undergo line broadening at 25 ºC.  The temperature was 
not increased significantly as the Kelch domain is unstable and aggregates at higher 
temperatures.    
Similarly, the 1H–15N HSQC of the Neh2ΔETGE-Kelch complex displays 
resonance signal loss for  residues Q14, D16, I20, W24, I28, D29, L30, G31, V32, S33, 
R34, F37, F39 and S40.  Chemical shift changes are also observed for L6, L11, S13, Q14, 
L23, and R25.  Increasing the temperature to 30 ºC reduced peak broadening.  The indole 
ring of the tryptophan as well as a weak peak for Q14 is detected at 30 ºC (Figure 3.12b 
in cyan).  Remarkably, both the Neh2ΔDLG and Neh2ΔETGE retain their signature 
spectra of a disordered protein, a narrow proton dimension, in the bound state with the 
Kelch domain.  This indicates that both Neh2ΔDLG and Neh2ΔETGE do not undergo a 
large structural transition, from a disordered to ordered state, in the target bound state.  
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3.3.5  Secondary structure analysis of the Neh2 domain, Neh2ΔDLG and 
Neh2ΔETGE 
Upon the deletion of the first thirty-three residues of the N-terminal, chemical 
shift changes were observed in the C-terminal region of the Neh2 domain.  Similarly, 
deletion of the ETGE region led to minor changes in the N-terminal region as observed in 
the NMR HSQCs in Figure 3.11b.   The data suggested that the N-terminal region maybe 
interacting with the C-terminal region of the protein.  To study if there is any secondary 
structural elements in the Neh2 domain that maybe leading to this weak interaction 
between the two termini of the domain, the secondary structure of the Neh2 and its 
variants were studied by CD spectroscopy.  The far-UV CD spectra of the Neh2, 
Neh2ΔDLG and Neh2ΔETGE in Figure 3.13a,b&c indicate that the Neh2 domain is 
helical in nature.  The secondary structure content of the Neh2 and its variants were 
quantitatively determined by CDSSTR analysis program available on the Dichroweb 
website (Whitmore and Wallace 2008).  The results indicate that the Neh2 domain has 
76% helical, 7% β-strand, 17% disordered/turn structure in 50 mM sodium phosphate 
buffer at pH 7.0.  Based on the CD spectra the Neh2ΔDLG contains 78% helical, 4% β-
strand and 17% disordered/turn structure.   The Neh2ΔETGE CD data analysis revealed 
65% helical, 6% β-strand and 17% disordered/turn structure in 50 mM sodium phosphate 
buffer at pH 7.0.    When a protein contains a region of α-helical content, the spectral 
contribution from the helix may swamp the signal of other secondary structure content 
(Whitmore. and Wallace. 2007) .  This is because, firstly the ϕ/ψ angles of helices are 
well defined, and secondly, helical components produce very intense CD signals.  Thus 
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Figure 3.13.  Secondary structure of the Neh2 protein and its variants measured by far-UV CD 
spectropolarimetry. The figure displays the spectra of (a) Neh2 FL (full length), (b) Neh2ΔETGE, (c) Neh2ΔDLG.  The 
far-UV CD spectra of Neh2 and its variants show a high degree of α-helical structure. 
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the accuracy of the disordered content by CD is compromised (Whitmore and Wallace 
2008). Hence, the observed high helical content in Neh2 and its variants could be 
resulting from the intense signal of the central helix.  Interestingly, the θ222/208 for the full 
length Neh2 is 0.72, 0.78 for NehΔETGE, and 0.80 for Neh2ΔDLG indicative of isolated 
non-interacting helices (Lavigne, Kondejewski et al. 1995).  
The stability of the helical structure for Neh2, Neh2ΔDLG and Neh2ΔETGE was 
tested by thermal unfolding experiments.  The protein was properly refolded after the 
thermal denaturation as shown in the overlay of the post melt CD spectra with the pre 
melt CD spectra in Figure 3.13a,b&c.  Remarkably, the Neh2 domain and its two variants 
did not show a clear cooperative sigmoidal melt with the increase in solution temperature 
(Figure 3.14).  The lack of a cooperative unfolding indicates the absence of a stable 
structure and thereby confirms the disordered nature of Neh2, Neh2ΔETGE and 
Neh2ΔDLG. 
3.3.6 Hydrodynamic radius of Neh2 protein 
Sedimentation velocity, an analytical ultra-centrifugation (AUC) technique, is an 
alternative method to determine the molecular weight and hydrodynamic (Stokes) radius 
of proteins in solution.  For the purpose of this study, sedimentation velocity technique 
was used to further enhance our understanding of the intrinsic nature of the Neh2 domain.  
Although the NMR data and the CD data agree that the Neh2 is a disordered protein with 
some helical structure, understanding of the hydrodynamic radius would provide further 
information about the compactness of the Neh2 domain.  In the sedimentation velocity 
run, a 0.2 mg/mL concentration of the Neh2 domain was used. The data was fitted using  
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Figure 3.14. Thermal melting of Neh2 FL and its variants Neh2ΔETGE and 
Neh2ΔDLG at 222 nm. Unfolding is monitored by the increase of [Θ] as a 
function of temperature.   
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Figure 3.15.  Analytical ultracentrifugation experiment of  
Neh2 domain.  The sedimentation of Neh2 (40 µM) was analyzed 
with a Beckman Coulter XL-I analytical ultracentrifuge at 4°C and at 
60,000 rpm. 
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a size distribution analysis in a program called SEDFIT (Brown and Schuck 2006).  The 
presence of more rapidly sedimenting peaks in Figure 3.15, corresponding to a molecular 
mass of 63 kDa, indicates the existence of aggregates in the sample.  A peak with 
molecular mass of 13.9 kDa is also observed and this peak corresponds to the Neh2 
domain. The SEDFIT program calculated the sw to be 0.7795, sw (20, w) to be 0.8005 and 
a stokes radius of 2.55 nm (25.5 Å).   
3.3.7  Backbone Dynamics of the Neh2 protein 
The lack of chemical shift dispersion in the 1H-15N HSQC spectrum of the human 
Neh2 domain is typical of an unstructured protein.  However, the SSP scores and the CD 
data indicate the presence of a pronounced helical as well as a β-sheet structure in the 
Neh2 domain.  This suggests that Neh2 domain is amongst the biologically active 
disordered proteins that retain some secondary structure (Eliezer, Kutluay et al. 2001; 
Bienkiewicz, Adkins et al. 2002; Mark, Liao et al. 2005).  To relate the average 
secondary structure with Neh2 dynamics, the amide backbone dynamics of the Neh2 
domain and the Neh2ΔDLG construct were studied by NMR relaxation experiments. The 
R1, R2, and the steady-state heteronuclear NOE values provide information of motion on 
the picosecond-to-microsecond timescale thus helping identify regions restricted in 
motion and regions with high flexibility (Kay, Torchia et al. 1989).  For the Neh2 
domain, of the 84 assigned resonances, 74 were used for the measurement of the R1, R2 
and the heteronuclear NOE values (Figures 3.16). The R1 values range from 0.77 ± 0.01 
s-1 to 1.88 ± 0.03 s-1 with an average of 1.56 ± 0.03 s-1.  The R2 values range from 1.25 ± 
0.03 s-1 to 17.71 ± 0.68 s-1 with an average of 8.27 ± 0.23 s-1.  The steady-state NOE 
values range from -1.87 ± 0.02 s-1 to 0.61 ± 0.03 s-1 with an average of 0.10 ± 0.02s-1.   
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Figure 3.16.  Backbone 15N NMR relaxation data for Neh2 full-length 
(red) and Neh2 ΔDLG (blue). (a) Longitudinal relaxation rate (R1); (b) 
transverse relaxation rate (R2); 1H-15N heteronuclear NOE.   
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The R1 values, of the 24 resonances of the Neh2ΔDLG, range from 0.78 ± 0.003 s-
1 to 1.88 ± 0.01 s-1 with an average of 1.62 ± 0.01 s-1.  The R2 values range from 1.12 ± 
0.024 s-1 to 12.47 ± 0.17 s-1 with an average of 7.07 ± 0.17 s-1.  The steady-state NOE 
values range from -1.54 ± 0.001 s-1 to 0.7 ± 0.01 s-1 with an average of 0.004 ± 0.003s-1.   
 Discussion 3.4
The human Nrf2 protein is a major regulator of the oxidative stress response 
pathway.  Limited number of studies have examined the Kelch-Nrf2 interaction in full-
length context (Lo, Li et al. 2006; Tong, Katoh et al. 2006; Tong, Padmanabhan et al. 
2007).   In this work, a new high yield purification method for Neh2 domain of human 
Nrf2 allowed investigation of the Keap1-Nrf2 in full-length context.    
Purification of the Neh2 domain from the soluble fraction yielded about ~0.8 mg 
of impure protein from 1 L of M9 bacterial culture (Figure 3.3a), therefore, not suitable 
for structural and binding experimental studies.  One of the main objectives achieved in 
this part of the project was the increase in the final yield of Neh2 by more than 40 fold.  
The purity of the Neh2 in the final sample was also enhanced significantly (Figure 3.5b 
line 3).  Identical NMR HSQC spectra were obtained through the different protein 
purification methods, suggesting that the final structure of the Neh2 is not compromised 
with the high yield purification procedure. Additionally, the Neh2 obtained with the 
revised purification method is functional as it is capable of binding to the Kelch domain 
of Keap1 (Figure 3.10).  
Structural properties of the Neh2 domain were also assessed to ensure that it 
behaves similarly to the mouse Neh2 domain of Nrf2 (Tong, Katoh et al. 2006).  NMR 
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data revealed that the human Neh2 domain is intrinsically disordered.  However, analyses 
of the secondary structure propensity (SSP) scores show the N-terminal region with an α-
helical tendency, and central region to be helical in structure.  It has been recently 
reported that the N-terminal region forms a helical structure upon binding to Keap1 
(Fukutomi, Takagi et al. 2014).  The C-terminal region shows a tendency to form β-sheet 
like structure.  This data is consistent with what has been observed for the mouse Neh2 
domain (Tong, Katoh et al. 2006) and also with the PrDOS prediction (Figure 3.2).  
Residues 39 to 71 of the mouse Neh2 domain have been shown to form a central helix 
(Tong, Katoh et al. 2006).  Residues between 10 to 30 also have CSI values close to 1 for 
the mouse Neh2 domain indicating a tendency towards forming an α-helical structure 
(Tong, Katoh et al. 2006).  It has also been known from the crystal structures of the Neh2 
domain bound to the Kelch domain of Keap1 that both the mouse and human ETGE 
regions form a β-hairpin loop (Lo, Li et al. 2006; Padmanabhan, Tong et al. 2006).  The 
ETGE motif of the Neh2 domain of human Nrf2 has also been shown to have a tendency 
to form a β-turn structure in its free form (Cino, Wong-ekkabut et al. 2011).  Thus the 
SSP scores obtained for the full-length Neh2 domain of human Nrf2 are in a good 
agreement with previously published data and confirm that the Neh2 domain has a partial 
secondary structure.  
Two constructs corresponding to the low binding affinity motif, Neh2ΔETGE, 
and the high binding affinity motif, Neh2ΔDLG, were constructed to study the two site 
binding of the Neh2 domain with the Kelch domain of Keap1 (Tong, Katoh et al. 2006).  
Binding of the full-length Neh2 domain to Kelch undergoes substantial line broadening 
which could be attributed to the increase in molecular tumbling time due to the formation 
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of a large complex (~80 kDa) and to the intermediate conformational exchange between 
the free and bound states (Tong, Katoh et al. 2006).  However, the two constructs, form a 
complex of approximately 44 kDa each when bound to the Kelch domain individually.  
ProTα in the bound state to Kelch forms a complex of 46 kDa.  The bound state 1H-15N 
HSQC spectrum of the ProTα shows no resonance broadening (Khan, Cino et al. 2013).   
When compared to ProTα, the bound sate 1H-15N HSQC spectra of the Neh2ΔDLG and 
NehΔETGE (Figure 3.12 a&b) show dramatic signal broadening, even at higher 
temperatures. The observed line broadening effect can mostly be ascribed to the 
intermediate chemical exchange effects of the bound and the unbound forms of the Neh2 
variants.   
The Neh2ΔETGE-Kelch bound HSQC spectrum shows peak attenuations in 
flanking residues of the previously identified DLG motif (Tong, Katoh et al. 2006; Tong, 
Padmanabhan et al. 2007).  Recently, it was reported that residues M17 to Y46 are part of 
the DLG motif and crucial for interaction with the Keap1 protein (Fukutomi, Takagi et al. 
2014).   The observed chemical shift changes for the Neh2ΔETGE-Kelch are in par with 
this recent finding and emphasize the study of ligand binding in full-length proteins.  
Interestingly, NMR HSQC of the Neh2ΔDLG and Neh2ΔETGE reveal that upon 
introducing these deletions, the Neh2 domain retains its intrinsic disordered structure 
(Figure 3.11).  A narrow spectra in the proton dimension is also observed in the Kelch 
bound state for both Neh2 constructs (Figure 3.12) suggesting that Neh2 does not 
undergo a substantial structural transition in the target bound state similar to ProTα 
(Khan, Cino et al. 2013).   Moreover, the HSQC spectra of the two Neh2 variants in the 
free and the Kelch bound state revealed the possibility that the N and C termini of the 
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Neh2 domain maybe involved in interactions.  The CD data of the Neh2 domain indicates 
the presence of a pronounced helical structure in the Neh2 domain and its variants.  
However, the θ222/208 ratios below 1 indicate that the observed helical spectra are of a 
protein containing independent non-interacting helices (Lavigne, Kondejewski et al. 
1995).    
The compactness and the flexibility of the Neh2 domain were examined to 
explain the relation between the N and C termini.  Sedimentation velocity experiments 
revealed that the Neh2 has a hydrodynamic radius of around 25.5 Å.  For a structured 
protein with similar number of residues as that of the Neh2 domain, the hydrodynamic 
radius of the folded state is calculated to be 19 Å and for the fully denatured state the 
hydrodynamic radius of the same protein is around 32 Å (Wilkins, Grimshaw et al. 
1999).  ProTα is also similar in size as the Neh2 domain and has a hydrodynamic radius 
of around 34 Å (Yi, Boys et al. 2007).  The fact that the hydrodynamic radius of the Neh2 
domain is less than that of the ProTα and other denatured proteins of similar size strongly 
suggests that it is more compact in shape than the average unstructured protein of the 
same size.  Based on this it is possible that the N and C terminal residues maybe involved 
in long range interactions.   
The relaxation rates and the heteronuclear NOEs shed further light on the 
flexibility and compactness of the human Neh2 domain.   The average R1 rate observed 
for the Neh2 domain is 1.56 ± 0.03 s-1.  R1 values for Neh2 domain fall within the 
expected range of a folded protein of the same size.  For instance, the average R1 rate for 
the globular 89 amino acid Barstar is close to 2 s-1, obtained at 300 K, under 600 MHz 
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magnetic field (Sahu, Bhuyan et al. 2000).  When compared to ProTα (average R1 value 
of 2.45 s-1), Neh2 domain is more restricted in motion (Khan, Cino et al. 2013).   
For a globular protein with the same size as the Neh2 domain, the average R2 
values are approximately 10 s-1 (Walma, Aelen et al. 2004).  The high R2 rates of the 
Neh2 (average ~8 s-1) suggest that this domain is structured.  However, the N and C 
termini of the Neh2 domain have R2 values ranging from 1.25 s-1 to 6.0 s-1 and are 
comparable to ProTα (Khan, Cino et al. 2013).  Whereas, residues 19 to 80 (with the 
exception of residue 30, 43 and 44) have R2 values that range from 7 s-1 to 17.7 s-1.   The 
high R2 values for this helical region imply that it is dynamically restricted or experiences 
conformational exchange, or both.  
 The average R2 values for  the 99 residue β2-microglobulin, obtained under same 
magnetic field strength and temperature, are also very high, ranging from 7 s-1 to 18 s-1 
(Platt, McParland et al. 2005).  Experimental evidence suggests that these high R2 values 
for β2-microglobulin are a result of long range and non-native interactions between the 
aromatic residues found in the central region of the protein (Platt, McParland et al. 2005).  
In the Neh2 domain, we do not observe large cluster of aromatic residues; however, the 
phenylalanine residues, F37, F39, F70 and F71, and one Tyr 46 could possibly be 
involved in long range interactions.  These long range interactions, if any, would provide 
an explanation for the observed motional restriction of the central helical region as well 
as the lower hydrodynamic radius of the Neh2 domain.  
The steady-state 1H–15N NOE values are also in agreement with the R2 rates.  The 
negative NOE values of the N and C termini indicate these regions to be lacking 
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structure, therefore, are highly flexible.  Whereas the positive NOE values of the central 
region confirm the motional restriction of the helix.  
The relaxation rates reveal no significant difference between the R1 values of the 
full-length Neh2 domain and the Neh2ΔDLG.  The R2 values for residues 38 to 80 of the 
Neh2ΔDLG are higher than what is expected of a globular protein with the same size, 
confirming the lack of flexibility in this region or conformation exchange (Sahu, Bhuyan 
et al. 2000).  The NOE values of the central region increase slightly, making this region 
more restricted in motion, whereas, the C-terminal region remains disordered as observed 
for the wild type Neh2. The relaxation data also confirms that deleting the first thirty-
three residues does not lead to folding of the Neh2 domain.     
The work completed in this chapter allowed us to directly investigate the 
interaction of the full-length Neh2 domain of human Nrf2 with the Kelch domain in 
chapter 4.  Recently, there has been great interest in drug therapies using the Neh2 
domain as a target (Suzuki, Motohashi et al. 2013).  Binding studies with the full-length 
Neh2 domain can be used to study the effect of potential drug targets on the Nrf2-Keap1 
system.  Additionally, in Chapter 1, positive and negative regulators such as p62 and p21 
Cip1/WAF1 of the Nrf2 been mentioned.  This work lays the foundation for direct binding 
studies with p21Cip1/WAF1, which competes for Keap1 binding with Nrf2 (Taguchi, 
Motohashi et al. 2011).  
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Chapter 4  
 Molecular effects of cancer-associated somatic mutations on 4
the structural and target recognition properties of Keap1 
 
 Introduction 4.1
The Nrf2/Keap1 antioxidant pathway plays critical roles both in chemoprevention 
and cancer pathogenesis (Kwak and Kensler 2010; Müller and Hengstermann 2012; 
Jaramillo and Zhang 2013; Suzuki, Motohashi et al. 2013).  The transcription factor 
Nuclear factor erythroid 2-related factor-2 (Nrf2) induces the cellular defenses against 
reactive oxygen species and toxic substances by initiating the transcription of an array of 
cytoprotective genes, which are essential for the elimination of electrophilic and 
oxidative stresses before damage is caused to the cellular macromolecules (Itoh, Chiba et 
al. 1997; Itoh, Wakabayashi et al. 1999). Under normal conditions, its activity is 
suppressed by Keap1 (Kelch-like ECH-associated protein 1) in conjunction with the 
Cullin 3 (Cul3) E3 ubiquitin ligase complex via ubiquitin-mediated proteasomal 
degradation (Itoh, Wakabayashi et al. 1999; Kobayashi, Kang et al. 2004; Zhang, Lo et 
al. 2004; McMahon, Thomas et al. 2006).  In the presence of oxidative stress, however, 
specific cysteine residues in Keap1 are subjected to modifications by the oxidants (Zhang 
and Hannink 2003). The modified Keap1 is incapable of targeting Nrf2 for 
ubiquitination, allowing Nrf2 to translocate into the nucleus to initiate gene transcription 
(Itoh, Chiba et al. 1997).    
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Accumulation of Nrf2 in the nucleus however, can lead to aberrant cytoprotective 
gene expression if not regulated (McMahon, Itoh et al. 2003; Singh, Misra et al. 2006; 
Hayes and McMahon 2009).  Keap1 is a cytosolic protein that lacks a nuclear localization 
signal and cannot enter the nucleus on its own to regulate Nrf2 levels (Niture and Jaiswal 
2009).  Recent studies have revealed that the Keap1 protein can be shuttled to the nucleus 
in complex with ProTα, an intrinsically disordered protein that contains a nuclear 
localization signal (Niture and Jaiswal 2009).  Once in the nucleus, Keap1 mediates 
ubiquitination and proteasomal degradation of Nrf2, causing Nrf2 to return to its basal 
level. This regulatory mechanism is essential as the continuous expression of 
cytoprotective proteins can promote cell proliferation leading to tumorigenesis (Ohta, 
Iijima et al. 2008; Shibata, Kokubu et al. 2008; Jaramillo and Zhang 2013).   
As mentioned in chapter 1, the three main functional domains of Keap1, called 
the Broad complex, Tramtrack and Bric-a-Brac (BTB) domain, the intervening region 
(IVR), and the Kelch domain, all contribute to Nrf2 repression.  The N-terminal BTB 
domain is responsible for Keap1 dimerization.  This domain, together with the IVR 
domain, mediates the Keap1 interaction with the Cul3-E3 ligase complex required for the 
ubiquitination of Nrf2 (Cullinan, Gordan et al. 2004; Kobayashi, Kang et al. 2004; 
Zhang, Lo et al. 2004).  The C-terminal Kelch domain is responsible for target 
recognition.  Besides Nrf2 and ProTα, this domain has also been shown to interact with 
WTX (Camp, James et al. 2012), p62 (Komatsu, Kurokawa et al. 2010), PGAM5 (Lo and 
Hannink 2006), PALB2 (Ma, Cai et al. 2012), FAC1 (Strachan, Morgan et al. 2004), and 
IKKβ (Kim, You et al. 2010) to name a few (Hast, Goldfarb et al. 2013).  In the case of 
Nrf2, the N-terminal Neh2 domain of the protein harbors two Kelch-binding motifs via 
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the ETGE and DLG motifs (Tong, Katoh et al. 2006; Tong, Kobayashi et al. 2006).  This 
binding mechanism allows the lysine residues located in between these two motifs in the 
Neh2 domain to be properly positioned for ubiquitination (McMahon, Thomas et al. 
2006; Tong, Katoh et al. 2006; Tong, Kobayashi et al. 2006).  On the other hand, other 
targets of Keap1 like ProTα form a complex with the Kelch domain in a one to one 
stoichiometry (Khan, Cino et al. 2013).  
Over 200 somatic mutations within Keap1 have been reported in various types of 
cancer tissues and cancer-derived cell lines (Singh, Misra et al. 2006; Ohta, Iijima et al. 
2008; Shibata, Kokubu et al. 2008; Network 2012; Yoo, Kim et al. 2012; Hast, Cloer et 
al. 2014).   Several of them have been shown to be defective in inhibiting Nrf2 activity 
(Ohta, Iijima et al. 2008; Shibata, Kokubu et al. 2008; Suzuki, Maher et al. 2011), 
resulting in constitutive expression of cytoprotective enzymes in cancer cells thus 
promoting cell survival (Hayes and McMahon 2009).  It has been speculated that these 
mutations compromise Keap1’s structural integrity, rendering it incapable of promoting 
the ubiquitination of Nrf2 (Lo, Li et al. 2006; Hayes and McMahon 2009).  However, 
only a few studies of the structural and target-binding properties of these mutants have 
been carried out to date (Lo, Li et al. 2006; Hast, Cloer et al. 2014).  Therefore, the 
molecular links between these mutations and the diseases remain poorly understood.  
To address this problem, we set out to elucidate the effects of disease-associating 
missense mutations on the structural integrity and target recognition of Keap1 by using 
nuclear magnetic resonance (NMR) spectroscopy, CD spectropolarimetry and ITC.  We 
have chosen to focus on the Kelch domain of Keap1 in this study.  Importantly, close to 
50% of the missense somatic mutations identified in Keap1 so far are found to reside in 
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this domain (based on the data in the database of the Catalogue of Somatic Mutations in 
Cancer-COSMIC (Forbes, Bindal et al. 2011).  Crystallographic studies show that the 
Kelch domain adopts a six-bladed β-propeller conformation with several conserved 
amino acids that are important for maintaining the hydrogen bond network, linking the 
propeller blades and forming the hydrophobic core of the protein (Li, Zhang et al. 2004; 
Lo, Li et al. 2006; Padmanabhan, Tong et al. 2006).  In particular, there is a conserved 
glycine doublet found in each blade of the Kelch domain.  These two glycine residues are 
involved in an intrablade hydrogen bond network that may be instrumental in the folding 
of individual blade structures.  Both the ETGE and DLG motifs of Nrf2, as well as ProTα 
are found to bind to the same positively charged pocket located at the mouth of the 
central tunnel of the Kelch β-propeller (Lo, Li et al. 2006; Padmanabhan, Nakamura et al. 
2008).  
We have selected nine cancer-associated somatic mutations, G333C, G350S, 
G364C, G379D, R413L, R415G, A427V, G430C, G476R, to investigate their effects on 
the target recognition and structural integrity of the Kelch domain of Keap1 (Table 4.1) 
(Padmanabhan, Tong et al. 2006; Singh, Misra et al. 2006; Ohta, Iijima et al. 2008; 
Shibata, Kokubu et al. 2008; Hayes and McMahon 2009; Suzuki, Maher et al. 2011; Yoo, 
Kim et al. 2012). These mutants can be divided into three categories based on their 
location in the Kelch domain.  The R415 residue is one of the conserved Arg residues 
located in the positively charged vicinity in the bottom face of the propeller (Figure 4.1a)  
 
 
 
148 
 
 
Table 4.1. Somatic mutations included in this study. 
 
 
Abbreviations: ADC: Adenocarcinoma, SCC: Small cell carcinoma, LCC: Large cell 
carcinoma. References: Lo et al (2006) EMBO J, 25, 3605-3617; Hayes & McMahon 
(2009) Trends Biochem Sci, 34, 176-188. 
 
 
 
Type Location in 
Kelch 
Specimen Cancer 
Type 
G364C Blade II Cell line    
H1648 
Lung (ADC) 
R415G Blade III Patient Lung (ADC) 
R413L Blade III Patient Lung 
G350S Blade I Cell lines and  
Patient 
Lung 
A427V Blade III Patient Lung (SCC) 
G333C Blade I Cell line A549 Lung 
G379D Blade II Patient Gall Bladder  
(ADC) 
G430C Blade III Patient Lung (ADC) 
G476R Blade IV Patient Lung (LCC) 
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and it is directly involved in the interface formation with ProTα and Nrf2 (Lo, Li et al. 
2006; Padmanabhan, Tong et al. 2006; Padmanabhan, Nakamura et al. 2008).  The 
G364C and R413L mutants are also included in the same category as the R415G.  Even 
though these two residues do not directly participate in target binding, they are both next 
to residues that are involved in the ProTα and Nrf2 interactions (Figure 4.1a) (Lo, Li et 
al. 2006; Padmanabhan, Tong et al. 2006; Padmanabhan, Nakamura et al. 2008).  
Conversely, the second set of mutations, G350S and A427V, are distant from the binding 
interface.  The G350S as shown in Figure 4.1b is at the opposite side of the basic pocket, 
and the A427V is found within a β-strand of blade III of the propeller.  The last group, 
containing G333C, G379D, G430C, and G476R, are mutations that occur in the 
conserved double glycine repeats located in different blades (Figure 4.1c) (Li, Zhang et 
al. 2004).  Three of these four mutations, G333C, G379D and G430C, occur in the 
second position of the GG repeat while the G476R occurs in the first position of the 
doublet.  Since these glycine residues are expected to play an important structural role in 
the Kelch domain, it is important to assess the impacts of these mutations on the 
domain’s structural integrity and function.    
NMR and ITC were used to examine the interactions between Nrf2/ProTα and the 
Kelch mutants.  Nrf2 and ProTα have been shown to have the strongest and the weakest 
binding affinity, respectively, to the wild-type Kelch domain among all the known 
partners (Cino, Killoran et al. 2013).  Additionally, we have completed the backbone 
NMR chemical shift assignment of the 34 kDa Kelch domain of human Keap1 (Cino, 
Killoran et al. 2013).  This affords an effective way to probe the conformational changes  
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Figure 4.1. Mutation sites located in the Kelch domain of Keap1 (PDB: 1U6D (Li, Zhang et al. 2004)). 
(a) Somatic mutations occurring in the binding interface. (b) Mutations found outside the binding interface. 
(c) Mutations in the conserved double glycine repeats 
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induced upon mutating specific residues in the Kelch domain and provides a manner to 
observe regions important for target binding. Our results show that these somatic 
mutations exert differential effects on the structural integrity and target recognition 
properties of Keap1, implying that their molecular links to the cancer pathogenesis can be 
very distinct.      
 Materials and Methods 4.2
4.2.1 Cloning, expression and purification of Keap1-Kelch variants 
Mutant constructs of the Kelch domain were generated using the QuikChange II 
site-directed mutagenesis kit (Stratagene) with the wild-type human Kelch domain in the 
prokaryote expression vector pDEST17 (Life Technologies).  The following are the 
primers used for the mutations: 
G333C-5'-ctacaccgcgggctgctacttccgaca-3';  
G350S-5'-caaccccagtgacagcacctggctccg-3'; 
G364C-5'-aggtgccgcggagctgcctggccggctgcg-3';  
G379D-5'-gtacgccgtgggcgacaggaacaactcgcc-3';  
R413L-5'-atgagcgtgccccttaaccgcatcggg-3'; 
R415G-5'-agcgtgccccgtaacggcatcggggtgg-3'; 
A427V-5'-gatggccacatctatgtcgtcggcggct-3';  
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G430C-5'-atatgccgtcggctgctcccacggctg-3';  
G476R-5'-tgctttatgccgtgaggggctttgacggg-3'.  
Wild-type and mutational variants were expressed and purified following the 
protocols described in (Khan, Cino et al. 2013).  
4.2.2 Neh2 constructs, expression and purification 
The gene fragment of human Neh2 domain of Nrf2 (amino acid residues M1-
G98) and Neh2∆DLG (deletion of residues 1-33 from Neh2) were cloned out from the 
full length Nrf2 (purchased from Invitrogen; NM_006164) and then inserted into the 
Gateway pDEST17 vector.  The Neh2∆ETGE mutant (deletion of 79ETGE82 from Neh2) 
was constructed from the full-length Neh2 fragment using the QuikChange II site-
directed mutagenesis kit (Stratagene).  For each construct, a Tobacco Etch virus (Diaz-
Jullien, Perez-Estevez et al.) cleavage recognition site, ENLYFQG, was inserted between 
the histidine tag and the Neh2 fragment.  All three constructs were transformed into the 
Rosetta 2 (DE3)pLysS (Novagen) strain of Escherichia coli (E. coli) for protein 
expression in M9 media.  Cells were grown at 37°C and protein over-expression was 
induced at an OD600 of 0.6 with 0.5 mM of isopropyl β-D-thiogalactopyranoside (IPTG, 
BioShop).  The cells were allowed to grow overnight at 25°C before harvesting.  The 
Neh2 protein and its variants were purified batch wise by Nickel-Sepharose (GE 
Healthcare) affinity chromatography, followed by his-tag removal using TEV protease at 
25°C for 21 hours.  Uncleaved Neh2 and the his-tagged TEV protease were then removed 
by Nickel-Sepharose affinity chromatography.  The final protein sample was analyzed on 
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SDS-PAGE for purity and dialyzed into 50 mM sodium phosphate buffer, 100 mM NaCl, 
1 mM DTT, pH 7.0 for NMR and ITC experiments.  
4.2.3 Peptides 
The ProTα-ENGE peptide (> 98% purity), APANGNANEENGEQEADNEV, and 
the Neh2-ETGE peptide (> 98% purity), AFFAQLQLDEETGEFL, were ordered from 
GenScript USA Inc.  The Neh2-DLG peptide, IDILWRQDIDLGVSREVFDF, was 
ordered from the Tufts University Core Facility with a purity level above 95%.  The 
lyophilized peptides were dissolved and dialyzed into 50 mM sodium phosphate buffer, 
100 mM NaCl, and 1 mM DTT for ITC and NMR experiments. 
4.2.4 Nuclear magnetic resonance (NMR) experiments 
For the backbone resonance assignment of the Kelch domain of human Keap1, 
NMR experiments were performed at 25 °C on a Bruker Avance 800 MHz (National 
University of Singapore) spectrometer equipped with a cryogenic probe.  A 600 µM 2H-
15N-13C labeled sample of the Kelch domain was used to acquire 1H-15N-HSQC, 
HN(CO)CACB, HNCACB, and 15N-NOESY-HSQC spectra for sequential assignment of 
the protein.  The data was processed with NMRPipe (Delaglio, Grzesiek et al. 1995) and 
analyzed using CARA (http://cara.nmr.ch).  The chemical shifts were deposited in the 
Biological Magnetic Resonance Bank (accession number 19992).  
15N-labeled samples of the Kelch domain were prepared at a 200 µM 
concentration for the ligand-binding NMR experiments.  1H-15N HSQC experiments were 
performed on a Varian INOVA 600 MHz spectrometer with a cryogenic probe (UWO 
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Biomolecular NMR facility) at 25 °C.  Data was analyzed using NMRPipe (Delaglio, 
Grzesiek et al. 1995) and NMRView (Johnson 2004).   
4.2.5 Circular Dichroism (CD) Spectropolarimetry 
Wild-type and Kelch mutant protein solutions (~2.2  mg/mL) were each prepared 
in 50 mM sodium phosphate buffer, 100 mM NaCl, 1 mM DTT, pH 7.0.  Far-UV CD 
spectra were obtained in a 0.1 mm cuvette using a Jasco J-810 spectropolarimeter 
(Easton, MD), at 25 °C for wavelengths ranging from 190-260 nm.  The final curves for 
each sample represent the mean of twenty separate scans. The CD data (θ, in 
millidegrees) were converted to mean residue ellipticity ([θ]) using standard formula and 
the software supplied by the manufacturer.  The programs SELCON3, CDSSTR, and 
CONTIN provided by the DichroWeb were used to deconvolute the CD spectra 
(Whitmore and Wallace 2008). 
4.2.6 Isothermal Titration Calorimetry 
ITC experiments were carried out on a MicroCal™ VP-ITC.  All purified protein 
samples were dialyzed into 50 mM phosphate buffer with 100 mM NaCl and 1 mM DTT 
at pH 7.0.  In typical experiments, wild-type Kelch and mutational variants were prepared 
to a concentration of ~15 μM for the Neh2-ETGE peptide (~150 μM) titrations and ~60 
μM for the ProTα peptide (~800 μM) and Neh2-DLG peptide (~1-1.5 mM) titrations.  
Kelch or its mutational variants were loaded into the 1.42-mL cell, and ligands were 
loaded into the syringe (300 μL).  For the full-length Neh2 and Neh2∆ETGE experiments 
with the wild-type and mutants of Kelch, the Kelch was loaded into the syringe and the 
specified otherwise) starting with initial injection of 3 μL, followed by 59 injections of 
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5 μL, with spacing of 240 seconds to 300 seconds.  For the Neh2∆ETGE construct, 
titrations were performed at 25 °C, 20 °C, 15 °C, 10 °C and 5 °C.  The buffer blank was 
performed under the same conditions and showed negligible heats of binding.  The 
dissociation constant (Kd), stoichiometry of binding (n), binding enthalpy (ΔH), and 
entropy (ΔS) were obtained by fitting the data to a single-site binding model with the data 
analysis software (Origin 7) provided by the manufacturer.  Baselines were subtracted 
from final data using the Origin software.  For the full-length Neh2 experiments, the data 
were fitted either to a two-site binding model (wild-type Kelch, G350S, and A427V) or a 
one-site-binding model (G364C and R415G).  Protein concentrations were confirmed by 
amino acid analysis (Advanced Protein Technology Centre, The Hospital for Sick 
Children, Toronto, ON). 
  Results 4.3
4.3.1 Mutations exert differential effects on the solubility of the Kelch domain of 
Keap1 
The wild-type Kelch domain of human Keap1 was over-expressed in E. coli and 
purified by the procedure described previously (Khan, Cino et al. 2013).  Four of the 
Kelch mutants, G350S, G364C, R415G and A427V, were found to have similar solubility 
as the wild-type and were purified with comparable yields (Figure 4.2a).  The R413L, 
G333C, G379D, G430C and G476R mutants, on the other hand, were found almost 
exclusively in the insoluble fractions under various over-expression conditions tested.  
We selected to purify the G333C, G379D, and the R413L proteins from inclusion bodies 
using 8 M Urea and subjected to refolding.  Severe protein aggregation occurred upon  
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Figure 4.2. Coomassie-stained SDS-PAGE depicting the purification of Kelch 
and its mutational variants.  (a) Insoluble (insol) and soluble (sol) fractions of wild 
type Kelch, G350S, G364C, R415G and A427V mutants. (b) Insoluble (insol) and 
soluble (sol) fractions of G333C, G379D, R413L, G430C and G476R mutants of the 
Kelch domain.  The MW lanes are the molecular weight markers with molecular 
weights labeled on the left.  Arrow is drawn identifying the band corresponding to 
Kelch and its mutational variants. 
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refolding and only a small amount of soluble protein was obtained for the three mutants.  
The signals observed in the 1H-15N HSQC spectra (Figures 4.3a &b) of G333C and 
G379D proteins were broad and poorly dispersed in the proton dimension, suggesting 
that both mutants were aggregated.  While the 1H-15N HSQC spectrum of R413L (Figure 
4.3c) resembles that of a folded protein; however, we were unable to obtain a stable (even 
at 4 ºC) high purity protein sample.  
4.3.2 Effects of mutations on the target recognition of the Kelch domain 
To assess the effects of mutations on the target recognition of the Kelch domain 
of Keap1, we employed ITC to determine the binding affinities of the wild-type Kelch 
domain and the soluble mutants (G350S, G364C, R415G and A427V) to ProTα and the 
Neh2 domain of Nrf2.  Peptides Neh2 proteins were loaded into the cell.  Titrations were 
performed at 25 °C (unless encoding the Neh2-ETGE, Neh2-DLG, and ProTα-ENGE 
Kelch-binding motifs were used in the studies.  Table 4.2 lists the binding parameters of 
the wild-type and mutants of the Kelch domain to the ProTα-ENGE and Neh2-ETGE 
peptides.  Results of duplicate runs are shown in Table 4.3.    
The dissociation constant (Kd) of the wild-type Kelch/ProTα-ENGE and 
Kelch/Neh2-ETGE complexes were determined to be 2.7 ± 0.1 µM and 31 ± 2 nM, 
respectively.  These values are on par with the values of ~2.6 µM and ~20 nM for Kelch 
complex formation with full-length ProTα and with a 16-mer Neh2-ETGE peptide as 
reported in the literature (Lo, Li et al. 2006; Khan, Cino et al. 2013).  The binding 
affinities of the mutants to ProTα and Neh2-ETGE peptides varied.  While the G350S 
mutation has only minor effects on the target binding (3.0 ± 0.1 µM for the ProTα and to  
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Figure 4.3.  1H-15N HSQC NMR spectra of G333C (a), G379D (b), and R413L (c) mutants of the Kelch 
domain. 
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Table 4.2. Thermodynamic parameters for the binding of the Neh2 and ProTα peptides to the Kelch domain of human 
Keap1 at 25 ºC. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*n is the stoichiometry, Ka, and Kd are the association and dissociation constants, respectively.  ΔG = ΔH-TΔS = -RTln Ka, where T is 
the temperature in Kelvin, R is the gas constant. ΔH and ΔS are the enthalpy and entropy changes, respectively. The corresponding 
ITC isotherms are shown in Figure 4.4. Values listed in the table are based on one run, and the data for the duplicate run is provided in 
Table 4.3. ** The binding observed was very weak; therefore, values for n, Ka, Kd,  ΔH, ΔS, and ΔG could not be determined accurately.   
ENGE peptide 
of ProTα 
n* Ka* 
(105 M-1) 
Kd * 
(µM) 
∆H* 
(kcal/mol) 
T∆S* 
(kcal/mol) 
∆G* 
(kcal/mol) 
Wild-type 
Kelch 
1.07 ± 0.004 3.78 ± 0.15 2.65 ± 0.11 -17.1 ± 0.2  -9.50 -7.60 ± 0.02 
G350S 0.92 ± 0.02   3.33 ± 0. 07 3.00 ± 0.06 -18.1 ± 0.6 - 10.58 -7.52 ± 0.01 
G364C 0.98 ± 0.01 0.32 ± 0.02 31.3 ± 2.0 -14.17 ± 0.2 -8.03 -6.14 ± 0.04 
R415G** - - - - - - 
A427V 1.06 ± 0.003 5.25 ± 0.1  1.90 ± 0.04 -22.4 ± 0.1 -14.60 -7.80 ± 0.02 
ETGE peptide 
of Neh2 
n* Ka* 
(107 M-1) 
Kd * 
(nM) 
∆H* 
(kcal/mol) 
T∆S* 
(kcal/mol) 
∆G* 
(kcal/mol) 
Wild-type 
Kelch 
1.03 ± 0.007 3.18 ± 0.23 31.4 ± 2.3 -20.4 ± 0.09 -10.17 -10.23 ± 0.04 
G350S 1.01 ± 0.005 2.65 ± 0.3 37.7 ± 4.3 -18.9 ± 0.17 -8.78 -10.12 ± 0.06 
G364C 1.07 ± 0.03 0.29 ± 0.01 345 ± 12 -11.53 ± 0.4 -2.72 -8.81 ± 0.02 
R415G** - - - - - - 
A427V 1.11 ± 0.002 6.44 ± 0.67 15.5 ± 1.6 -19.6 ± 0.13 -8.95 -10.65 ± 0.06 
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Table 4.3. Thermodynamic parameters for the binding of the Neh2 and ProT α peptides to the human Kelch domain of Keap1 
at 25 °C (duplicate run). 
ENGE peptide 
of ProTα 
n* Ka* 
(105 M-1) 
Kd * 
(µM) 
∆H* 
(kcal/mol) 
  T∆S* 
(kcal/mol) 
∆G* 
(kcal/mol) 
Wild-type 
Kelch 
1.03 ± 0.005 4.01  ± 0.2 2.49 ± 0.12 -17.7 ± 0.12 -10.07 -7.64 ± 0.03  
G350S 0.96 ± 0.003 2.73 ± 0.05 3.66 ± 0.07 -19.2 ± 0.11 -11.79 -7.41 ± 0.01 
G364C 1.06 ± 0.2 0.29 ± 0.01 34.5 ± 1.2 -15.9 ± 0.03 -9.82 -6.08 ± 0.02 
R415G** - - - - - - 
A427V 1.04 ± 0.004 5.24 ± 0.2 1.91 ± 0.07 -22.3 ± 0.15 -14.50 -7.80 ± 0.02 
ETGE peptide 
of Neh2 
n* Ka* 
(107 M-1) 
Kd * 
(nM) 
∆H* 
(kcal/mol) 
  T∆S* 
(kcal/mol) 
∆G* 
(kcal/mol) 
Wild-type 
Kelch 
1.01 ± 0.002 3.43 ± 0.5  29.2 ± 4.4 -21.0 ± 0.18 -10.73 -10.27 ± 0.09 
G350S 1.0 ± 0.003 2.62 ± 0.3 38.2 ± 4.3 -19.2 ± 0.11 -9.09 -10.11 ± 0.06 
G364C 1.08 ± 0.03 0.4 ± 0.02 250 ± 13  -10.63 ± 0.04 -1.63 -9.0 ± 0.03 
R415G** - - - - - - 
A427V 1.05 ± 0.003 4.33 ± 0.5 23.1 ± 2.7 -19.7 ± 0.19 -9.29 -10.41 ± 0.07 
 
 
*n is the stoichiometry, Ka, and Kd are the association and dissociation constants, respectively.  ΔG = ΔH-TΔS = -RTlnKa, where T 
is the temperature in Kelvin, R is the gas constant. ΔH and ΔS are the enthalpy and entropy changes, respectively. Values listed in 
the table are based on one run, and the data for the duplicate run is provided in Table 4.2. ** The binding observed was very weak, 
therefore, accurate values for n, Ka, Kd, ΔH, ΔS, and ΔG could not be calculated.  
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38 ± 4 nM for the Neh2-ETGE peptides), the G364C mutation lowered the binding 
affinity for both Neh2-ETGE and ProTα by >10 fold compared to the wild-type complex 
(31 ± 2 µM for the ProTα and to 345 ± 12 nM for the Neh2-ETGE peptides).  Our ITC 
data show that the interactions of G364C with targets are enthalpically less favorable 
compared to the wild-type interactions.  Replacement of the Gly residue with a Cys may 
restrict the conformational freedom of the neighboring region and/or possibly disrupt the 
wild-type hydrogen bond network.    
The binding affinities of Kelch to both the ProTα and Neh2-ETGE peptides were 
severely impaired by the R415G mutation to an extent that the affinities could not be 
accurately determined by ITC (Figures 4.4d & i).  Intriguingly, in contrast to G350S, 
G364C and R415G, the interactions with ProTα and Neh2–ETGE peptides were 
modestly strengthened with the A427V mutation.  The Kd values are 1.90 ± 0.04 µM and 
16 ± 2 nM, respectively. Interestingly, the A427V-ProTα complex formation was 
enthalpically more favorable, while the entropy change is more negative in comparison 
with the wild-type.   
We have also attempted to measure the binding affinities of a 20-residue Neh2-
DLG peptide (encoding the sequence of I20-F39 of Nrf2) to the wild-type Kelch (Figure 
4.4 k) and the four mutants; however, no binding was detected by ITC at 25°C in any 
case.  Our results suggest that either the interaction between the Kelch domain and the 
Neh2-DLG peptide is very weak or the ∆H of the binding is close to zero. This 
observation is in good agreement with results obtained very recently by Fukutomi et al. 
(Fukutomi, Takagi et al. 2014) showing that the binding of the Kelch domain with a 16- 
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Figure 4.4.  ITC profiles of titrating ProTα-ENGE peptide to wild-type Kelch. (a), G350S (b), 
G364C (c), R415G (d), and A427V (e), respectively; (f-j) show the ITC profiles of titrating Neh2-
ETGE peptide to wild-type Kelch (f), G350S (g),G364C (h), R415G (i), and A427V (j), respectively; 
(k) ITC profile of titrating Neh2-DLG peptide to wild-type Kelch.   
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mer peptide containing the previously defined DLG motif of Nrf2 (I22-V36) (Tong, 
Padmanabhan et al. 2007) was too weak to be detected by the differential scanning 
fluorimetry.  
The Neh2∆ETGE (deletion of 79ETGE82 from full-length Neh2) construct was 
then used to investigate the Kelch-binding of the DLG motif in the context of full-length 
Neh2.  Figures 4.5a-e show the isotherms for the binding of the Neh2∆ETGE protein to 
the Kelch domain at 25 °C, 20 °C, 15 °C, 10 °C and 5 °C, respectively.  From the ITC 
isotherms in Figure 4.5 it is apparent that the complex formation is endothermic at low 
temperatures and as the temperature is increased, the enthalpy change becomes smaller.  
Table 4.4 lists the thermodynamic parameters for the Neh2∆ETGE-Kelch complex at 5 
°C and 10 °C.  With the buffer conditions used in this study, the Ka of the human 
Neh2∆ETGE/Kelch complex was determined to be ~2.8×106 M-1 at 10 oC. The value is 
similar to what was determined for the mouse Neh2∆ETGE/Kelch complex formation at 
25 oC (2.0 ×106 M-1) (Tong, Katoh et al. 2006).  We then estimated the ∆Cp value based 
on the ∆H values at the 5 °C and 10 °C.  Based on the calculated ∆Cp value of -0.47 kcal 
mol-1 K-1, the ∆H at 25 oC was estimated to be ~ -1.2 kcal/mol. This small value of 
enthalpy change explains why binding between the Neh2∆ETGE and the Kelch domain 
could not be observed at 25 oC by ITC.  
4.3.3 Somatic mutations in the Kelch domain affect its interaction with the full-
length Neh2 domain 
To examine how the somatic mutations in the Kelch domain affect its interactions   
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Figure 4.5. ITC profiles of titrating wild-type Kelch to Neh2ΔETGE at 25 oC (a), 20 oC (b), 15 oC (c), 10 oC (d), and 
5 ºC, respectively. 
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Table 4.4. Thermodynamic parameters for the binding of the Kelch domain of 
Keap1 to Neh2ΔETGE at different temperatures. 
 
*n is the stoichiometry, Ka, and Kd are the association and dissociation constants, 
respectively.  ΔG = ΔH – TΔS = -RTlnKa, where T is the temperature in Kelvin, R is the 
gas constant. ΔH and ΔS are the enthalpy and entropy changes, respectively.  
  
Temp (° C) n* Ka* 
(106 M-1) 
Kd * 
(nM) 
∆H* 
(kcal/mol) 
T∆S* 
(kcal/mol) 
∆G* 
(kcal/mol) 
Titration set 1       
5 0.90 ± 0.03 3.03 ± 0.14 330 ± 15 8.13 ± 0.11 16.37 -8.24 ± 0.03 
10 1.02 ± 0.17 2.85 ± 0.13 351 ± 16 5.80 ± 0.06 14.16 -8.36 ± 0.03 
       
Titration set 2       
5 1.10 ± 0.02 3.13 ± 0.18 319 ± 18 8.70 ± 0.15 16.96 -8.26 ± 0.03 
10 0.97 ± 0.02 2.66 ± 0.11 376 ± 16 5.64 ± 0.04 13.96 -8.32 ± 0.02 
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with the DLG and ETGE motifs in the context of full-length Neh2, ITC experiments were 
carried out at 5 °C to determine the binding parameters of the wild-type Kelch and four 
mutational variants with the Neh2 domain (residues 1-98) of Nrf2.  Kelch proteins were 
titrated to the full-length Neh2 and the isotherms were fit to either a two-site or one-site 
binding model.  The results are listed in Table 4.5 (Figures 4.6 a-e) shows the ITC 
isotherms and the results of the duplicate runs are listed in Table 4.6). Similar to what 
was observed for the binding of the Kelch domain to the Neh2-ETGE peptide, both 
R415G and G364C mutations dramatically weakened Kelch’s interaction with the ETGE 
motif of the full-length Neh2. Compared to the wild-type Kelch, which binds to the 
ETGE motif with a Kd of 1.26 ± 0.03 nM, G364C and R415G have binding affinities that 
are 37 and 870 fold lower, respectively. On the other hand, the G350S and A427V 
mutations show no significant impact on the ETGE binding. It is noteworthy that the 
binding affinities of the Neh2-ETGE motif to the wild-type and mutational variants of 
Kelch are tighter when present in the full-length Neh2 protein as opposed to a peptide.  
For instance, the Kelch R145G provided a measurable affinity of ~1.1 µM when titrated 
to full-length Neh2 but could not be accurately determined for the ETGE peptide (Figure 
4.6d).  
As observed for the mouse Kelch-DLG complex (Tong, Katoh et al. 2006), the 
DLG motif in the human Neh2 also binds significantly weaker to the Kelch domain 
compared to the ETGE motif (Kd of 179 nM vs 1.26 nM).  For the mutants, the binding
167 
 
 
Table 4.5. Thermodynamic parameters for the binding of the wild-type and mutational variants of Kelch to the full length 
Neh2 at 5° C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The isotherms of wild-type Kelch, G350S and A427V mutants were fit to a two-site-binding model, assuming that the binding 
affinities of the ETGE motif are higher than that of the DLG motif.  The isotherms of G364C and R415G mutants were fit to a 
one-site-binding model.  n is the stoichiometry, Ka, and Kd are the association and dissociation constants, respectively.  ΔG = ΔH – 
TΔS = -RTlnKa, where T is the temperature in Kelvin, R is the gas constant, ΔH and ΔS are the enthalpy and entropy changes, 
respectively. Values listed in the table are based on one run, the data for the duplicate run is provided in Table 4.6 
 
Protein n Ka 
(107 M-1) 
Kd  
(nM) 
∆H 
(kcal/mol) 
T∆S 
(kcal/mol) 
∆G 
(kcal/mol) 
Kelch ETGE 0.90 ± 
0.00(3) 
79.2 ± 2.07 1.26 ± 0.03  -20.34 ± 0.12 -9.02 -11.32 ± 0.01 
DLG 0.93 ± 0.02 0.56 ± 0.012 179 ± 4  9.04 ± 0.03 17.62 -8.58 ± 0.01 
G350S ETGE 0.91± 0.01 60.9 ± 2.99 1.64 ± 0.08 -20.13 ± 0.07 -8.96 -11.17 ± 0.03 
DLG 0.93 ± 0.01 0.35 ± 0.014 286 ± 11 10.61 ± 0.12 18.93 -8.32 ± 0.02 
G364C ETGE 0.92 ± 0.01 2.15 ± 0.18 46.5 ± 3.9  -15.09 ± 0.06 -5.77 -9.32 ± 0.04 
DLG - - - - - - 
R415G ETGE 1.03 ± 0.01 0.091 ± 0.008 1099 ± 97 -13.35 ± 0.12 -5.77 -7.58 ± 0.05  
DLG - - - - - - 
A427V ETGE 0.91 ± 0.01 79.1 ± 4.9 1.26 ± 0.08 -20.17 ± 0.17 -8.85 -11.32 ± 0.03 
DLG 1.00 ± 0.03 0.56 ± 0.021 179 ± 7 9.44 ± 0.10 18.02 -8.58 ± 0.02 
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Table  4.6. Thermodynamic parameters for the binding of the Kelch and Kelch mutational variants to full length Neh2 at 
5° C (duplicate runs). 
Protein n* Ka* 
(107 M-1) 
Kd * 
(nM) 
∆H* 
(kcal/mol) 
T∆S* 
(kcal/mol) 
∆G* 
(kcal/mol) 
Kelch ETGE 1.06 ± 0.04 73.3 ± 1.84 1.36 ± 0.03  -19.02 ± 0.08 -7.74 -11.28 ± 0.01 
DLG 1.12 ± 0.02 0.46 ± 0.010 217 ± 5 8.46 ± 0.10 16.93 -8.47 ± 0.01 
G350S ETGE 1.07± 0.01 51.8 ± 1.79 1.93 ± 0.07 -19.83 ± 0.13 -8.74 -11.08 ± 0.02 
DLG 1.1 ± 0.03 0.36 ± 0.011 278 ± 8 9.52 ± 0.09 17.86 -8.34 ± 0.02 
G364C ETGE 0.92 ± 0.01 2.34 ± 0.12 42.7 ± 2.2  -15.0 ± 0.12 -5.63 -9.37 ± 0.03 
DLG - - - - - - 
R415G ETGE 1.0 ± 0.01 0.089 ± 0.008 1124 ± 101  -13.40 ± 0.05 -5.83 -7.57 ± 0.05 
DLG - - - - - - 
A427V ETGE 0.91 ± 0.00(3) 68.4 ± 1.95 1.46 ± 0.04 -20.69 ± 0.14 -9.45 -11.24 ± 0.02 
DLG 1.00 ± 0.01 0.53 ± 0.014 189 ± 5 9.52 ± 0.02 18.07 -8.55 ± 0.01 
 
The isotherms of wild-type Kelch, G350S and A427V mutants were fit to a two-site-binding model, assuming that the binding 
affinities of the ETGE motif are higher than that of the DLG motif.  The isotherms of G364C and R415G mutants were fit to a 
one-site-binding model. n is the stoichiometry, Ka, and Kd are the association and dissociation constants, respectively.  ΔG = ΔH – 
TΔS = -RTlnKa, where T is the temperature in Kelvin, R is the gas constant, ΔH and ΔS are the enthalpy and entropy changes, 
respectively.  
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Figure 4.6.  ITC profiles of titrating wild-type Kelch and mutational variants to full length Neh2 5 ºC   
(a) wild-type Kelch (b), G350S (c), G464C (d), R415G (e), and A427V  respectively. 
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affinity of the G350S to the DLG motif decreased by less than two-fold while the A427V 
mutant has the same affinity (Kd of 179 ± 4 nM) as compared to the wild-type.  The 
binding parameters indicate that in the presence of either of these two somatic mutations, 
the Kelch domain should still be able to interact effectively with both the ETGE and 
DLG motifs of Nrf2.  On the other hand, the interactions of the DLG motif with G364C 
and R415G could not be detected by ITC (Figures 4.6 c & d).  
4.3.4 Probing structural changes of Kelch and its mutational variants by CD and 
NMR 
CD and NMR were used to identify the effects of missense mutations on the 
overall folding and local conformation of the Kelch domain.  The CD results revealed 
that the β-sheet secondary structure content, observed in the wild-type Kelch domain, is 
preserved in G364C, G350S, R415G and A427V (Figure 4.7).  The percentages of β-
sheet and disordered regions estimated from the deconvolution CD spectra are almost 
identical to the wild-type protein (Table 4.7), strongly suggesting that these four 
mutations do not have a significant effect on the overall fold of the Kelch domain.  
We then used NMR spectroscopy to investigate the effects of somatic mutations 
on the local structural changes and ligand-binding of the Kelch domain.  To be able to 
monitor the site-specific conformational changes upon mutation and target binding, 
backbone chemical shift assignment of the 34-kDa human Kelch domain was performed.   
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Figure 4.7. CD spectra of Kelch and mutational variants.  The spectra of the 
mutants appears similar to the wild type Kelch domain suggesting no significant 
changes occur in the secondary structure content of the mutational variants of the Kelch 
domain listed.  
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Table 4.7. Deconvulated CD data for the WT Kelch and mutational variants 
 
Protein Helix β-sheet Turn Unordered 
WT-Kelch 0.063 0.432 0.120 0.385 
G350S 0.063 0.433 0.120 0.384 
G364C 0.063 0.432 0.118 0.386 
R415G 0.062 0.415 0.120 0.394 
A427V 0.061 0.436 0.119 0.384 
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1HN, 15N, 13Cα, 13Cβ resonance signals were assigned using the HNCACB, 
HN(CO)CACB, and 15N NOESY- HSQC experiments.  The assigned 1H–15N TROSY–
HSQC spectrum is showed in Figure 4.8.  Although the Kelch amino acid sequence 
contains regions of degeneracy (Figure 4.8), we were able to assign 92 % of the 1HN and 
15N resonances of the non-proline residues, 91.6 % of 13Cα and 90.7 % of 13Cβ of all 
residues.  The chemical shift assignments of the human Kelch domain are comparable to 
the assignments of the Kelch domain of mouse Keap1 that we have completed previously 
(Cino, Killoran et al. 2013).  
To probe the conformational changes of Kelch upon mutations, 1H-15N TROSY-
HSQCs of G364C, R415G, G350S, and A427V were collected and compared to the wild-
type Kelch spectrum (Figures 4.9).  The dispersion of the amide peaks for all four 
mutants is similar to that of the wild-type Kelch.  Further analysis of the chemical shift 
perturbations (Figure 4.10) revealed that A427V displayed the largest amplitude of peak 
shifts followed by G364C, R415G and G350S.  It is noteworthy that large chemical shift 
changes are observed for some residues that are located far from the mutation sites in the 
protein sequence for A427V, G364C and R415G mutants.  For instance, A427 is located 
in the middle of the second β-strand of Blade III.  Mutating of this residue to a valine 
caused peak shifts of a significant number of residues clustered in Blade II (residues 
V360-M409) and Blade III (S410-L457), in particular, S363, G379, E446 and A466 
residues (Figure 4.10c).   The S363 and G379 residues also undergo a substantial change 
in the G364C spectrum (Figure 4.10b).  
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Figure 4.8. Backbone resonance assignments of the Kelch domain of human 
Keap1. (a) 1H-15N HSQC spectrum of 2H/15N/13C labeled Kelch domain of Keap1. 
(b) Amino acid sequence of the Kelch domain, unassigned residues are colored in 
red. Amino acids appearing in grey are residual residues from the affinity tag 
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Figure 4.9. Overlay of the 1H-15N TROSY-HSQC NMR spectra of wild-type Kelch (black) and mutants  
(a) G364C, (b) R415G (c) G350S, and (d) A427V. 
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Figure 4.10. 1HN and 15N chemical shift changes of the Kelch mutants. Residues with traceable assigned 
resonances are colored based on composite 1HN and 15N chemical shift changes (∆δ=[(∆δHN)2+(∆δN/5)2]1/2  in ppm). 
(a) G350S, (b) G364C, (c) A427V and (d) R415G.   
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4.3.5 NMR analysis of the interactions of Kelch with Neh2 and ProTα peptides  
Figures 4.11a-c show the 1H-15N HSQC spectra of the wild-type Kelch domain in 
the presence of 5 molar equivalents of unlabeled Neh2-ETGE, Neh2-DLG and ProTα-
ENGE peptides, respectively.  Quantitative analysis of the Kelch chemical shift 
perturbations revealed large changes in S363, G417, G462, S508, G527, and T576 in the 
ETGE and ProTα bound state (Figures 4.11 a & c).  Some of these residues are directly 
involved in complex formation with targets, whereas the peak shift of others may be due 
to the changes in their local chemical environment (Lo, Li et al. 2006; Padmanabhan, 
Nakamura et al. 2008).  For example, S363 was found to form a hydrogen bond with the 
E46 of ProTα in the complex (Padmanabhan, Nakamura et al. 2008).  Meanwhile, the 
G462 residue does not interact with ProTα directly, rather it forms a intramolecular 
hydrogen bond with R415 which is involved in a salt bridge with E43 of ProTα 
(Padmanabhan, Nakamura et al. 2008).   
The amplitudes and pattern of chemical shift changes of G350S upon binding to 
the Neh2-ETGE and ProTα-ENGE peptides were comparable to those of the wild-type 
(Figure 4.12c, Figure 4.13c, Figures 4.15a&c).  G364C and R415G displayed smaller 
amplitudes of chemical shift changes upon binding to the Neh2-ETGE and ProTα-ENGE 
peptides (Figures 4.12 a&b, Figures 4.13 a&b, Figures 4.15b&d). Despite the difference 
in the amplitudes of changes, the overall chemical shift perturbation pattern is similar to 
the wild-type, suggesting that in the presence of either one of these two mutations, Kelch 
can still bind to the Neh2-ETGE and ProTα-ENGE peptides in similar modes.  This is in 
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agreement with our ITC data showing that both R415G and G364C were able to interact 
with the ETGE motif in the full-length Neh2 but with lower affinities.  
Titration of the Neh2-DLG peptide to the wild-type Kelch domain (Figures 4.11b 
& 4.15e) results in large resonance shifts of R354, D385, H436 and A607.  The H436 
residue was found to interact with the conserved G430 residue. The chemical 
environment of the G430 is influenced by the R415 residue, which takes part in hydrogen 
bonding with the targets (Tong, Padmanabhan et al. 2007).  Similarly, the chemical 
environment of other Kelch residues undergoing large peak shifts are affected by amino 
acids involved in hydrogen bonding with targets.  Figures 4.14a-d show the 1H-15N 
HSQC spectra of G364C, R415G, G350S, and A427V in the absence and presence of 
five molar equivalents of the Neh2-DLG peptides.  For the G350S and A427V mutants, 
while many resonance signals broaden out in the ligand-bound state, both mutants display 
similar chemical shift attenuation patterns as the wild-type Kelch.  Our NMR data is in 
accordance with the ITC data, indicating that both A427V and G350S mutants can bind 
to the Neh2-DLG motif. 
On the other hand, the relatively minor chemical shift changes observed for the 
G364C and R415G upon addition of DLG peptides indicate that the complex formation is 
disrupted by the mutations (Figure 4.15 and Figures 4.14a & b).  In fact, for the G364C, 
we observe no significant peak broadening and only minor resonance perturbations 
across the whole spectrum. The minor shifts observed in the bound state NMR spectra of 
G364C-DLG complex and R415G-DLG complex together with our ITC data suggest that 
the presence of either one of these two somatic mutations in the Kelch domain can 
depress the ability of Keap1 to interact with the DLG motif of Neh2.   
179 
 
 
 
 
 
Figure 4.11. 1H-15N HSQC NMR spectra of the wild-type Kelch domain in the absence (black) and presence of five molar 
equivalents of (a) Neh2-ETGE peptide, (b) Neh2-DLG peptide,  and (c) ProTα peptide.  
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Figure 4.12. Overlay of the 1H-15N HSQC NMR spectra of the (a) G364C, (b) R415G, (c) G350S, and 
(d) A427V Kelch mutations in the absence (black) and presence (orange) of a two molar equivalent 
the Neh2-ETGE peptide. 
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Figure 4.13. Overlay of the 1H-15N HSQC NMR spectra of the (a) G364C, (b) R415G, (c) G350S, and (d) 
A427V Kelch mutations in the absence (black) and presence (orange) of a two molar equivalent of the 
ProTα-ENGE peptide. 
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Figure 4.13. Overlay of the 1H-15N HSQC NMR spectra of the Kelch (a) G364C, (b) R415G, (c) G350S, 
and (d) A427V mutations in the absence (black) and presence (orange) of a five molar equivalent of the 
Neh2-DLG peptide. 
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Figure 4.14. Composite 1HN and 15N chemical shift perturbation (∆δ=[(∆δHN)2+(∆δN/5)2]1/2) analysis of the 
wild type and the four mutants in the presence of two molar equivalents of ProTα peptide. (a, b), two molar 
equivalents of Neh2-ETGE peptide (c, d), and five molar equivalents of Neh2-DLG peptide (e, f). The boundaries 
of the propeller blades are defined based on (Li, Zhang et al. 2004). 
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 DISCUSSION 4.4
In this work, we have characterized the effects of cancer-associated somatic 
mutations on structure and target recognition of Keap1.  Nine mutations identified in lung 
cancer patients or cancer cell lines, were selected based on their structural importance in 
the Kelch domain (Table 4.1).   ITC, CD and NMR techniques were used to quantify the 
binding parameters of these mutational variants with two of the binding targets of Keap1 
and to assess the conformational changes these mutations induce on the Kelch structure.  
Our results indicated that the disease-linked somatic mutations have differential effects 
on the structural integrity and the target recognition of Keap1.  
The G333, G379, G430, G476 and R413 residues are conserved in the Kelch 
domain.  Our protein expression, purification and NMR data (Figures 4.3) suggest that 
mutating these residues can result in the unfolding/misfolding of the Kelch domain.  
Further in vivo experiments are required to verify these findings.  As mentioned earlier, 
the G333, G379, G430 and G476 all play key roles in the folding of the Kelch domain 
(Li, Zhang et al. 2004).  The crystal structure of the human Kelch domain (PDB: 1U6D) 
shows that the backbone torsion angles of these four glycines are generally located in 
disallowed regions. Therefore, mutating these residues to any other amino acid with a β-
carbon side chain may induce severe conformational strain in the structure, causing the 
protein to unfold/misfold.  Previous studies using immunoprecipitation and luciferase 
assays have demonstrated that the G333C, G379D, and G430C mutants are defective in 
repressing Nrf2-mediated transcription of cytoprotective genes (Singh, Misra et al. 2006; 
Ohta, Iijima et al. 2008; Shibata, Kokubu et al. 2008).  In agreement with these findings, 
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our results suggest that reduction in protein stability is the cause of the loss-of-function of 
these mutants.  We speculate that any other mutations occurring in the double glycine 
repeats (e.g. G333S and G524C listed in the COSMIC database) will be detrimental to 
Kelch’s structural integrity (Singh, Misra et al. 2006; Ohta, Iijima et al. 2008; Shibata, 
Kokubu et al. 2008).  
Although the 1H-15N HSQC spectrum of Kelch R413L resembled that of a folded 
protein (Figure 4.3), the mutant is not stable compared to the wild-type Kelch.  R413, 
located in Blade III, is one of the conserved Arg residues found in all six blades of the β-
propeller structure (Li, Zhang et al. 2004).  The side-chain of this residue is involved in 
inter-blade hydrogen bonding with G379, the first residue of the glycine doublet in Blade 
II (Li, Zhang et al. 2004).  It has been suggested that the inter-blade hydrogen bonding 
between these conserved Arg and Gly residues are important for maintaining the Kelch 
structure (Li, Zhang et al. 2004).  Our results demonstrated that a single point mutation in 
the R413 position is sufficient to destabilize the protein, and probably leads to the loss of 
function.  The impacts of mutations of other conserved Arg residues (e.g. R362Q, 
R460G, R460S, R554Q, and R601W listed in COSMIC) on the protein stability remain to 
be elucidated.   
Unlike the G333C, G379D, R413L, G430C, and G476R mutants, G350S, G364C, 
R415G, and A427V have comparable solubility to the wild-type protein.  CD analysis of 
these four mutational variants illustrated that they all possess similar secondary structure 
contents as the wild-type (Figure 4.7).  On the other hand, our ITC results clearly 
demonstrated that, depending on their locations in the protein, these four mutations exert 
differential impacts on the target binding of the Kelch domain.  The G350 residue is 
186 
 
 
located in a loop region at the opposite face of the ligand-binding pocket of the β-
propeller structure, forming a hydrogen bond with the neighboring N346 residue (Li, 
Zhang et al. 2004). Crystal structures of the Kelch domain in complex with the Neh2-
ETGE, Neh2-DLG, and ProTα peptides revealed that this residue was not directly 
involved in the interactions with targets (Lo, Li et al. 2006; Tong, Padmanabhan et al. 
2007; Padmanabhan, Nakamura et al. 2008).  Even though the G350S mutation has been 
identified in non-small-cell lung cancer cell lines (Singh, Misra et al. 2006) and gastric 
cancer tissue (Yoo, Kim et al. 2012), the mutation appears to cause no substantial 
changes to the binding of ProTα or the Neh2 domain of Nrf2: only a 1-2 fold decrease in 
the binding affinity to ProTα, Neh2-ETGE, and Neh2-DLG motifs compared to the wild-
type Kelch were observed.  Our NMR data demonstrate that the G350S mutation does not 
lead to any significant change in the protein structure. Together, our results suggest that 
this particular mutation does not hamper the complex formation of Keap1 with Nrf2 and 
ProTα.  Effects of this mutation on Keap1’s interactions with other targets, however, 
remain to be investigated (Cino, Killoran et al. 2013; Hast, Cloer et al. 2014). 
The Kelch A427V is another cancer-linked mutation (identified in cancer tissue of 
a patient with small cell carcinoma (Ohta, Iijima et al. 2008)) that was observed to 
interact with Nrf2 and ProTα with similar affinities to wild-type Kelch.  In fact, this 
particular Ala to Val substitution resulted in modest increases (~ 2 fold) in the binding 
affinity of Kelch to ProTα-ENGE and Neh2-ETGE peptides (Table 4.2).  Our NMR 
results further confirm that the binding of this mutant to ProTα, Neh2-ETGE and Neh2-
DLG motifs are similar to the wild-type interactions with targets.  Intriguingly, while the 
G350S mutation resulted in subtle chemical shift changes to residues around the mutation 
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site (Figure 4.10a), the A427V mutation, found in the β2 strand of blade III, leads to local 
structural changes in blades II and III, which are reflected by the substantial chemical 
shift changes observed (Figure 4.10c).  However, these local structural changes do not 
impair the binding of Kelch to either Neh2 or ProTα.  Since the Kelch domain of Keap1 
also mediates the interaction with WTX (Camp, James et al. 2012), p62 (Komatsu, 
Kurokawa et al. 2010), PGAM5 (Lo and Hannink 2006), PALB2 (Ma, Cai et al. 2012), 
FAC1 (Strachan, Morgan et al. 2004), IKKβ (Kim, You et al. 2010) and Bcl2 (Niture and 
Jaiswal 2011), characterizing the effect of the A427V mutation on the binding of these 
targets will provide further insight into the links of this particular somatic mutation to the 
associated disease.  It is noteworthy that Hast et al. (Hast, Cloer et al. 2014) recently 
reported that the R470C, D422N, and G423V mutations also increase the binding to Nrf2 
compared to the wild-type Keap1 based on their immunoprecipitation and Western blot 
analysis.  However, the molecular effects of these cancer-associated mutations on the 
structure of Kelch remain unknown. 
Meanwhile, our ITC and NMR results show that both the G364C and R415G 
mutations impair Kelch’s ability to interact with Nrf2 and ProTα, albeit to different 
extents.  The G364C substitution resulted in significantly lower affinity for both Neh2-
ETGE and ProTα peptides (Kd(Neh2-ETGE) = 345 nM and Kd(ProTα) = 31 µM vs 
Kd(Neh2-ETGE) = 31 nM  and Kd(ProTα) = 2.7 µM for the wild-type Kelch).  The 
substantial decrease in affinity for the ETGE motif was also observed in the context of 
full-length Neh2 domain (Kd = 47 nM vs Kd = 1.26 nM for wild-type Kelch).  The crystal 
structure of the human Kelch domain in complex with the ETGE peptide illustrates that 
G364 has ψ/ϕ torsion angles of left-handed helix and is not involved in hydrogen bonding 
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with the target.  However, this Gly residue is located next to S363, which forms hydrogen 
bonds with E82 of the ETGE peptides (Lo, Li et al. 2006; Padmanabhan, Nakamura et al. 
2008).   Replacing the Gly with a Cys residue may restrict the orientation of the S363 
side chain from forming hydrogen bonds with E82.  Additionally, the G364C mutation 
may also affect the intra-molecular hydrogen bonding with the G603 residue (Li, Zhang 
et al. 2004).  It is noteworthy that even though the G364C and R415G mutations 
significantly weaken the interactions of Kelch with ProTα and the ETGE motif of Neh2, 
low binding affinities with these two targets could still be measured.  On the other hand, 
no interaction between the DLG motif and these two mutants could be detected by ITC. 
The R415 residue of Kelch is directly involved in the binding with targets (Lo, Li 
et al. 2006; Padmanabhan, Nakamura et al. 2008; Komatsu, Kurokawa et al. 2010).  In 
the mouse Keap1-ProTα peptide complex, R415 is involved in electrostatic interactions 
with the E43 residue of ProTα (Padmanabhan, Nakamura et al. 2008).  This Arg residue 
also forms salt bridges with the E79 residue in the binding interface with the Neh2-ETGE 
peptide (Lo, Li et al. 2006).  As such, it is not a surprise that replacing this critical Arg 
residue in the positively charged pocket with a non-polar Gly can significantly weaken 
the interactions of the Kelch domain with its targets, and this was observed in our ITC 
and NMR binding studies with ProTα and Neh2.  In agreement with this, a study by 
Tong et al (Tong, Katoh et al. 2006), which replaced R415 with a Lys also attenuated the 
binding of Kelch to the ETGE motif of Neh2 domain.  Similarly, Lo et al (Lo, Li et al. 
2006) detected no Nrf2 repressive activity for the R415A mutant.  We speculate that 
mutations of other residues that are in direct contact with the ETGE and DLG motifs of 
Neh2 (e.g. Y334H, R483C, S555C, and Y572C) will ultimately impair the interaction of 
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Keap1 with Nrf2.  Further in vivo and in vitro experiments will allow correlating the 
molecular effects of different categories of mutations with their impacts on the Nrf2-
repression function systematically. 
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Chapter 5 
 Summary 5
  Introduction 5.1
The last decade of structural studies led to the discovery of proteins that lack a 
stable tertiary structure yet are part of vital biological functions.  These proteins, now 
widely referred to as, intrinsically disordered proteins (IDPs), have altered the long 
believed protein-function paradigm, which hypothesized that cellular processes were only 
performed by proteins with definite static structure.  Nevertheless, it has been established 
that over one third of eukaryotic proteins have intrinsically disordered regions that are 
thirty residues or longer in length (Ward, Sodhi et al. 2004).  Furthermore, with the 
advances in experimental technology, conformational flexibility of folded proteins has 
also been brought into light (Uversky 2013).  Structural studies of IDPs have also 
enhanced our understanding of their conformational plasticity.  It has been noted that 
IDPs do not exist as true random coils as the name suggests (Uversky 2013).  Rather 
these proteins contain residual structure that is significant to executing biological activity.   
The new model defining the structure of functional proteins can be viewed as a 
continuous spectrum of differently disordered conformations extending from fully 
ordered to completely structure-less proteins (Uversky 2013).   
The lack of structure provides several functional advantages to IDPs compared to 
ordered proteins and domains.  Some of these advantages include the existence of a large 
interaction surface area, the presence of short linear motifs as well as structural motifs 
provide IDPs with the advantage to scaffold and interact with numerous targets, and the 
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diverse post-translational modifications of IDPs facilitate regulation of their function and 
stability with in a cell (Gunasekaran, Tsai et al. 2003; Diella, Haslam et al. 2008; 
Fuxreiter, Tompa et al. 2008; Galea, Wang et al. 2008).  IDPs interact with other proteins 
with high specificity and low affinity.  Such binding mechanism allows fast association 
with targets and rapid dissociation after the signaling process is completed (Wright and 
Dyson 2009).   Intriguingly, proteins that participate in binding, regulatory, and signaling 
functions such as transcription factors are enriched in intrinsically disordered regions, for 
the reason that the structural and biochemical properties of IDPs are well suited to carry 
out these tasks (Fuxreiter, Tompa et al. 2008; Galea, Wang et al. 2008; Wright and Dyson 
2009) .  
Because IDPs play key roles in cellular processes, many diseases are a result of 
abnormal functions of IDPs, reviewed in (Uversky, Oldfield et al. 2008).  Therefore, 
elucidating the means by which these proteins function is central to the design of 
therapeutic agents.  In this thesis, the role of two intrinsically disordered proteins, Nrf2, a 
bZIP transcription factor, and Prothymosin α (ProTα), a protein with wide range of 
cellular functions, has been investigated in the oxidative stress response.   The oxidative 
stress response regulated by Nrf2 is one of the cells’ approach by which it eliminates 
electrophilic and oxidative toxins.  
 Previous Work 5.2
The Nrf2 (nuclear factor erythroid 2-related factor 2) mediated signaling pathway 
is an adaptive response to environmental and endogenous stress stimuli whose goal is to 
retain a normal cellular environment by eliminating the stress factors (Itoh, Chiba et al. 
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1997).  The Kelch-like ECH-associated protein 1 (Keap1) plays a central role in the 
regulation of Nrf2.  The Keap1 protein was discovered as an inhibitor of the Nrf2 protein 
by the yeast two hybrid screening (Itoh, Wakabayashi et al. 1999).  Keap1 anchors the 
Nrf2 in the cytoplasmic environment of the cell by binding to the N-terminal Neh2 
domain of Nrf2.  During normal cellular conditions, a single Nrf2 protein is bound to a 
Keap1 homo dimer. The Keap1 is a Nrf2 linker protein for interaction with the Cul3-
based E2-ubiquitin ligase complex, leading to continuous ubiquitination of Nrf2 followed 
by proteosomal degradation (Kobayashi, Kang et al. 2004).  High levels of Nrf2 and Nrf2 
regulated genes have been observed in Keap1 disrupted mice, thus, demonstrating the 
important role Keap1 plays in the negative regulation of Nrf2 (Wakabayashi, Itoh et al. 
2003).  
The structure of the mouse and human Kelch domain has been crystalized in the 
free and bound state with the ETGE motif of the Neh2 domain (Li, Zhang et al. 2004; Lo, 
Li et al. 2006; Padmanabhan, Tong et al. 2006).  Crystal structures of the mouse Kelch 
domain with the mouse ProTα peptide and DLG-Neh2 peptide are also reported in 
literature (Tong, Padmanabhan et al. 2007; Padmanabhan, Nakamura et al. 2008).  It has 
been determined that the immobilization of the Nrf2 by Keap1 occurs in a sequential 
manner where the high affinity site, ETGE motif, binds first, followed by the docking of 
the DLG motif onto a second Kelch domain of the homo dimer Keap1 protein (Tong, 
Kobayashi et al. 2006).   The Keap1-ProTα complex has been shown to shipped into the 
nucleus, where, ProTα dissociates and Nrf2 degradation is initiated again to reestablish 
homeostatic conditions (Niture and Jaiswal 2009).    
197 
 
 
Structural analysis of the ProTα and Nrf2 to the Keap1 protein have also been 
performed using molecular dynamic studies (Cino, Wong-ekkabut et al. 2011).   It has 
been proposed that the binding of ProTα and the Neh2 domain to the Keap1 protein 
occurs via preformed bound-state-like β-turns, and that the residues outside of the motifs 
may also contribute to the stability of the structural elements (Cino, Wong-ekkabut et al. 
2011).  Preformed structural elements of other Kelch binding targets, PGAM5 (Lo and 
Hannink 2006), p62 (Komatsu, Kurokawa et al. 2010), WTX (Camp, James et al. 2012), 
FAC1 (Strachan, Morgan et al. 2004), PALB2 (Ma, Cai et al. 2012), and IKKβ (Kim, 
You et al. 2010) have also been examined and it has been suggested that their binding 
affinity to the Keap1 protein is dependent on the extent of preformed bound-state like 
conformation in the free structure (Cino, Killoran et al. 2013).   
Mutations in Nrf2 and Keap1 in human cancers have been also reported in 
literature (Shibata, Kokubu et al. 2008; Hast, Cloer et al. 2014).  Such mutations have 
been linked with constitutive expression of pro-survival enzymes in tumors, thus 
displaying resistance to chemotherapy and providing advantageous growth to tumor cells 
(Padmanabhan, Tong et al. 2006).   Cancer therapy of patients with mutations in Keap1 
and Nrf2 have shown poorer prognosis than cancer patients lacking mutations in the two 
proteins (Shibata, Kokubu et al. 2008).  Effects of many of these somatic mutations on 
Keap1’s ability to repress Nrf2 activity have been established.  For example, 
Padmanabhan, et al. have demonstrated in cell studies that the G430C and G364C 
mutations are unable to suppress Nrf2 mediated transcription.  Hast et al recently 
examined the R320 mutation in the Kelch domain of Keap1 and showed that it has a 
stronger affinity for Keap1 targets, Nrf2 and Cul3 (Hast, Cloer et al. 2014) and has 
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proposed the presence of “super binding” mutations.  Moreover, a Keap1 protein with the 
R320 mutation was able to ubiquitinate Nrf2 but could not promote its degradation (Hast, 
Cloer et al. 2014).    
 Studies of the Keap1 and Nrf2 mutations have made it evident that inhibition of 
Nrf2 can repress tumor cell proliferation and enhance apoptosis (Shibata, Kokubu et al. 
2008).  It has been also demonstrated experimentally that introduction of Nrf2-specific 
small interfering RNA into cancer cells showed decreased in the growth rate of the cells, 
making it a great drug target (Shibata, Kokubu et al. 2008). 
 Fuzzy complex between the flexible ProTα and Kelch domain of human 5.3
Keap1 
The protein structure-function paradigm was believed to be still applicable to 
disordered proteins in the target bound state, as it was observed that IDPs adopt a 
structure upon complex formation.  This view was challenged by the discovery of IDPs 
that retained their flexible nature in the ligand bound states. Investigation of the ProTα 
complex formation with the Kelch domain of the human Keap1 in chapter 2 revealed that 
the ProTα-Kelch complex falls into this “fuzzy” category of disordered proteins. A 
narrow proton dimension in the HSQC spectra is hallmark of disordered proteins.  The 
1H-15N HSQC of ProTα in the free and bound states exhibited a narrow proton dimension 
signifying that the protein remained disordered upon complex formation. The R1, R2, and 
steady state NOE parameters obtained through the spin relaxation experiments further 
strengthened the presence of a flexible state of ProTα in the ligand bound state.  The R1 
values averaged to be 2.47 s-1 in the bound state, larger than what is observed for a 
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protein with the same size as ProTα.  Such high R1 values result from internal motions on 
a picosecond-to-nanosecond timescale. Significant increases in the R2 values for the 
binding region of the ProTα were observed in the bound state, however, these high values 
in the bound state are still smaller than what is expected for a 46-kDa folded protein.  
Additionally, the small NOE and amide exchange values reinforced that ProTα falls into 
the fuzzy complex category upon complex formation with the Kelch domain of the 
human Keap1.   
 Binding interface of human ProTα with the Kelch domain of human Keap1 5.4
Karapetian et al. were the first to identify the binding interface of the mouse 
ProTα to the Kelch domain (Karapetian, Evstafieva et al. 2005).  A static image of the 
bound ProTα to the Kelch domain of the mouse Keap1 protein is also available (PDB id: 
2Z32).  In this crystal structure, a 16 residue ProTα peptide containing the ENGE motif is 
bound to the Kelch propeller structure (Padmanabhan, Nakamura et al. 2008).  In chapter 
2 of this work, binding region of the human ProTα to the Kelch domain of Keap1 is 
further investigated.  NMR, peptide array, and ITC experimental work added to our 
understanding of the Keap1 interaction with the ProTα protein.   The results indicated 
that the region in human ProTα, which binds to the bottom face of the Kelch domain 
involves more critical residues than previously probed in the mouse ProTα (Karapetian, 
Evstafieva et al. 2005).  The peptide array clearly demonstrated that mutations in the 
38NANEENGE45 region were damaging to the binding of the Kelch. Mutations of the 
E51, which had been previously shown to be important for the interaction with the Kelch 
domain, appeared to have no effect on the binding to target (Karapetian, Evstafieva et al. 
2005). Thermodynamic parameters of mutational variants of ProTα and chemical shift 
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perturbations in the ProTα HSQC spectrum upon Kelch binding also confirmed that 
flanking residues surrounding the ENGE motif are essential for ProTα-Kelch complex 
formation.  
Another important point experimental work presented in chapter 2 demonstrated 
is that although peptides are able to mimic binding motifs of proteins, their mechanism of 
association with targets can vary from the full length protein.  The binding enthalpy and 
entropy of the ProTα peptide differed from that of the full length protein upon forming a 
complex with Kelch.  MD simulation studies have revealed that the ProTα peptide has a 
greater loss of enthalpy due to the folding from a structure-less state to the bound-state β-
hairpin like structure (Cino, Wong-ekkabut et al. 2011). Additionally, because the peptide 
has a lower propensity than the full-length ProTα protein in forming the bound-state β-
hairpin like structure, the entropy loss associated with forming the bound state structure 
will be higher for the peptide as observed in this work (Cino, Wong-ekkabut et al. 2011). 
Thus it is important where possible to study ligand binding in full-length proteins as 
understanding the mechanism of interaction in full-length protein may aid in the proper 
design of drug agents.  
  The Neh2 domain of human Nrf2 5.5
The purification of the Neh2 domain of the Nrf2 has been discovered to be 
challenging as demonstrated for the mouse system (Tong, Yamamoto et al. 2008).  In this 
work, a new protocol for the purification of the human Neh2 domain of Nrf2 is 
established, which yields high quantity of pure protein allowing studying the role of the 
full-length Neh2 domain in the oxidative stress response.  The amide backbone resonance 
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assignment of the human Neh2 domain has laid the foundation for future ligand binding 
work with the Kelch domain or other binding targets that interact with the Neh2 domain, 
such as the p21 protein (Chen, Sun et al. 2009).   
Structural analysis of the Neh2 domain of human Nrf2 revealed that Neh2 has 
greater residual structure, compare to the flexible ProTα.  The central region of the 
human Neh2 domain is helical in nature and the C-terminal end has a β-turn propensity as 
observed for the mouse Neh2 (Tong, Katoh et al. 2006).  Based on the relaxation data, the 
N-terminal region of the Neh2 domain, residues 14 to 31, appears to possess residual 
structure, NOE values increase up to 0.4 indicating that the region is less flexible.  
Resonances of residues involved in complex formation undergo line broadening and 
cannot be observed even when temperature is increased by 5 ºC.   Nevertheless, the 1H-
15N HSQC spectra of the Neh2ΔDLG and Neh2ΔETGE in the Kelch bound state reveal a 
narrow proton dimension of the Neh2 protein.   Additionally, relaxation data of the Neh2-
Kelch complex is not available, yet, based on the 1H-15N HSQC spectra one can conclude 
that the Neh2 regions not involved in forming binding interface predominantly remain 
unchanged in structure.    
 Interaction between the Neh2 and Kelch domain 5.6
NMR and ITC studies of the complex formation between the Neh2 domain of 
mouse Nrf2 and the Kelch domain of mouse Keap1 demonstrated that the process is 
exothermic for both the DLG and ETGE motifs with a ΔH of  ~ -7 for the DLG-Kelch 
complex formation (Tong, Katoh et al. 2006).  Upon titration of the Neh2 to the Kelch 
domain of human Keap1 at room temperature and vice versa, a two site binding profile, 
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as seen in the mouse system was not observed for  the binding of the Neh2 and Kelch 
domains  (Tong, Katoh et al. 2006). Lowering the temperature revealed that the ΔH 
associated with the DLG-Kelch binding is close to -1.2 kcal/mol providing an 
explanation why a two site model could not be detected at room temperature.   ITC 
experiments performed at 5 ºC exhibit a two site binding for the Kelch-Neh2 complex 
using human derived constructs.  These results suggest that the mechanism of binding of 
the DLG motif of Neh2 to the Kelch domain of the human Keap1 maybe different than 
what is observed in the mouse system.   
 Order in disorder and its implication in target binding 5.7
The Neh2 domain of Nrf2 and ProTα are great examples for studying target 
binding of IDPs.  In this work, the binding of ProTα and Nrf2 with the Kelch domain has 
delineated the underlying mechanism of their differential binding to the Kelch domain.   
As stated earlier, IDPs are not true random coils (Uversky 2013).  Some IDPS have 
secondary structures and preformed structural elements that have important implications 
in target binding.  Previous studies of the Neh2 domain and ProTα combined with this 
work emphasize that ProTα and the Neh2 domain behave differently structurally in the 
free and target bound states with Kelch (Padmanabhan, Tong et al. 2006; Tong, 
Padmanabhan et al. 2007; Padmanabhan, Nakamura et al. 2008; Cino, Wong-ekkabut et 
al. 2011).  It has been demonstrated that the full length ProTα is highly flexible and less 
compact compare to the Neh2 domain of Nrf2 in the free and target bound.  A high 
entropic penalty is associated with attaining the β-turn structure required for 
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ProTα interaction with the Kelch domain resulting in a higher dissociation constant 
compare to the Neh2-ETGE –Kelch complex (Khan  2013).   
The data presented in chapter 3 shows presence of secondary structure content 
and a compact Neh2 domain of the Nrf2 protein compare to ProTα.   The Neh2 -ETGE 
motif has preformed β-turn like structure in the free state which allows less energy spent 
on adopting a bound state like structure and thus  binds tighter to the Kelch domain 
(Cino, Wong-ekkabut et al. 2011).   Additionally, the SSP scores of the N-terminal region 
of the Neh2 domain in chapter 3 displays an α-helical propensity (Figure 5.1a).  Recently, 
Fukutomi et al, showed that the Neh2-DLG motif under goes a disorder to order 
transition by adopting a stable helix in the target bound state (Fukutomi, Takagi et al. 
2014).    
These differences in the presence of preformed structural elements and the overall 
compactness between ProTα and the Neh2 domain of Nrf2 have important implication in 
their differential binding affinity to the Kelch domain of human Keap1.  A detail list of 
differences that contribute to the binding affinity of these two disordered proteins to the 
Kelch domain is presented in table 5.1.  
 Somatic mutations in the Kelch domain and its impact on target recognition 5.8
The G364C and G430C were amongst the first somatic mutations, isolated from 
lung cancer tissue of a patient and lung cancer-derived cell lines, respectively, exposed in 
the Kelch domain of Keap1 (Padmanabhan, Tong et al. 2006).  Luciferase assays of the 
G430C and G364C had revealed that in the presence of these mutations, Keap1 could not  
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Table 5.1.  A table listing structural differences between Neh2 and ProTα.  The presence of 
preformed structural elements allows Neh2 to form a tighter complex with the Kelch domain of 
Keap1 compare to ProTα.  
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perform its Nrf2 repression role, leading to constitutive Nrf2 mediated enzyme 
expression. This continuous presence of cytoprotective enzymes aided tumor cell 
proliferation (Padmanabhan, Tong et al. 2006).  Since the initial discovery of these 
mutations, numerous other somatic alterations within the Keap1 protein have been 
revealed.   In this thesis, nine somatic mutations, in the Kelch domain of human Keap1, 
discovered either in patient tissues or cancer cell lines, were created and their impact on 
Kelch structural integrity and Kelch target recognition was elucidated.  
 The purification procedure applied to obtain pure soluble samples for G333C, 
G379D, G430C, and G476R mutants resulted in aggregation of the protein samples and 
could not be used for ligand binding studies.  These glycine residues, occur as doublets in 
the β-propeller and are found to be critical for the structural integrity of the Kelch domain 
(Li, Zhang et al. 2004), thus, introduction of other amino acids with β-carbon side chain 
will result in misfolding or unfolding of the Kelch domain.  Since ProTα and Nrf2 are the 
weakest and strongest binding partners of the Kelch domain, respectively, (Cino, Killoran 
et al. 2013), we speculate that the Keap1 protein containing mutations within this double 
glycine region of the Kelch domain will also be incapable of interacting with other 
known targets such as p62, PALB2,  (Komatsu, Kurokawa et al. 2010).   
Another mutation that rendered the overall structural stability of the Kelch 
propeller is the R413L mutation.  It is a conserved arginine residue detected in all six 
blades of the Kelch domain and its side chain hydrogen bonds with the conserved G379 
residue. The 1H-15N HSQC obtained from the soluble fraction of this mutant resulted in a 
spectrum that resembled a folded protein but could not be compared to the wild-type 
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spectrum of the Kelch domain. Additionally, the protein sample and purity were 
compromised even at low temperatures.  Based on the experimental evidence presented 
in chapter 4, it can be concluded that a mutation in this conserved Arg residue has an 
impact on the β-propeller structure and is not able to maintain wild-type interactions with 
targets. 
The G350S, G364C, R415G, and A427V mutations were also studied.  It has been 
shown through CD and NMR that the secondary structure content of the wild-type is not 
disrupted in these mutants and these mutations do not undergo aggregation. Binding 
studies with ProTα and Neh2 revealed that the G350S and A427V are able to maintain 
wild-type interactions.  In fact the comparatively stronger binding of the A427V mutant 
to ProTα and Neh2 suggests that it may fall into the “super binder” category as observed 
with some other mutants (Hast, Cloer et al. 2014).  The G364C and R415G mutations that 
occur on the binding interface are unable to interact with the DLG motif of the Neh2 
domain.   
 Conclusion 5.9
The work in this thesis has added valuable information to the understanding of the 
underlying mechanism by which the Kelch domain of the human Keap1 interacts with its 
targets.  A new purification protocol of the Neh2 domain of the human Nrf2 protein has 
opened doors for future studies of the oxidative stress response in the human system.   
Details on the binding affinity of Kelch mutational variants affirm that the double 
glycines  and the conserved Arg residues are critical for the structural integrity of the 
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Kelch domain.   Other mutations studied in this work did not affect the overall stability of 
the β-propeller but did result in differential binding to targets.   
 Future Work 5.10
The data presented in this thesis demonstrate that some mutations occurring 
within the Kelch domain of the Keap1 protein in cancer patients or derived from cancer 
cells lines are able to maintain wild-type target binding.  Since poorer prognosis of cancer 
patients with mutations in Keap1 has been noted (Shibata, Kokubu et al. 2008), it will be 
of great interest to analyze the binding of these mutant proteins in in vivo functional 
assays such as luciferase assays and determine whether they are still able to carry out 
Nrf2 degradation in normal and tumor cells.   Additionally, this work provides the NMR 
backbone resonance assignment of the Kelch domain allowing studying the impact of 
these mutations on binding to other targets such as p62 (Komatsu, Kurokawa et al. 2010), 
PGAM5(Lo and Hannink 2006),  PALB2(Ma, Cai et al. 2012), WTX(Camp, James et al. 
2012), IKKβ (Kim, You et al. 2010) or FAC1(Strachan, Morgan et al. 2004).   Such 
studies can shed further light on how these mutations are pro cell survival in tumor cells.  
The binding studies can also aid in understanding the underlying mechanism of 
interaction between Keap1 and other targets.  
Many proteins have been reported in literature that are in competition with Nrf2 
for Keap1 binding and promote the activation of the Nrf2 signaling pathway.   Recently, 
p21Cip1/WAF1 has been shown to compete Keap1 for Nrf2 binding (Chen, Sun et al. 2009).   
Immunoprecipitation assays indicated that the C-terminal region of the p21 binds to the 
DLG motif of the Neh2 domain and thus prevents Nrf2 ubiquitination (Chen, Sun et al. 
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2009).   The C-terminal of the p21is disordered in conformation and adopts a helical 
structure in CaM bound state, and remains extended when interacting with the PCNA 
(Gulbis, Kelman et al. 1996; Yoon, Venkatachalam et al. 2009).  Binding studies of the 
C-terminal region of the p21 to the Neh2 domain can add further to our understanding of 
how disordered proteins interact with other unstructured partners.  Whether the Neh2 
domain or the p21 adopt a structured state upon binding to a structure-less protein is also 
exciting to examine.  Such studies show the structural flexibility of disordered proteins 
upon ligand binding, that is, the disorderd protein can adopt diverse conformations upon 
binding different targets via the same binding site.  This information is crucial to 
understanding the binding mechanism of Nrf2 with its partners and the information is 
crucial to designing drug agents that are used to repress Nrf2 activity in chemotherapy. 
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